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Summary 
Mastitis is the single most important cause of financial loss to the dairy industry 
worldwide with production losses amounting to more than $US 2 billion annually.  In 
Australia, losses as a result of mastitis are estimated to be in excess of $A 150 million 
per year, mainly due to decreased milk output and reduced milk quality payments.  
Although the introduction of mastitis control schemes has been successful in reducing 
the incidence of contagious mastitis caused by Streptococcus agalactiae and 
Staphylococcus aureus in dairy herds, these measures have had little impact on 
environmental pathogens, notably Streptococcus uberis and Escherichia coli. 
 
In this study, approximately 300 individual quarter milk samples from cases 
comprising both clinical and subclinical cases of mastitis and from cows with low 
somatic cell counts in their milk were screened.  In total, 46 isolates were confirmed to 
be S. uberis following biochemical tests including hydrolysis of esculin and hippurate, 
species-specific 16S / 23S rRNA gene PCRs and 16S rRNA gene sequencing 
analysis.  These highly characterized and clinically diverse Australian S. uberis 
isolates were used in all subsequent experiments. 
 
Analyses of the Australian isolates by pulsed-field gel electrophoresis (PFGE) 
demonstrated the occurrence of a genetically diverse population, with the 
predomination of no particular clone or PFGE type.  The possible transmission of 
specific S. uberis PFGE type[s] between individual cows or within quarters of the same 
cow was observed in four instances but such events were uncommon.  In addition, 
consistent with previous epidemiological studies, there was no evidence of the 
occurrence of an identical PFGE type from different herds in the Australian isolates. 
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In contrast to the genetically diverse population identified by PFGE analyses, 
multilocus sequence typing (MLST) analysis of the Australian isolates identified a 
cluster of MLST types associated with clinical and subclinical mastitis and one 
associated with cows with low somatic cell counts in their milk.  Specifically, 
genotypes belonging to the global clonal complex (GCC) sequence type 5s (ST5s) and 
GCC ST143s were highly associated (P < 0.006) with clinical and subclinical mastitis 
and may represent a lineage of virulent isolates, whereas isolates belonging to GCC 
ST86 were associated only with cows with low somatic cell counts in their milk. 
 
In addition, this study has, for the first time, demonstrated the occurrence of identical 
sequence types (ST60 and ST184) between different continents (Australia and United 
Kingdom [UK]) and different countries (Australia and New Zealand).  The 
standardized index of association and the empirical estimation of the rate of 
recombination within the Australian isolates revealed evidence of substantial 
recombination and were consistent with results from earlier MLST-based 
epidemiological studies. 
 
In this study, the highly characterized and clinically diverse Australian S. uberis 
isolates facilitated the investigation of S. uberis virulence factors utilizing a subtractive 
hybridization approach.  Subtractive hybridization, using genomic DNA from an 
isolate from a cow with a low cell count to enrich for sequences from genomic DNA 
from a S. uberis isolate from a case of clinical mastitis, facilitated the identification and 
characterization of two putative virulence-associated sequences (T3-06 and T4-19) 
that were highly associated with clinical / subclinical mastitis and GCC type. 
 
Summary 
 
 
   3 
The subtractive hybridization clone T4-19 encoded a transposase-like gene 
sequence highly homologous to a sequence identified adjacent to the C5a peptidase 
virulence factor gene in S. agalactiae.   Whilst this transposase-like gene alone is 
unlikely to represent a S. uberis virulence factor, the T4-19 transposase-like sequence 
was nevertheless a useful virulence marker exhibiting a high association with both 
disease status and GCC type in the Australian isolates.  In addition to T4-19, three 
additional clones (T1-16; T4-01 and T4-17) related to known bacteriophage and 
transposon sequences were also identified.  The occurrence of such bacteriophage, 
transposon and transposase-like sequences is indicative of their possible role in 
mutation and rearrangement of genomic DNA or horizontal gene transfer and may 
account for the substantial recombination observed in the S. uberis population as 
observed following MLST analysis. 
 
By analogy with known collagen-like virulence factors in S. aureus and 
Streptococcus pyogenes, the putative collagen-like surface protein encoded by the 
S. uberis subtractive hybridization clone T3-06 may represent a new S. uberis 
virulence factor. 
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1 Chapter 1 Literature Review 
1.1 Overview of mastitis 
1.1.1 Mastitis 
Mastitis is an inflammation of mammary gland tissue that is usually due to a 
microbial infection.  Mastitis pathogens enter the teat canal, migrate to the udder, 
multiply and elicit inflammation (Brightling et al., 1998).  Typical signs of inflammation 
include increased vascular permeability, vasodilation, edema, increased blood flow, 
polymorphonuclear neutrophils margination and migration, decreased mammary 
synthetic activity, pain and fever (Harmon, 1994).  Consequent mammary tissue 
damage reduces the number and activity of epithelial cells and consequently 
contributes to decreased milk production.  In addition, mastitis can occur as a result of 
sterile inflammation due to chemical, physical or mechanical disturbance (Harmon, 
1994; Leigh, 1999). 
 
1.1.2 Clinical mastitis 
Mastitis has been classified into three categories; clinical, subclinical and chronic 
mastitis.  Clinical mastitis is characterised by abnormal milk, which contains protein 
aggregates and clots visible to the naked eye, swelling or pain in the udder, 
sometimes accompanied by systemic signs such as elevated rectal temperature, 
lethargy, or anorexia.  In severe cases, it may develop into bacteraemia, septicaemia 
and death of the animal.  In addition, mastitis has been identified as the most 
common cause of death in adult dairy cows (Kossaibati and Esslemont, 1997).  The 
annual mortality rate of mastitis is estimated to be 0.6% of lactating cows (Bradley and 
Green, 2001).  Clinical mastitis is easily diagnosed and treated with antibiotics; 
however the milk from cows with clinical mastitis must be withheld (Harmon, 1994; 
Leigh, 1999). 
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1.1.3 Subclinical mastitis 
Subclinical mastitis is an infection of the mammary gland of the cow, which occurs 
without obvious clinical signs such as abnormal milk, udder swelling or tenderness, or 
systemic signs such as fever (Leigh, 1999).  In addition, subclinical mastitis is 
characterized by an influx of somatic cells, primarily polymorphonuclear neutrophils, 
into the mammary gland.  The migration of more immune cells into the mammary 
gland causes deterioration of the blood-milk barrier and mammary epithelium damage, 
and subsequently leads to death of epithelial cells.  Meanwhile, polymorphonuclear 
neutrophils harm the mammary tissue by releasing reactive oxygen intermediates and 
proteolytic enzymes (Zhao and Lacasse, 2008).  Consequently subclinical mastitis 
leads to reduced milk production, presence of bacteria in milk and changes in milk 
composition such as raised somatic cell counts (SCC) (Harmon, 1994).  
Nevertheless, the signs of subclinical mastitis are subtle and it is difficult for farmers to 
recognise infection (Harmon, 1994).  Diagnosis of subclinical mastitis is generally 
made by somatic cell counting which is a useful measure to increase the awareness 
of subclinical mastitis, and by bacterial cultures to confirm diagnosis (Brightling et al., 
1998; Harmon, 1994). 
 
1.1.4 Acute and chronic mastitis 
Depending on the duration of infections and the onset and appearance of clinical 
signs, mastitis is classified as acute or chronic.  Acute mastitis is severe 
inflammation of the mammary gland usually without any marked systemic reaction.  
Chronic mastitis is an infection of long duration, which may show periodic clinical 
symptoms.  It is almost impossible to eradicate chronic mastitis.  Dry cow treatment 
is used routinely but is only partially effective in controlling chronic mastitis (Brightling 
et al., 1998; Harmon, 1994). 
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1.1.5 Bovine mastitis pathogens 
More than 135 organisms have been associated with clinical mastitis (Watts, 1988).  
Bovine mastitis can be caused by bacteria, mycoplasma, yeasts and algae (Bradley, 
2002), however, the majority of mastitis cases are caused by five organisms; 
S. aureus, S. agalactiae, E. coli, S. uberis and Streptococcus dysgalactiae (Leigh, 
1999).  Bacterial species causing mastitis are classified into contagious or 
environmental pathogens.  Pathogens typically transmitted from cow-to-cow at 
milking are classified as contagious pathogens.  They are able to survive within the 
host, in particular within the mammary gland and are associated with clinical or 
subclinical infections, typically increasing the SCC in milk from the infected quarter 
(Brightling et al., 1998). 
 
S. aureus and S. agalactiae are known as major causes of contagious bovine 
mastitis.  S. aureus causes clinical and subclinical mastitis and often causes chronic 
infection which is rarely cured and causes sporadic clinical phases (Brouillette and 
Malouin, 2005; Daley et al., 1991).  The virulence of S. aureus depends on its ability 
to adhere to mammary tissue and to fibronectin via the fibronectin-binding protein, 
and its ability to disseminate in mammary gland (Brouillette and Malouin, 2005; 
Schwarz-Linek et al., 2006).  In addition, S. aureus expresses antiphagocytic factors 
in addition to toxins α, β, γ, and enterotoxins in milk (Sutra and Poutrel, 1994). 
 
While S. agalactiae causes neonatal septicemia in humans, in dairy cattle it causes 
clinical and subclinical mastitis that can develop into chronic infection lasting several 
months (Brightling et al., 1998).  During the course of S. agalactiae infection, 
adherence and invasion of epithelial cells is facilitated by a fibrinogen receptor FbsA 
(Schubert et al., 2004).  In addition, capsule expression in S. agalactiae could be an 
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important virulence factor in bovine mastitis as suggested in a previous study which 
demonstrated that adhesion of S. agalactiae to epithelial cells was directly 
proportional to the degree of encapsulation (Martinez et al., 2000).  S. agalactiae can 
only survive for a very short time in the environment and is an obligate intramammary 
pathogen.  As a result the bovine udder, in particular a chronically infected udder, is 
recognized as the most likely reservoir (Keefe, 1997).  As S. agalactiae is 
susceptible to penicillin therapy, it can therefore be readily eliminated from an infected 
udder and herds can be maintained free of infection (Keefe, 1997). 
 
In contrast, environmental pathogens are generally regarded as opportunistic 
pathogens of the mammary gland since most infections appear to be caused by 
different strains, and it is believed that such pathogens are not transmitted between 
cows.  Their reservoirs are believed to be the cow’s environment including their 
faeces (Brightling et al., 1998; Harmon, 1994).  Such environmental pathogens 
include the coliforms, environmental streptococci and enterococci.  The coliforms 
include E. coli, Klebsiella spp., Enterobacter spp., and Citrobacter species with 
S. dysgalactiae, S. uberis, S. bovis, Enterococcus faecium, and 
Enterococcus faecalis being the most common environmental streptococci and 
enterococci (Brightling et al., 1998; Harmon, 1994). 
 
Approximately 70 to 80% of mastitis cases caused by coliforms develop into clinical 
mastitis compared with only 30 to 50% of environmental streptococcal infections, with 
the proportion varying widely between herds and clinical signs varying with from 
moderate to severe (Harmon, 1994; Milner et al., 1997).  The remaining cases of 
mastitis caused by environmental streptococci are subclinical, and may persist until 
the end of the lactation and even through a dry period (Grommers et al., 1985).  
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Chronic subclinical mastitis due to environmental streptococci may develop into acute 
mastitis, and ineffective treatment often results in continual bacterial shedding and 
extended risk to the herd (Brightling et al., 1998; Harmon, 1994). 
 
Different farm management practices largely influence the spectrum of pathogens 
observed within a herd.  Cows in confined herds had more clinical cases more than 
those in pastoral herds (Washburn et al., 2002).  Specifically, environmental 
pathogens, in particular coliforms E. coli and Klebsiella spp, cause the majority of 
instances of mastitis in confined herds (Compton et al., 2007; Goldberg et al., 1992) 
whereas in pastoral farm systems such as practiced in New Zealand and Australia, 
coliform mastitis is rare but the prevalence of mastitis due to S. uberis is relatively 
common (Compton et al., 2007; McDougall et al., 2004; Phuektes et al., 2001b). 
 
In addition, coagulase negative staphylococci, Corynebacterium bovis, 
Arcanobacterium pyogenes and Nocardia spp. are considered to be minor bovine 
mastitis pathogens.  A number of studies support the proposition that low-grade 
infections of the lactating gland by C. bovis or coagulase-negative staphylococci may 
be protective against secondary infections by more clinically significant pathogens, 
mediated via the minor enhancement of milk leukocyte concentration.  In contrast, 
several other studies have shown that the rate of infection by environmental 
streptococci may be enhanced in quarters where either C. bovis or 
coagulase-negative staphylococci are present (Berry and Hillerton, 2002b).  One 
explanation for these conflicting observations could be that colonization by C. bovis or 
coagulase-negative staphylococci within the teat duct rendered it more susceptible to 
subsequent bacterial infection (Galton et al., 1988). 
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Although Nocardia spp. are uncommon causes of mastitis, these bacteria can be 
introduced into the udder on dairy farms with poor hygiene and management practices 
(Pisoni et al., 2008) or unsanitary infusion practices during dry cow therapy (Leslie et 
al., 1992) resulting in a very severe form of mastitis (Leslie et al., 1992).  For 
example, a recent study reported an outbreak of N. neocaledoniensis in a dairy farm 
in Italy (Pisoni et al., 2008) and an earlier study described an epizootic of bovine 
nocardia mastitis that occurred in Canada in the late 1980s (Manninen et al., 1993).  
The outbreak was caused by a unique clone of N. farcinica that was introduced 
through the use of contaminated dry cow intramammary products (Brown et al., 2007).  
Adequate teat-end preparation and careful dry cow treatment could reduce cases of 
mastitis caused by Nocardia spp. (Leslie et al., 1992), however antibiotic therapy has 
little effect and accordingly infected cows with Nocardia spp. should be removed from 
a herd or culled (Battig et al., 1990). 
 
1.1.6 Somatic cell count 
Somatic cells in cow’s milk have an important role in both mammary gland 
immunity and protection against mastitis.  The main cells present in milk are 
leukocytes, including macrophages and neutrophils.  Mammary gland infection 
usually initiates the secretion of chemokines from macrophages.  These chemokines 
initiate the recruitment of the large number of neutrophils which can engulf and 
destroy pathogens in the infected mammary glands (Sordillo et al., 1997). 
 
Previous studies have demonstrated that the correlation between SCC and mastitis 
was positive and linear suggesting SCC can be used as an alternative method for the 
diagnosis of clinical and subclinical mastitis (Brightling et al., 1998; Green et al., 2004).  
For instance, the uninfected udder generally has SCC levels of <150,000 cells/ml 
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(Lee et al., 1980; Leigh, 1999).  Milk from subclinical mastitis usually 
contains >250,000 cells/ml whereas milk from cows with clinical mastitis usually 
contains in excess of 2,000,000 cells/ml.  In addition, there is an inverse linear 
relationship between SCC of >200,000 cells/ml and milk yield, with a 2.5% decrease 
in yield for each 100,000 cells increase in SCC (Philpot, 1984). 
 
The types of mastitis pathogens can be routinely monitored based on SCC patterns.  
A previous study demonstrated that the pattern of SCC before and after onset of 
clinical mastitis was predictive of the type of pathogen (de Haas et al., 2002).  For 
instance, clinical mastitis by E. coli causes an elevation of SCC, however the SCC 
returns quickly to a low level.  In the case of clinical mastitis caused by S. aureus, the 
SCC is high before the onset of clinical mastitis, and it remains high after the infection 
has subsided.  Clinical mastitis associated with environmental Streptococcus spp., 
S. dysgalactiae, and S. uberis, demonstrated a continuous increase in SCC before an 
occurrence of clinical mastitis, and the level of SCC remains high after onset of clinical 
mastitis (de Haas et al., 2002). 
 
Elevated SCC levels which are not associated with clinical disease may occur for 
up to 20 days, in particular, after calving and in late lactation when milk volume is low.  
In particular, cows producing less than 5 liters per day are likely to have abnormal milk 
composition, including an elevated SCC.  In addition, a study demonstrated that 
stress such as vibration and noise during milking increased SCC levels in cow’s milk 
(Gygax and Nosal, 2006).  Furthermore, it has been demonstrated that SCC can 
vary before and after milking (Olde Riekerink et al., 2007).  For instance, the SCC 
before milking was significantly lower than the SCC after milking in quarters with no 
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intra-mammary infections suggesting that milk samples for SCC should be taken 
immediately before milking for obtaining accurate results (Olde Riekerink et al., 2007). 
 
1.1.7 Bulk tank somatic cell count 
Bulk tank somatic cell count (BTSCC) from the entire milking herd can be used to 
monitor mastitis status, milk quality and production at a herd level (Brightling et al., 
1998).  Often BTSCC is determined several times a month by the milk company.  
Each increase in the BTSCC of 100,000 cells/ml reflects a 10% increase in the 
number of infected cows in the herd; in herds with BTSCC <200,000 cells/ml, a 
sudden increase of BTSCC may indicate the onset of a case of clinical mastitis in the 
herd.  In addition, with increasing BTSCC, the rate of milk production declines and 
the quality of the milk deteriorates (Brightling et al., 1998). 
 
An excellent level of mastitis control is reflected by a BTSCC of <150,000 cells/ml 
and well managed herds can maintain yearly BTSCC averages of <100,000 cells/ml 
(Leigh, 1999).  Dairy famers receive a premium payment from most dairy companies 
in many countries including the UK, the US and Australia for maintaining a level of 
BTSCC <250,000 cells/ml whereas milk with high BTSCC achieve lower rates of 
payment (Brightling et al., 1998).  The introduction of the milk quality payment criteria 
has provided a strong financial incentive for farmers to reduce the prevalence of 
subclinical mastitis in their herds (Guest, 1993).  In addition, milk with 
BTSCC >400,000 cells/ml or milk with obvious physical signs of mastitis are not 
considered fit for human consumption by the European Union (Leigh, 1999). 
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1.2 Mastitis control 
1.2.1 Economic significance of mastitis 
Mastitis is the single most important cause of financial loss to the dairy industry 
worldwide (Beck et al., 1992; Petrovski et al., 2006), with production losses amounting 
to more than $US 2 billion annually (Kossaibati and Esslemont, 1997; Wells et al., 
1998).  The dairy industry in Australia has an annual production of approximately 
10 billion liters, valued at $A 3.3 billion (Dairy Australia, 2006) and is mainly 
concentrated in the Southern states with 65% of milk production originating from the 
state of Victoria.  Production losses in the Australian dairy industry as a result of 
mastitis are in excess of $A 150 million per year (Mein and Smolenaars, 2000). 
 
Dairy farm profitability is directly affected by mastitis.  This is mainly due to 
decreases in milk production by up to 25%, changes in milk composition, reduced milk 
quality and increased BTSCC, all of which reduce the premium bonus from milk 
companies (Brightling et al., 1998).  In addition, dairy farmers suffer losses due to the 
need for increased veterinary intervention, increased labour costs, loss of income due 
to the need to withhold milk during treatment of clinical cases, reduced fertility and the 
premature culling of affected animals (Beck et al., 1992; Bradley, 2002; Esslemont 
and Kossaibati, 2002; Petrovski et al., 2006; Swinkels et al., 2005b).  The 
management and control of clinical / subclinical mastitis and the maintenance a low 
BTSCC are critical to dairy farm profitability (Swinkels et al., 2005a). 
 
1.2.2 Mastitis control 
The introduction of the Five Point Plan that was developed by the National Institute 
for Research in Dairying in the 1960s significantly progressed mastitis control in the 
UK (Bradley, 2002).  The strategy of this program included the adoption of good 
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milking techniques, the correct maintenance of milking equipment, post-milking teat 
disinfection, the use of therapeutic and prophylactic antibiotics, the culling of 
persistently infected animals, in conjunction with on-going monitoring of BTSCC and 
regular herd testing (Esslemont and Kossaibati, 2002). 
 
In the 1940s, the average BTSCC in the UK was 750,000 cells/ml and most cases 
of mastitis were caused by S. agalactiae and S. aureus.  The effect of mastitis 
control was significant during the late 1960s to early 1980s when the average BTSCC 
in the UK fell from over 600,000 cells/ml to 400,000 cells/ml, and subsequently 
declined continuously to 180,000 cells/ml in 1996 (Booth, 1997).  In addition, the 
prevalence of contagious pathogens such as S. aureus and S. agalactiae has been 
reduced markedly during this period (Table  1-1) (Bradley, 2002; King, 1981; Mylrea et 
al., 1977).  It is generally believed that these BTSCC reductions and concomitant 
improvements in milk quality were achieved by the successful implementation of 
mastitis control measures (Esslemont and Kossaibati, 2002). 
 
The Australian mastitis control program, Countdown Downunder, developed 
guidelines for mastitis control and technical notes for dairy farmers (Brightling et al., 
1998).  These guidelines cover periods of calving, lactation and the dry period; they 
included management strategies for reducing environmental exposure to mastitis 
pathogens, preventing mastitis through good udder hygiene, the maintenance of 
milking equipment and on-going BTSCC monitoring.  The aims of the Countdown 
Downunder program are to reduce the BTSCC to <250,000 cells/ml in 90% of 
Australian dairy farms and to reduce BTSCC to <400,000 cells/ml in 100% dairy 
farms.  In 2003, 93.8% of dairy herds in Australia had BTSCC below <400,000 
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cells/ml and 71.3% of dairy herds had BTSCC <250,000 cells/ml (Dairy Australia, 
2003). 
 
1.2.3 The changing prevalence of mastitis pathogens 
Since the 1980s, environmental pathogens such as S. uberis and E. coli have 
emerged as important mastitis causing pathogens in the UK (Table  1-1) (Bradley, 
2002; Bramley, 1984).  A previous study reported that the most prevalent bacteria 
isolated from milk samples (n = 2,257) from clinical mastitis in the UK were S. uberis 
(37%), enterobacteriaceae (23%) and coagulase negative Staphylococcus spp. (10%) 
(Milne et al., 2002).  Another study carried out in England and Wales reported that 
S. uberis and E. coli were isolated from 23·5 % and 19·8% of clinical mastitis cases 
respectively (Bradley et al., 2007).  Furthermore, previous studies conducted in the 
US, Canada and the Netherlands have reported that 14 to 26% of clinical mastitis 
cases were caused by S. uberis (Jayarao et al., 1999; Khan et al., 2003).  In 
Australia, a high incidence of clinical mastitis caused by S. uberis (22.7% of cases) 
has been reported (Watson et al., 1996). 
 
Several authors have suggested that the niche vacated by contagious mastitis 
pathogens has been filled by environmental pathogens, resulting in an increased 
prevalence of intramammary infections (Hogan and Smith, 1997; Jayarao et al., 1999; 
Rambeaud et al., 2004).  Such changes in the prevalence of mastitis pathogens 
suggest that the introduction of mastitis control programs have had little influence on 
the incidence of environmental mastitis pathogens, in particular S. uberis which has 
emerged as a major mastitis pathogen worldwide (King, 1981; Mylrea et al., 1977). 
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Table  1-1. Incidence and aetiology of clinical mastitis in dairy herds in the UK 
(Quarter cases/100 cows/year) (Bradley, 2002) 
 
Pathogens 1967 1982 1998 
S. aureus 67 (43.8%) 7 (17.5%) 2.2 (5.3%) 
S. agalactiae 6 (4%) 1 (2.5%) - 
S. dysgalactiae 16 (10.5%) 4 (10%) 2.0 (4.8%) 
S. uberis 7 (4.6%) 9 (22.5%) 5.3 (12.7%) 
E. coli 7 (4.6%) 10 (25%) 14.4 (34.6%) 
Others 50 (32.7%) 9 (22.5%) 17.7 (42.6%) 
Total 153 (100%) 40 (100%) 41.6 (100%) 
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1.2.4 Characteristics of S. uberis 
S. uberis is a Gram positive coccus that is catalase negative, and hydrolyses 
hippurate and esculin (Khan et al., 2003; Phuektes et al., 2001b).  S. uberis is 
serologically heterogeneous (Bramley, 1984; Khan et al., 2003) and more than 50% of 
strains are non-groupable (Khan et al., 2003; Roguinsky, 1971). 
 
While S. uberis can be isolated from sheep, goats, horses, pigs, dogs, buffaloes, 
foxes and occasionally from humans, it is mainly isolated from cows’ milk and various 
parts of body including the mammary gland and also from the environment including 
soil, water and straw bedding (Bramley, 1984; Leigh, 1999; Zadoks et al., 2005b).  In 
particular, straw bedding and faeces are important sources of S. uberis especially in 
cold climates (Bramley, 1982).  Ninety percent of soil samples from herd lying, 
gathering and traffic areas contained S. uberis whereas none of the soil samples from 
non-herd environments yielded S. uberis (Zadoks et al., 2005b).  These results 
suggest that S. uberis is highly associated with the environment could be a reservoir 
of S. uberis (Wang et al., 1999; Zadoks et al., 2003; Zadoks et al., 2005b). 
 
Clinical mastitis caused by S. uberis is generally mild in lactating and non-lactating 
cattle (Schalm et al., 1971), however some cases can be severe and associated with 
pyrexia (Bramley, 1984).  Mammary quarter infection by S. uberis can be persistent 
and chronic resulting in elevated SCC over several weeks (Schalm et al., 1971; Wang 
et al., 1999). 
 
The incidence of S. uberis mastitis is higher during early lactation and at the end of 
lactation (McDougall et al., 2004; Williamson et al., 1995) and also common in the dry 
period just before calving.  Approximately 20% of mastitis cases at calving were 
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caused by S. uberis (Bramley, 1984), and over 50% of quarters that were infected 
with S. uberis during the dry period subsequently developed clinical mastitis (Bradley, 
2002; Bramley, 1984; McDonald and Anderson, 1981). 
 
1.2.5 Prevention of environmental streptococcal mastitis 
In addition to mastitis control programs, limiting exposure to the environmental 
pathogens and the management of the cow’s environment are essential for preventing 
environmental streptococcal mastitis.  Specifically, lying and bedding areas should 
be clean and dry during lactation (Brown et al., 2000).  Bacterial shedding, especially 
in faeces, provides the most important source of environmental contamination which 
can be managed by appropriate treatments including hygienic milking practices.  
These straightforward measures can lead to a lower prevalence of mastitis caused by 
the environmental bacteria (Berry and Hillerton, 2002b; Galton et al., 1988; Hillerton 
and Berry, 2003). 
 
The prophylactic use of antibiotics during dry cow treatment is highly effective in 
eliminating these pathogens and preventing new intramammary infections during the 
dry period and subsequently reduces clinical mastitis in the next lactation (Berry and 
Hillerton, 2002b; Brightling et al., 1998; Green et al., 2005; Hillerton and Berry, 2003; 
King, 1981).  The most successful antibiotics in managing mastitis have been the 
penicillins.  While some pathogens can acquire multi-antibiotic resistance, the 
resistance of Streptococcus spp. to penicillin G has been shown to have changed little 
for last 40 years (Rossitto et al., 2002).  In addition, as dry cow treatment is not an 
option for organic milk producers, an alternative for antibiotic prophylaxis is required.  
An internal teat sealant of bismuth subnitrate applied at dry-off has been shown to be 
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especially effective in preventing mastitis by S. uberis during the dry period (Berry and 
Hillerton, 2002a; Hillerton and Berry, 2003). 
 
1.2.6 Vaccination 
The use of vaccination to control mastitis in dairy cattle is common.  Several 
mastitis vaccines are commercially available for immunization against S. aureus and 
E. coli.  One vaccine for S. aureus, Somato-Staph®, contains the somatic antigens of 
phage types I, II, III, IV and miscellaneous groups of S. aureus, however this vaccine 
has limited ability to prevent new infections (Nickerson, 1999; Yancey, 1993). 
 
There are three coliform mastitis vaccines available on the market: J-5 Bacterin 
contains coliform bacterin; JVac® contains a bacterin-toxoid mixture; and 
Endovac-Bovi® contains the bacterin-toxoid generated from a mutant strain of 
Salmonella typhimurium.  All coliform mastitis vaccines contain formulations of Gram 
negative core region of lipopolysaccharide antigens to elicit non-specific immunity 
directed against Gram negative mastitis pathogens (Hogan et al., 1992; Hogan et al., 
1995; Yancey, 1993).  Since the efficacy of these vaccines has been demonstrated 
both experimentally and in field trials in commercial dairy herds (Hogan et al., 1992; 
Hogan et al., 1995), their use against Gram negative bacterial mastitis has become 
standard practice on many dairy farms in the US (Hogan et al., 1992; Hogan et al., 
1995). 
 
The increasing prevalence of environmental streptococci including S. uberis has 
resulted in increased research on vaccines against these pathogens (Leigh, 1999).  
Repeated immunization with a killed S. uberis vaccine was effective in reducing the 
number of bacteria in milk from animals that were experimentally challenged with the 
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same strain of S. uberis; however immunization did not reduce the SCC (Finch et al., 
1994; Leigh, 1999).  In addition, Hill et al. (1994) vaccinated cows with both a live 
S. uberis vaccine by the sub-cutaneous route and bacterial cell wall antigens by the 
intramammary route (Hill et al., 1994; Leigh, 1999).  This vaccination protocol 
demonstrated some protection against subsequent experimental challenge (Hill et al., 
1994; Leigh, 1999), however this strategy was less effective against heterologous 
strains (Finch et al., 1997).  Subcutaneous immunization with a subunit vaccine 
consisting of S. uberis plasminogen activator (PauA) demonstrated 37.5–62.5% 
protection from clinical disease following experimental challenge with a different strain.  
The vaccine did not elicit an inflammatory response; the mean SCC from immunized 
animals following challenge remained below 300,000 cells/mL of milk (Leigh, 1999; 
Leigh et al., 1999; Yancey, 1999). 
 
A vaccine trial of another important environmental streptococcus, S. dysgalactiae 
was conducted by Bolton et al. (2004).  The surface proteins GapC and Mig of 
S. dysgalactiae are potential protective antigens against bovine mastitis.  
Immunization with these two proteins from S. dysgalactiae strain SDG8 conferred 
protective immunity against homologous bacterial challenge with a significant 
reduction in SCC in the vaccinated cow’s milk in a dry cow model (Bolton et al., 2004).  
Although the mastitis caused by S. dysgalactiae has been reduced following the 
introduction of mastitis control measures (Bradley, 2002; King, 1981; Mylrea et al., 
1977), a vaccine for S. dysgalactiae could still be beneficial. 
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1.2.7 Identification and typing schemes of mastitis pathogens 
1.2.7.1 Conventional identification of mastitis pathogens 
Whenever a herd is facing problems with either clinical mastitis or rising cell counts 
in cows’ milk, bacteriological culture followed by bacterial identification and typing is 
critical for mastitis control and treatment at a herd level (Brightling et al., 1998).   
 
Bacteriological culture is a standard method of isolating mastitis pathogens from 
milk samples.  In brief, milk samples for culturing are collected aseptically following 
cleaning teat ends with 70% alcohol and discarding the first squirt of milk.  Bacteria in 
milk are initially cultured on blood agar, which will grow all organisms, and 
subsequently on a number of selective media.  MacConkey agar is a selective 
medium used to identify coliforms; thallium sulfate-crystal violet-B toxin blood agar is 
used to identify S. agalactiae; bile esculin agar such as Edward’s agar is used to 
identify major Streptococcus species in bovine mastitis pathogens.  Cultured 
bacteria are can be identified using phenotypic, serological and biochemical tests 
(Brightling et al., 1998; Filev and Kabaivanov, 1981). 
 
Conventional methods including Gram stain; aesculin and sodium hippurate 
hydrolysis; inulin, raffinose and mannitol hydrolysis; CAMP test; failure to grow in the 
presence of 6.5% NaCl; 0.1% methylene blue reduction and Lancefield serotyping are 
commonly used to identify streptococci isolated from milk sample (Lammler, 1991; 
McDonald and McDonald, 1976)(Khan et al., 2003; Phuektes et al., 2001b).  In 
addition, rapid identification commercial kits such as API 20 Strep or Rapid Strep 
system and the Vitek automated system, are available and widely used for 
identification of Streptococcus species.  
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While the conventional identification methods are widely used in diagnostic 
veterinary microbiology for species identification of bacterial pathogens and are 
regarded as “Gold standard” for differentiating Streptococcus spp., S. uberis and 
S. parauberis cannot be readily differentiated since more than 50% of S. uberis 
strains are ungroupable (Bentley et al., 1993)(Lammler, 1991; McDonald and 
McDonald, 1976), and accuracy of the conventional methods has been questioned 
(Fortin et al., 2003; McDonald et al., 2005). 
 
1.2.7.2 Molecular based identification of Streptococcus species 
In an attempt to improve the accuracy of mastitis pathogen identification in 
particular Streptococcus spp., several molecular methods have facilitated the 
differentiation of closely related Streptococcus spp. 
 
Jayarao et al. (1991) used restriction fragment length polymorphism (RFLP) 
analysis of the entire 16S rRNA gene to differentiate S. uberis from S. parauberis 
(Jayarao et al., 1991a) and later Bentley et al. (1993) developed oligonucleotide 
probes specific for the V2 region of the 16S rRNA gene to differentiate the two species 
(Bentley et al., 1993).  PCR–RFLP analysis of the intergenic region of the 16S–23S 
ribosomal DNA has facilitated species identification of streptococcal mastitis 
pathogens (McDonald et al., 2005).   
 
PCR has become a common diagnostic tool for rapid identification of bacterial 
pathogens.  A PCR that specifically amplified the 16S rRNA gene has been used to 
identify S. uberis, S. parauberis, S. dysgalactiae, S. agalactiae, Enterococcus and 
Aerococcus species (Jayarao et al., 1991a; Jayarao et al., 1992).  
Hassan et al. (2001) designed primers that targeted the species-specific region of the 
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16S rRNA gene, the 23S rRNA gene, and the 16S-23S rRNA intergenic spacer region 
to differentiate S. uberis from S. parauberis (Hassan et al., 2001).  In addition, a 
multiplex PCR assay amplifying the 16S-23S rRNA intergenic spacer region has been 
developed for detection of S. aureus, S. agalactiae, S. dysgalactiae and S. uberis 
(Phuektes et al., 2001a). 
 
Sequencing analysis of highly conserved 16S rRNA gene facilitates species 
identification and phylogenetic analysis providing quantitative relationships between 
strains (Fitch and Margoliash, 1967; Lane et al., 1985) and has been applied to the 
identification of a broad range of bacteria (Rantakokko-Jalava et al., 2000).  This 
scheme has been applied identification of S. uberis for differentiation of 
closely-related species with the same phenotype such as S. parauberis (Clarridge, 
2004; Pullinger et al., 2006).   
 
Recently the complete genome sequence of S. uberis strain O140J has been 
completed and is available from the Sanger Institute which greatly facilitates the 
molecular characterization of this species, e.g. identification of unknown virulence 
factors, and further development of molecular identification and typing schemes.   
 
1.2.7.3 Molecular typing of Streptococcus species 
Several molecular typing schemes (Baseggio et al., 1997; Douglas et al., 2000; 
Gillespie et al., 1998; Khan et al., 2003; Leigh and Lincoln, 1997; Phuektes et al., 
2001b; Wang et al., 1999; Ward et al., 2001) have been applied to further understand 
the epidemiology of mastitis pathogens.  RFLP (Jayarao et al., 1991a), PFGE 
(Baseggio et al., 1997; Douglas et al., 2000; Gillespie et al., 1998; Khan et al., 2003; 
Phuektes et al., 2001b; Wang et al., 1999) and MLST schemes (Coffey et al., 2006; 
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Pullinger et al., 2006) have been widely used in Streptococcus species.  Earlier 
PFGE studies demonstrated highly diverse genotypes in S. uberis populations 
(Baseggio et al., 1997; Douglas et al., 2000; Gillespie et al., 1998; Khan et al., 2003; 
Phuektes et al., 2001b; Wang et al., 1999).   
 
Recently application and development of algorisms further improved phylogenetic 
analyses following molecular typing.  UPGMA (Unweighted Pair Group Method with 
Arithmetic Mean) is a simple method of tree construction (Jolley et al., 2004; Jolley et 
al., 2001; Sneath and Sokal, 1973), and trees reflect the phenotypic similarities 
between operational taxonomic units (Jolley et al., 2004; Jolley et al., 2001; Sneath 
and Sokal, 1973).  PFGE analysis with UPGMA demonstrates phylogenetic 
relationships between PFGE profiles and facilitates further understanding of 
epidemiology of species and identification of possible virulent PFGE profiles (Thong et 
al., 2004).  Furthermore, MLST with new algorithms BURST and eBURST further 
improve phylogenetic analysis (Feil et al., 2004; Jolley et al., 2004; Jolley et al., 2001; 
Spratt et al., 2004).  The BURST and eBURST algorithms identify groups of related 
genotypes in the population and attempt to identify the founding genotype of each 
group (Feil et al., 2004; Spratt et al., 2004).  These new algorisms facilitate 
demonstrating ancestral lineage and the relationship between possible ancestral and 
descendent strains (Feil et al., 2004; Jolley et al., 2004; Jolley et al., 2001; Spratt et al., 
2004). 
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1.3 Research aims 
Subclinical and clinical mastitis are major causes of loss in milk production and 
cause significant economic losses for dairy farmers worldwide (Beck et al., 1992; 
Daley et al., 1991; Petrovski et al., 2006).  While the introduction of mastitis control 
schemes has been successful in reducing the incidence of contagious mastitis caused 
by S. agalactiae and S. aureus in dairy herds (Esslemont and Kossaibati, 2002; Leigh, 
1999), these measures have had little impact on environmental pathogens, in 
particular S. uberis (Bradley, 2002; Bramley, 1984). 
 
Since the 1980s, the prevalence of S. uberis has increased and it has been 
recognized as an important cause of mastitis in many dairy herds worldwide (Bradley, 
2002; Bramley, 1984; Jayarao et al., 1999; Khan et al., 2003) (Table  1-1).  However, 
despite the significant rise in the prevalence of S. uberis over the last two decades, 
little is known about the epidemiology and pathogenicity of S. uberis.  In order to 
address these problems, further characterization of S. uberis based on worldwide 
epidemiological studies and investigation of virulence factors need to be undertaken 
to provide the basis for the development of any future effective vaccines. 
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1.3.1 Aims 
The primary aim of this study was to investigate the molecular epidemiology of 
S. uberis mastitis in Australian dairy herds using molecular techniques (pulsed-field 
gel electrophoresis [PFGE] and multilocus sequence typing [MLST]).   
 
While previous studies used PFGE to determine the molecular epidemiology of 
S. uberis in Australia and elsewhere (Baseggio et al., 1997; Douglas et al., 2000; 
Gillespie et al., 1998; Khan et al., 2003; Phuektes et al., 2001b; Wang et al., 1999), no 
study has performed inter-laboratory comparisons of S. uberis epidemiological data 
on a global scale.  The main aim of the study was to apply S. uberis MLST scheme 
(Coffey et al., 2006) to Australian S. uberis isolates in order to elucidate the molecular 
epidemiology of Australian S. uberis isolates in relation to the global population.  A 
second aim was to investigate whether particular lineages of S. uberis are associated 
with mastitis in Australian dairy herds.  The third aim was to investigate whether 
there were any differences in putative virulence factor genes between strains of 
S. uberis from cases of clinical mastitis and those from cows with low cell counts in 
their milk. 
 
The specific objectives of this study were: 
• To determine the molecular epidemiology of S. uberis in bovine mastitis in 
Australian dairy herds, specifically the distribution of subspecies of S. uberis 
using PFGE and MLST. 
• To identify possible highly virulent lineages of S. uberis in the Australian 
S. uberis population using MLST. 
• To identify novel virulence-associated genes of S. uberis by subtractive 
hybridization. 
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• To investigate the association between the prevalence of putative 
virulence-associated genes and disease status or clusters detected by MLST. 
• To investigate the distribution of putative virulence-associated genes in the 
Australian S. uberis population using virulence-associated gene-specific 
PCRs. 
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2 Chapter 2 Materials and Reagents 
2.1 Materials 
Adaptor 1 and Adaptor 2R Clontech Laboratories, Inc., Palo Alto, CA, US 
Agar No.1 Oxoid Ltd., Basingstoke, UK 
Agarose (Molecular biology grade) Progen, Darra, Queensland, Australia 
Ampicillin Sigma-Aldrich Co., St. Louis, MO, US 
Anti-Digoxigenin-AP  Roche Diagnostics, Basel, Switzerland 
API 20 Strep bioMerieux, Marcy l’Etoile, France 
ATP Sigma-Aldrich Co., St. Louis, MO, US 
BigDye® Terminator v3.1 Applied Biosystems, Foster City, CA, US 
Blocking reagent Roche Diagnostics, Basel, Switzerland 
Boric acid Sigma-Aldrich Co., St. Louis, MO, US 
Bovine serum albumin (BSA) Promega, Madison, WI, US 
Brain heart infusion (BHI) Oxoid Ltd., Basingstoke, Hampshire, UK 
Buffer EB QIAGEN, Hilden, Germany 
Buffer PB  QIAGEN, Hilden, Germany 
Buffer PE QIAGEN, Hilden, Germany 
Deoxynucleotide triphosphate (dNTP) Promega, Madison, WI, US 
Dilution buffer  Clontech Laboratories, Inc., Palo Alto, CA, US 
Digoxigenin-11-dUTP Roche Diagnostics, Basel, Switzerland 
DIG-dUTP/dNTP labeling mixture (10 x)  Roche Diagnostics, Basel, Switzerland 
Edward’s agar Oxoid Ltd., Basingstoke, UK 
Ethidium bromide BDH. Laboratory Supplies, Poole, UK 
Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich Co., St. Louis, MO, US 
Ethanol BDH. Laboratory Supplies, Poole, UK 
Expand Long Template Enzyme mix  Roche Diagnostics, Basel, Switzerland 
Expand Long Template buffer 3  Roche Diagnostics, Basel, Switzerland 
Glycerol Research Organics, Cleveland, Ohio, US 
Hexanucleotide mixture (10 x)  Roche Diagnostics, Basel, Switzerland 
Horse blood Oxoid Ltd., Basingstoke, UK 
Hybond N+ nylon membrane Amersham, Little Chalfont, UK 
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Hybridization buffer (4 x) Clontech Laboratories, Inc., Palo Alto, CA, US 
Isopropanol Sigma-Aldrich Co., St. Louis, MO, US 
IPTG Sigma-Aldrich Co., St. Louis, MO, US 
Klenow enzyme Roche Diagnostics, Basel, Switzerland 
Lambda Ladder PFG Marker New England Biolabs, Beverly, MA, US 
Ligation buffer (10 x)  Clontech Laboratories, Inc., Palo Alto, CA, US 
Low melting point, molecular biology grade Progen Industries, Darra, Australia 
Lysozyme Boehringer, Mannheim, Germany 
MassRuler™ DNA Ladder, Low Range  MBI Fermentas, Hanover, MD, US 
MassRuler™ DNA Loading Dye (6 x) MBI Fermentas, Hanover, MD, US 
MgCl2 QIAGEN, Hilden, Germany 
Molecular grade water  Sigma-Aldrich Co., St. Louis, MO, US 
NBT/BCIP solution  Roche Diagnostics, Basel, Switzerland 
NEBbuffer 1 (10 x) New England BioLabs, Beverley, MA, US 
Nested PCR primer1 and primer 2R  Clontech Laboratories, Inc., Palo Alto, CA, US 
Nuclei lysis solution Promega, Madison, WI, US 
One Shot® TOP10F’ chemically competent 
E. coli  
Invitrogen, Carlsbad, CA, US 
PCR-Select™ Bacterial Genome Subtraction 
Kit 
Clontech Laboratories, Inc., Palo Alto, CA, US 
PCR buffer (10 x) QIAGEN, Hilden, Germany 
PCR reaction tubes (0.5 ml) ABgene, Epsom, KT19 9AP, UK 
PCR DIG Labeling Kit Roche Diagnostics, Basel, Switzerland 
PCR DIG Labeling Mix Roche Diagnostics, Basel, Switzerland 
pCR®2.1-TOPO® vector Invitrogen, Carlsbad, CA, US 
PCR tube, thermo tubes (0.2ml) ABgene, Epsom, KT19 9AP, UK 
Pfu DNA polymerase Promega, Madison, WI, US 
Pfu DNA polymerase buffer (10 x) Promega, Madison, WI, US 
Phenylmethylsulfonylflouride (PMSF) Sigma-Aldrich Co., St. Louis, MO, US 
Plug mould Bio-Rad Laboratories, Hercules, CA, US 
Polyethylene glycol (PEG) 8000  Sigma-Aldrich Co., St. Louis, MO, US 
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Potassium acetate Sigma-Aldrich Co., St. Louis, MO, US 
Primers Sigma Genosys, Castle Hill NSW, Australia 
Primer1  Clontech Laboratories, Inc., Palo Alto, CA, US  
Protect Bacterial Preservers Technical Service Consultants Limited, Lancashire, 
UK 
Proteinase K Sigma-Aldrich Co., St. Louis, MO, US 
Protein precipitation solution Promega, Madison, WI, US 
QIAquick column  QIAGEN, Hilden, Germany 
QIAquick Gel Extraction Kit QIAGEN, Hilden, Germany 
QIAquick PCR Purification Kit QIAGEN, Hilden, Germany 
Restriction enzyme, EcoR I Promega, Madison, WI, US 
Restriction enzyme, Hind III Promega, Madison, WI, US 
Restriction enzyme, Rsa I  New England BioLabs, Beverley, MA, US 
Restriction enzyme, Sma I MBI Fermentas, Hanover, MD, US 
Restriction enzyme buffer E Promega, Madison, WI, US 
Restriction enzyme buffer H Promega, Madison, WI, US 
Restriction buffer, Tango buffer (10 x) MBI Fermentas, Hanover, MD, US 
RNAse solution Promega, Madison, WI, US 
Salt solution (TOPO TA Cloning® Kit) Invitrogen, Carlsbad, CA, US 
Sarkosyl (N-Lauroylsarcosine) Sigma-Aldrich Co., St. Louis, MO, US 
SeaKem® Gold Agarose Cambrex Bio Science Rockland, Inc., Rockland, ME, 
US 
Sequencing buffer Applied Biosystems, Foster City, CA, US 
SOC medium (TOPO TA Cloning® Kit) Invitrogen, Carlsbad, CA, US 
Sodium acetate Sigma Chemical Co., St. Louis., Mo., US 
Sodium chloride (NaCl) Fluka Chemical Corp., Ronkonkoma, NY, US 
Sodium citric acid BDH. Laboratory Supplies, Poole, UK 
Sodium dodecylsulphate (SDS) BDH Laboratory Supplies, Poole, UK 
Sodium deoxycholate BDH Laboratory Supplies, Poole, UK 
Sodium hydroxide (NaOH) BDH. Laboratory Supplies, Poole, UK 
Taq DNA polymerase QIAGEN, Hilden, Germany 
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T4 DNA ligase New England BioLabs, Beverley, MA, US 
Todd-Hewitt broth (THB) Oxoid Ltd., Basingstoke, UK 
TOPO TA Cloning® Kit Invitrogen, Carlsbad, CA, US 
Tris HCl  Progen, Darra, Queensland, Australia 
TrizmaⓇ Base Sigma-Aldrich Co., St. Louis, MO, US 
Tween 20 Sigma-Aldrich Co., St. Louis, MO, US 
Whatman 3MM paper  Whatman Laboratory Products Inc., Clifton, NJ, US 
Wizard® Genomic DNA Purification Kit  Promega, Madison, WI, US 
X-Gal  Progen, Darra, Queensland, Australia 
 
2.2 Equipment 
ABI 3100 automated sequencer  Applied Biosystems, Foster City, CA, US 
Bio-Dot microfiltration apparatus  Bio-Rad, Hercules, CA, US 
CHEF DR-II chamber Bio-Rad, Hercules, CA, US 
Gel Doc 2000 imaging system Bio-Rad, Hercules, CA, US 
Hybaid PCR Express thermocycler Hybaid Ltd., Teddington, UK 
Hybaid Shake 'n' Stack Hybridization Oven Hybaid Ltd., Teddington, UK 
Power PAC, POWER PAC 300 Bio-Rad, Hercules, CA, US 
Submerged horizontal electrophoresis system, WIDE 
MINI-SUBTM CELL 
Bio-Rad, Hercules, CA, US 
UV-Visible Recording Spectrophotometer UV-160 Simazu Corp., Tokyo, Japan 
UV transilluminator, Spectroline®, Model TR-302, 302 
nm ultraviolet 
Enerstat, Melbourne, Australia 
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2.3 Media 
2.3.1 Bacteriological media 
2.3.1.1 Brain heart infusion (BHI) broth / agar 
This medium was prepared according to the manufacturer’s instructions.  For BHI 
agar, Agar No.1 was added to the medium at a final concentration of 1% (v/v) prior to 
autoclaving.   
 
2.3.1.2 Horse blood agar (HBA) 
Columbia agar base was prepared according to the manufacturer’s instructions and 
cooled to 50°C.  Defibrinated horse blood was added aseptically to the agar to a final 
concentration of 5% (v/v) and mixed gently before pouring into Petri dishes. 
 
2.3.1.3 Luria Bertani (LB) agar with ampicillin 
LB agar consisted of 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl 
and 1% (w/v) Agar No.1, and sterilized by autoclaving at 121°C for 15 min.  Following 
cooling to 55°C, ampicillin was added to the agar at the final concentration of 
50 µg/ml. 
 
2.3.1.4 Luria Bertani (LB) broth with ampicillin 
LB agar consisted of 1% (w/v) tryptone, 0.5% (w/v) yeast extract and 1% (w/v) 
NaCl, and sterilized by autoclaving at 121°C for 15 min.  Following cooling to 55°C, 
ampicillin was added to the agar at the final concentration of 50 µg/ml. 
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2.4 Reagents 
2.4.1 General reagents 
PEG (polyethylene glycol) solution: 20% (w/v) polyethylene glycol 8000, 2.5 M NaCl 
DNA rehydration solution: 10 mM Tris-HCl (pH 7.4), 1 mM EDTA (pH 8.0) 
Tris EDTA (TE) buffer: 10 mM Tris-HCl (pH 7.6), 1 mM EDTA (pH 8.0) 
Tris-acetate-EDTA (TAE) buffer pH 8.3: 40 mM Tris acetate, 1 mM EDTA 
 
2.4.1.1 Reagents for plasmid DNA extraction and purification using the alkaline 
lysis method 
NaOH/SDS: 0.2 M NaOH, 1% (w/v) SDS 
Potassium acetate solution: 3 M potassium acetate, 2 M glacial acetic acid 
TEG buffer: 50 mM Tris-HCl (pH 7.5), 0.5 mM EDTA, 5% glycerol, 50 mM 
TEG/ lysozyme: 50 mM Tris-HCl (pH 7.5), 0.5 mM EDTA, 5% glycerol, 50 mM, 
lysozyme (6 µg/µl) 
 
2.4.1.2 Reagents for PFGE 
Lysis solution: 0.2% sodium deoxycholate, 0.5% sodium lauroyl sarcosine, 1 mg/ml 
lysozyme, 6 mM Tris-HCl (pH 7.6), 1 M NaCl, 0.1 M EDTA (pH 7.6) 
ESP buffer: 0.5 M EDTA (pH 8.6), 1% sodium lauroyl sarcosine, 1 mg/ml proteinase K 
Tris-borate-EDTA (TBE) buffer pH 8.3: 0.9 M Tris, 0.9 M boric acid, 0.01 M EDTA 
Pett IV buffer: 10 mM Tris-HCl (pH 7.6), 1 M NaCl 
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2.4.1.3 Reagents for Southern blotting and DNA dot blotting 
10 x maleic acid buffer (MAB) pH 7.5: 1.0 M maleic acid, 1.5 M NaCl 
20 x SSC pH 7.0: 3 M NaCl, 0.3 M sodium citrate 
Neutralization solution pH 7.5: 0.5 M Tris, 3 M NaCl 
Denaturation solution: 0.5 M NaOH, 1.5 M NaCl 
10% Blocking reagent: dissolve Blocking reagent in 1 x MAB to a final concentration 
of 10% (w/v) 
Blocking buffer: dilute 10% Blocking reagent 1:10 with 1 x MAB 
Standard hybridization buffer: 5 x SSC, 0.1% NLS, 0.02% (w/v) SDS, 1% Blocking 
reagent 
Washing buffer: 1 x MAB, 0.3% (v/v) Tween 20  
10 x Detection buffer pH 9.5, 1 M Tris HCl, 1 M NaCl 
2 x Wash solution: 2 x SCC, 0.1% (w/v) SDS 
0.5 x Wash solution: 0.5 x SCC, 0.1% (w/v) SDS 
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2.5 Bacterial isolates 
2.5.1 Collection of milk samples 
Quarter milk samples were collected from dairy cattle with clinical mastitis, 
subclinical mastitis and cows with low SCC in their milk according to Australian 
guidelines (Brightling et al., 1998).  The cows used in this study have been managed 
in a pasture system.  The milk samples used in this study were mainly collected from 
two dairy farms.  Most samples were collected in September to November, that is in 
early lactation.  No samples were collected in the dry period.  The dairy farm at 
Newry had approximately 600 cows whereas the farm at Timboon had approximately 
200 cows.  Both the dairy farm at Newry and Timboon, where the majority milk 
samples were collected, had a prior history of a high incidence of clinical and 
subclinical S. uberis mastitis.  There were no contagious episodes of mastitis 
reported during the study. 
 
Each teat was cleaned and wiped with a paper towel soaked in 90% ethanol and 
the first squirt was discarded prior to collecting 1 ml of fresh milk from each quarter.  
Samples were kept at 4°C during transportation and cultured immediately on arrival at 
the laboratory. 
 
The location of milk collection and number of milk samples at each of the dairy 
farms are summarized in Table  2-1.  Background information of these cows, 
including herd testing date, individual cow somatic cell count (ICSCC) and age of 
cows were obtained from veterinary surgeons working for the dairy farms and are 
detailed in Table  2-2 and Table  2-3.   
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2.5.2 Classification and definition of disease status of cows at the time of milk 
collection 
Clinical mastitis was defined as the presence of clots in milk or visible signs of 
inflammation in the mammary glands.  Cows were considered to have subclinical 
mastitis if the ICSCC, performed by a herd testing service on a pooled milk sample 
within one week of culture, was >250,000 cells/ml, otherwise they were placed in the 
low cell count category (Brightling et al., 1998).  In all cases the allocation of disease 
status for each of the milk samples was based on the criteria of Zadoks et al. (2003) 
(Zadoks et al., 2003), if the three ICSCC results closest to the date of culture were 
considered. 
 
2.5.3 Isolation of S. uberis 
Milk was cultured immediately on arrival at the laboratory by spreading 50 µl over 
the surface of one HBA plate and one Edward’s agar plate.  Plates were incubated at 
37°C for 48 hrs.  Bacterial colonies resembling Streptococcus spp. were subcultured 
onto BHI agar and incubated at 37°C for 24 hrs.  If multiple morphologically different 
colonies grew on a primary culture plate, each of these was subcultured to BHI agar. 
 
2.5.4 Preliminary identification of S. uberis by conventional methods 
All of the subcultured isolates were Gram stained and examined for catalase 
activity, hydrolysis of esculin and hippurate, or by the API 20 Strep.  Gram positive 
cocci that were catalase negative and hydrolyzed hippurate and esculin were 
biochemically identified as S. uberis.  Species were subsequently confirmed by 
species-specific PCRs (Hassan et al., 2001) and 16S rRNA gene sequence analysis 
(Pullinger et al., 2006), as described in Chapter 3. 
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The biochemical tests and API 20 Strep were conducted by Ms. Nalin Wongkattiya 
(PhD student).  For details of these biochemical tests refer to the PhD thesis of Ms. 
Nalin Wongkattiya (Wongkattiya, PhD thesis, RMIT University, 2008).   
 
2.5.4.1 Isolates obtained from milk samples from a dairy farm in Timboon 
(Western Victoria) 
Eighty quarter milk samples were collected on 5th September 2004 from 20 cows 
that had been identified as having subclinical mastitis on the basis of herd tests.  
From these milk samples, 10 S. uberis isolates were obtained from milk samples of 
five cows with subclinical mastitis (10 quarters). 
 
A further five quarter milk samples from five cows with clinical mastitis were 
obtained from the owner of the farm on the same day.  These isolates had been 
stored at -20°C by the farmer.  Two S. uberis isolates were subsequently obtained 
from these milk samples (two quarters).   
 
In total, 12 S. uberis isolates were obtained from 7 cows (12 quarters).  Of these, 
two were from clinical mastitis cases and 10 were from cows with subclinical mastitis 
(Table  2-1). 
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2.5.4.2 Isolates obtained from milk samples from a dairy farm in Newry (Eastern, 
Victoria) 
180 quarter milk samples were collected from 45 cows on a dairy farm in Newry 
(Eastern, Victoria) on 19th October 2004.  Sixteen isolates were obtained from milk 
samples from 11 cows (15 quarters).  Of the 16 isolates, one isolate was from a cow 
with clinical mastitis (1 quarter), five isolates from five cows with subclinical mastitis (5 
quarters) and 10 isolates were from five cows with low cell counts in their milk (9 
quarters). 
 
From the same farm, another 26 quarter milk samples were obtained from 24 cows 
with clinical mastitis over a period of two months from November 2005 to December 
2005.  Thirteen isolates were obtained from milk samples from 13 cows (13 
quarters). 
 
In total, 29 S. uberis isolates were obtained from 24 cows (28 quarters).  Of these, 
14 isolates were from cows with clinical mastitis, 5 were from subclinical and 10 from 
cows with low cell counts (Table  2-1).   
 
2.5.5 Isolates obtained from various locations in Victoria 
An additional five S. uberis isolates were obtained from a centralized veterinary 
diagnostic laboratory (Gippsland Vetnostics, Traralgon, Victoria) between April and 
May 2006.  These were isolated from quarter milk samples (n = 5) from dairy cattle 
(n = 5) from various parts of Victoria (Table  2-1 and Table  2-4). 
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2.5.6 Infection rate of S. uberis 
The infection rate of herd at Timboon was 28% and in Newry was 24%.  These 
percentages were based on the number of cows where S. uberis was identified in 
their quarter milk samples per the total number of cows from which quarter milk 
samples were collected (25 and 45 cows in Timboon and Newry respectively).   
 
All quarter milk samples from Timboon and Newry were collected in 2004.  
Additional samples (number) from another herd in Newry in 2005 were selectively 
obtained from cases of clinical mastitis, and accordingly no information is available 
with regard to the rate of infection of the samples obtained in 2005. 
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Table  2-1. Summary of milk collection and number of isolates from milk samples 
 
Location 
(Collection date / period) 
Noa. of quarter samples 
collected 
(from no. of cows) 
No. of quarters samples 
(from no. of cows) 
infected by S. uberis 
No. of isolatesb 
 
Timboon 
(2004, September) 85 (25) 12 (7) 12 
Newly 
(2004, October) 180 (45) 15 (11) 16 
Newly 
(2005, November to 
December) 
26 (24) 13 (13) 13 
Various part of Victoriac 
(2006, April to May) N/A N/A 5 
Total 291 (94) 40 (31) 46 
 
a No, number. 
b No. of isolates is based on PFGE types as described in Chapter 4. 
c Bacterial samples were obtained from a centralized veterinary diagnostic laboratory (Gippsland 
Vetnostics, Traralgon, Victoria).   
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Table  2-2. Individual cow somatic cell counts obtained from dairy cows in Timboon 
 
 
Date of herd testing for ICSCC  
(103 cells /ml) 
Date of milk 
collection 
Cowa 
ID 
Disease statusb 
at milk collection
 4/08/04 18/08/04 23/08/04 
5/09/04 684 S  3342 1319 1557 
5/09/04 686 S  2216 396 2820 
5/09/04 796 S    685 
5/09/04 816 S  746  1216 
5/09/04 853 C     
5/09/04 868 S  572  1290 
5/09/04 883 C  771  262 
 
a Cow ID, cow identification. 
b Disease status is indicated as follows: C, clinical mastitis; S, subclinical mastitis; L, low somatic 
cell count.  
Blank in the ICSCC result indicates herd testing was not done. 
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Table  2-3. Individual somatic cell counts obtained from dairy cattle in Newry 
 
 Date of herd testing for ICSCC (103 cells /ml) Date of milk 
collection 
Cowa 
ID 
Disease statusb 
at milk collection Age 18/11/05 5/10/05 11/05/05 9/03/05 18/01/05 30/11/04 14/10/04 8/09/04 19/05/04 10/03/04 20/01/04 
19/10/04 2042 S 11     1119 1224 5263 2367 832 116 516 
19/10/04 2407 S 11   313 243 187 432 768 0 557 605 393 
19/10/04 2581 S 7   369 349 441 457 295 0 573 453 368 
19/10/04 2655 S 7     355 821 481 566 105 48 75 
19/10/04 2690 S 7 345 208 225 329 435 746 975 0 113 226 101 
19/10/04 2893 C (M) 5 68 4925 243 102 1771 753 283 0 94 35 56 
19/10/04 3133 L 4 202 61 219 188 554 394 170 40 384 144 140 
19/10/04 3147 L 4 294 640 81 57 108 106 48 0 80 111 94 
19/10/04 3217 L 3 28 19 90 103 131 145 73 31 51 45 31 
19/10/04 3327 L 3 13 9 87 247 120 119 80 537    
19/10/04 3333 L 3      91 56 23    
               
21/11/05 2169 C (M) 10 80 447 353 248 1160 281 837 163 290 571 261 
21/11/05 2481 C (M) 8 559 27 236 245 175 158 281 127 66 49 78 
21/11/05 2530 C (M) 8 59 13 111 119 83 121 75 166 211 198 90 
21/11/05 2565 C (M) 8 191 3938 151 110 117 935 392 6823 1128 154 310 
21/11/05 2730 C (M) 6 1206 2786 262 358 157 424 206  602 297 156 
21/11/05 2874 C (M) 6 589  437 1436 73 72 64 620 2951 113 69 
21/11/05 2956 C (M) 5 174 22 79 105 144 268 239  141 343 155 
21/11/05 2988 C (M) 5 180 135 101 66 127 167 74 40 79 51 31 
21/11/05 3064 C (M) 5 345 46 304 260 151 101 801 115 106 58 79 
21/11/05 3209 C (M) 3 2126 31 28 45 49 84 494 47 40 38 48 
               
12/12/05 2285 C (M) 9 1032 229 184 601 1066 1696 2584  173 52 86 
6/12/05 2520 C (M) 8 2687 2691 184 550 219 118 263 1054 549 1222 212 
6/12/05 2907 C (M) 5 868 269 182 99 123 127 266 221 151 102 49 
               
a Cow ID, cow identification. 
b Disease status is indicated as follows: C, clinical mastitis; S, subclinical mastitis; L, low somatic cell count.  (M) indicates moderate clinical mastitis. 
Blank in the ICSCC result indicates herd testing was not done. 
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Table  2-4. List of S. uberis isolates from a centralized veterinary diagnostic laboratory 
 
 
Farm Sample IDa 
Disease 
statusb Clinical history Isolate ID
c 
Korumburra 5838 C Mastitis 5838 
Moe 5851 C Mastitis 5851 
Camperdown 5867 S High SCC 5867 
Maffra 6093 C Mastitis 6093 
Maffra 6104 C Mastitis 6104 
 
a Sample ID, sample identification. 
b Disease status is indicated as follows: C, clinical mastitis; S, subclinical mastitis; L, low 
somatic cell count. 
C Isolate ID, isolate identification. 
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3 Chapter 3 S. uberis Species Identification at the Molecular Level 
3.1 Introduction 
3.1.1 Conventional identification of S. uberis 
Conventional methods are widely used in diagnostic veterinary microbiology for 
species identification of bacterial pathogens including S. uberis, but their accuracy 
has been questioned (Fortin et al., 2003; McDonald et al., 2005).  Conventional 
methods, which include Gram stain, catalase test, esculin and sodium hippurate 
hydrolysis, are commonly used to identify S. uberis from milk samples (Khan et al., 
2003; Phuektes et al., 2001b).  Other useful tests are inulin and mannitol hydrolysis 
and failure to grow in the presence of 6.5% NaCl (to exclude Enterococcus species). 
 
The serological identification of S. uberis is of limited value since more than 50% of 
strains are ungroupable (Bentley et al., 1993).  The rapid identification kit, 
API 20 strep, is available for Streptococcus spp. and is also widely used, but this kit 
correctly identifies only 75 to 95% of S. uberis isolates previously identified as 
S. uberis by conventional biochemical methods (Jayarao et al., 1991b; Leigh, 1999; 
Poutrel and Ryniewicz, 1984).  While a test for β-glucuronidase could differentiate 
S. uberis from the commensal species Streptococcus parauberis, neither 
conventional biochemical testing nor API 20 strep alone are able to definitively 
distinguish these two species (Hassan et al., 2001; Jayarao et al., 1991a; Williams 
and Collins, 1990).  In addition, according to the manufacture’s instructions, 
S. parauberis is not included in the API 20 strep database. 
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3.1.2 Molecular-based differentiation of S. uberis from S. parauberis 
In an attempt to improve the accuracy of S. uberis identification, several groups 
have described molecular methods that have facilitated the differentiation of S. uberis 
from S. parauberis.  Hybridization of radio-labelled DNA complementary to the 16S 
rRNA gene against well defined isolates suggested the existence of two distinct 
S. uberis genotypes, designated as S. uberis type I and type II, however, S. uberis 
type II was later designated S. parauberis on the basis of the 16S rRNA gene 
sequence differences between these two types (Williams and Collins, 1990).  
Initially, Jayarao et al. (1991) used RFLP analysis of the entire 16S rRNA gene to 
differentiate S. uberis from S. parauberis (Jayarao et al., 1991a) and later Bentley et 
al. (1993) developed oligonucleotide probes specific for the V2 region of the 16S 
rRNA gene to differentiate the two species (Bentley et al., 1993). 
 
More recently, PCR–RFLP analysis of the intergenic region of the 16S–23S 
ribosomal DNA has facilitated species identification of streptococcal mastitis 
pathogens.  From fifty-seven isolates initially classified by conventional tests as 
S. uberis, 47 were identified as S. uberis and six as S. parauberis as determined by 
their unique 16S–23S PCR-RFLP patterns (McDonald et al., 2005). 
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3.1.3 Identification of S. uberis by PCR 
PCR has become a common diagnostic tool for the identification of bacterial 
pathogens since it is less time consuming than other molecular methods.  Several 
species-specific PCR protocols for S. uberis have been developed.  
Hassan et al. (2001) designed primers that targeted the species-specific region of the 
16S rRNA gene, the 23S rRNA gene, and the 16S-23S rRNA intergenic spacer region 
(Hassan et al., 2001) and protocols using these primers have been applied in many 
studies (Coffey et al., 2006; Field et al., 2003; Khan et al., 2003; Zadoks et al., 2005a; 
Zadoks et al., 2005b).  Another species-specific PCR developed to differentiate 
S. uberis and S. parauberis used species-specific primers targeting sodA, which 
encodes superoxide dismutase A and cpn60, which encodes chaperonin 60 (Alber et 
al., 2004).  In addition, a multiplex PCR assay amplifying the 16S-23S rRNA 
intergenic spacer region has been developed for simultaneous detection of S. aureus, 
S. agalactiae, S. dysgalactiae and S. uberis in bulk milk samples (Phuektes et al., 
2001a). 
 
3.1.4 Identification of species using 16S rRNA gene sequencing 
16S rRNA gene sequencing facilitates species identification and phylogenetic 
analysis providing quantitative relationships between strains (Fitch and Margoliash, 
1967; Lane et al., 1985) and avoids the subjectivity associated with the interpretation 
of results obtained using conventional tests (Bentley and Leigh, 1995b). 
 
While candidate genes for phylogenetic analysis include the 5S, 16S and 23S 
rRNA genes and the 16S-23S intergenic spacer region, 16S rRNA gene sequence 
determination has proven the most useful for phylogenetic analysis since it is highly 
conserved and is therefore useful for establishing distant phylogenetic relationships 
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(Clarridge, 2004).  In addition, this gene is universally distributed, which makes it 
possible to determine phylogenetic relationships among all bacteria as well as higher 
organisms (Lane et al., 1985; Woese, 1987).  Moreover, 16S rRNA gene sequence 
data can be compared with database libraries.  There are several such databases 
publically available; for instance, GenBank (http://www.ncbi.nlm.nih.gov/); the 
Ribosomal Database Project 2 (RDP-II) (http://rdp.cme.msu.edu/html/); the Ribosomal 
Database Project at the European Molecular Biology Laboratory 
(http://www.ebi.ac.uk/embl/); Smart Gene IDNS (http://www.smartgene.ch), and the 
Ribosomal Differentiation of Medical Microorganisms (http://www.ridom.com/) 
(Clarridge, 2004).  For these reasons, 16S rRNA gene sequence determination has 
become the “Gold Standard” for species identification (Clarridge, 2004) and has been 
applied to the identification of a broad range of bacteria (Rantakokko-Jalava et al., 
2000). 
 
16S rRNA gene sequence analysis is also a powerful method for the differentiation 
of closely-related species with the same phenotype.  For example, an isolate from an 
abscess appeared to be a Streptococcus spp. as determined by routine phenotypic 
methods, but was subsequently identified by 16S rRNA gene sequence determination 
as Gemella bergena (Clarridge, 2004).   
 
3.1.5 Differentiation of S. uberis from closely related species 
Differentiation of S. uberis from closely related species, including S. parauberis, is 
important since the inability to definitively identify S. uberis could result in erroneous 
conclusions regarding the epidemiology of S. uberis (Jayarao et al., 1991a).  In 
addition, the lack of a suitable identification method for S. uberis could affect studies 
on the pathogenesis of S. uberis (Jayarao et al., 1991a).  For instance, 
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misidentification of Aerococcus spp., Enterococcus spp. and Lactococcus spp. as 
S. uberis has been reported using biochemical and serological tests for identification 
of Gram positive, catalase negative cocci from milk (Fortin et al., 2003; McDonald et 
al., 2005).  Previous PFGE studies have demonstrated S. uberis to be highly 
heterogenous (Douglas et al., 2000; McDougall et al., 2004; Phuektes et al., 2001b; 
Wang et al., 1999) which may be partly due to the inclusion of closely related species 
using inadequate conventional identification methods (McDonald et al., 2005).  
Therefore, a reliable identification method to differentiate S. uberis from closely 
related species is needed. 
 
3.1.6 Aims  
The aims of this study were: 
1. To compare 16S rRNA sequencing with conventional identification based on 
standard biochemical tests and the PCR amplification of 16S and 23S rRNA 
gene. 
2. To use 16S rRNA sequence alignments to demonstrate the phylogenetic 
relatedness of S. uberis and closely related species isolated from milk 
samples. 
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3.2 Methods  
3.2.1 Bacterial isolates and biochemical identification tests 
In total 53 isolates, comprising 48 bacterial isolates which morphologically 
resembled Streptococcus spp. on HBA and Edward’s agar and five isolates which 
were biochemically identified as S. uberis by a veterinary diagnostic laboratory, were 
used in this investigation. 
 
Gram stain and biochemical tests (esculin, hippurate and inulin test) for the 48 
isolates were performed by Ms. Nalin Wongkattiya.  Isolates that were with Gram 
positive cocci, catalase negative and hydrolyzed esculin and hippurate were 
provisionally assigned as S. uberis. 
 
Details with regard to collection of milk samples, isolation of bacterial strains and 
SCC have been described in Chapter 2. 
 
3.2.2 DNA template preparation 
3.2.2.1 Boiling method 
Bacterial genomic DNA was extracted using the boiling method.  Bacterial isolates 
were grown on either HBA or BHI agar and incubated overnight at 37°C.  Cells were 
collected with a sterile swab and resuspended in 400 µl of molecular grade water in a 
sterile screw cap tube.  The bacterial suspension was adjusted to McFarland 
standard 3 (approximately 108 CFU/ml) and the bacterial suspension boiled for 
10 min, then vortexed briefly and centrifuged for 3 min at 16,100 × g.  A 200 µl 
aliquot of the supernatant was transferred to a new centrifuge tube and kept at -20°C 
until use.  
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3.2.3 S. uberis species-specific PCRs 
3.2.3.1 16S and 23S rRNA gene PCRs 
A minor modification of the species-specific PCRs described by Hassan et al. 
(2001) was used for S. uberis primary species identification.  Both the 16S and 23S 
rRNA PCR mixtures contained 1 x PCR buffer, 1.5 mM MgCl2, 0.2 mM each dNTP 
(dATP, dCTP, dGTP, and dTTP), 0.2 µM of either the 16S or the 23S rRNA gene 
primers, 0.625 U of Taq DNA polymerase, template genomic DNA (50 ng) and 
molecular grade water, added to a final volume of 25 µl.  All amplification reactions 
were performed using a Hybaid PCR Express thermocycler and details of the PCR 
amplification conditions and primers used are listed in Table  3-1. 
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Table  3-1. PCR primer specifications and cycling conditions 
 
Primer 
Name 
Target 
gene Primer function (s) 
PCR 
product 
(bp) 
Primer sequence 
PCR 
Cycling 
Conditiona 
Reference 
Ub-I 
Ub-II 16S rRNA 
PCR 
(species identification) 
445 
5'- CGC ATG ACA ATA GGG TAC A -3' 
5'-GCC TTT AAC TTC AGA CTT ATC A-3' 
1 
 
(Hassan et al., 2001) 
Ub-23S-I 
Ub-23S-II 23S rRNA 
PCR 
(species identification) 
451 
5'-CGT ATT TAA AAT TGA CTT TAG CC-3' 
5'-AAT TTC TCC GCT ACC CAC-3' 
1 
 
(Hassan et al., 2001) 
16S forward
16S reverse 16S rRNA 
PCR, sequencing, 
(16S rRNA sequencing) 
534 
5'-GAG AGT TTG ATC CTG GCT CAG GA-3' 
5'-TTA CCG CGG CTG CTG GCA CGT-3' 
2 
 
(Pullinger et al., 2006) 
 
a1. 95ºC, 5 min; 28 x (95ºC, 30 s; 58ºC, 30 s; 72ºC, 2 min); 72ºC, 5 min. 
 2. 94ºC, 5 min; 35 x (94ºC, 30 s; 56ºC, 60 s; 72ºC, 90 s); 72ºC, 6 min. 
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3.2.3.2 PCR controls 
DNA extracts using the boiling method for S. uberis ATCC 700407 and 
S. parauberis ATCC 13386 were used as positive controls for PCRs. 
 
3.2.3.3 Gel electrophoresis 
PCR products were analyzed by agarose gel electrophoresis using a 100 bp DNA 
ladder (MassRuler™ DNA Ladder, Low Range) used as the molecular weight marker.  
Five ml of PCR product or ladder was loaded together with 1 µl DNA loading buffer 
(MassRuler™ DNA Loading Dye [6 x]) into wells of the gel.  The agarose gel was run 
at 100 V for 45 min in TAE buffer using a submerged gel electrophoresis system, 
WIDE MINI-SUBTM CELL.  The agarose gel was then stained with ethidium bromide 
(0.5 µg/ml) for 5 min, followed by distaining in running tap water for 30 min.  DNA 
bands were visualized following UV illumination using the Gel Doc 2000 imaging 
system. 
 
3.2.4 Species identification using 16S rRNA gene sequencing 
16S rRNA gene sequencing was performed as described below using a minor 
modification of a published method described by Pullinger et al. (2006). 
 
3.2.4.1 Amplification of 16S rRNA gene 
A 534 bp region of the 16S rRNA gene was amplified using PCR.  The PCR 
reaction mixture was the same as used for the 16S and the 23S rRNA gene PCRs 
except for the primers.  The PCR conditions and the primers used for this assay are 
listed in Table  3-1.   
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3.2.4.2 Purification of PCR products by precipitation with polyethylene glycol 
PCR products were purified by a modification of the DNA precipitation method 
using polyethylene glycol (PEG) as described by Rosenthal et al. (1993) 
(Applied-Biosystems, 1998; Rosenthal et al., 1993).  The PCR products were 
thoroughly mixed with twice their volume of PEG solution.  The mixture was then 
incubated for 10 min at 37°C and centrifuged for 10 min at 16,100 × g.  The 
supernatant was removed completely 400 μl of 70% (v/v) ethanol was added and the 
mixture was vortexed briefly.  After a second centrifugation at 16,100 × g for 5 min, 
the supernatant was carefully removed and the DNA pellet was air dried on a heat 
block at 73oC for 5 min.  The purified PCR product was resuspended in molecular 
grade water to a final concentration of 20 ng per μl as determined by comparing the 
band intensity with a molecular marker on a gel electrophoresis image.  The purified 
PCR product was stored at -20oC until required. 
 
3.2.5 PauA gene PCR 
A PauA gene PCR was used to investigate the presence of pauA in the Australian 
isolates using a modification of the method described by Zadoks et.al., 2005 (Zadoks 
et al., 2005a).  Details of the PauA gene PCR are given in section  6.2.3. 
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3.2.6 Sequencing procedure 
3.2.6.1 BigDye reaction 
The nucleotide sequence of the PCR product amplified from the 16S rRNA gene 
were determined in both directions using BigDye Terminator v3.1 chemistry with a 
modification of the method described by the Australian Genome Research facility 
(Australian Genome Research Facility, 2006).  The BigDye reaction mixture 
contained 0.5 µl of BigDye Terminator v3.1, 1.5 µl of 1 x Sequencing buffer, primer 
(0.4 µM) and 20 ng of purified PCR product, made up to a final reaction volume of 
5 µl.  The amplification conditions and primers used are detailed in Table  3-1. 
 
3.2.6.2 Purification of BigDye reaction products 
The BigDye extension reaction products were cleaned using a modification of the 
isopropanol precipitation method (Applied-Biosystems, 1998).  Five ml of BigDye 
reaction product was mixed with 15 µl of molecular grade water and 80 µl of 75% 
isopropanol, thoroughly mixed and then incubated for 15 min at room temperature.  
The mixture was then centrifuged for 20 min at 16,100 x g after which the supernatant 
was carefully aspirated.  A 250 μl aliquot of 75% isopropanol was added to each tube, 
the mixture vortexed briefly then centrifuged for 10 min at 16,100 x g and the 
supernatant carefully aspirated.  The DNA pellet was then air dried on a heat block at 
73oC for 5 min.  
 
3.2.6.3 Sequence determination 
Following purification, the BigDye reaction products were sent to the 
Microbiological Diagnostic Unit, University of Melbourne for DNA sequence 
determination using an ABI 3100 automated sequencer and the resulting 
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chromatograms were analysed using the ChromasPro software package 
(Technelysium Pty Ltd, Tewantin QLD, Australia).   
 
3.2.7 Data analysis 
3.2.7.1 Species identification confirmation using 16S rRNA gene sequence 
The 16S rRNA gene sequences were compared with the reference sequence of 
S. uberis, strain HN1 (AB023576.1) using Basic Local Alignment Search Tool for 
nucleotides (BLASTN) at the National Center for Biotechnology Information (NCBI) 
(http://www.ncbi.nlm.nih.gov/BLAST/) and individual isolates were designated as 
S. uberis if the 16S rRNA sequence was 100% identical to the reference sequence. 
 
3.2.7.2 Analysis of 16S rRNA gene sequence and primer binding sites 
All 16S rRNA gene sequences were analyzed by using BLASTN at NCBI and 
Sequence Match at RDP-II (http://rdp.cme.msu.edu/index.jsp) (Cole et al., 2007).  
RDP-II calculated a seqmatch score (S_ab) which is the number of (unique) 7-base 
oligomers shared between the sequence of interest and a given RDP sequence 
divided by the lowest number of unique oligos in either of the two sequences.  A 
score of one indicates a perfect match (Cole et al., 2007). 
 
A neighbour-joining (NJ) tree with branch length estimation was constructed based 
on the 16S rRNA gene sequence alignment using the function implemented in the 
CLUSTALW available at GenomeNet (http://align.genome.jp/).  Bootstrap analyses 
(1000 replications) were performed on the resulting tree with the Bootstrap option of 
the software.  The NJ algorithm is generally regarded as one of the most effective 
methods for reconstructing phylogenies from a matrix of pairwise evolutionary 
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dissimilarities (Silva et al., 2005), and the NJ tree allowed phylogenetic analysis 
between S. uberis isolates and other closely related species.   
 
Aligned 16S and 23S rRNA gene sequences were used for primer binding site 
analyses.  Reference sequences of 16S and 23S rRNA genes of S. uberis and 
closely related species were obtained from GenBank and sequence editing performed 
using Bioedit version 7.0.5. (http://www.mbio.ncsu.edu/BioEdit/bioedit.html) (Hall, 
1999). 
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3.3 Results 
3.3.1 Biochemical identification tests 
Of the 53 isolates used in Chapter 3, 48 isolates were further characterized using 
biochemical identification tests.  However, these were not performed on the five 
additional isolates obtained from Mayne Vetnostics, Traralgon, Victoria since these 
isolates had been definitively identified as S. uberis prior to receipt. 
 
Biochemical analysis of the 48 isolates morphologically resembling Streptococcus 
spp. was performed by Ms. Nalin Wongkattiya.  Of the 48 isolates, 46 were identified 
as S. uberis on the basis that they hydrolyzed both esculin and hippurate.  Two 
isolates, 815-5 and 780-3, were either esculin or hippurate negative and 40 of the 
isolates were Inulin positive.  The results of biochemical characterization are given in 
Table  3-2.  The additional five isolates obtained from the veterinary diagnostic 
laboratory are also included in Table  3-2. 
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Table  3-2. 16S rRNA gene sequence analysis and 16S, 23S rRNA and PauA gene PCR results of 53e 
Australian isolates 
 
 
a Isolate identification. 
b Nucleotide identity compared with closest matched species. 
c Seqmatch score was obtained from the RDP-II (Cole et al., 2007)  
e The 48 isolates characterized in this study and 5 additional isolates which had been assigned as S. uberis by Mayne Vetnostics, 
Traralgon, Victoria prior to receipt. 
ND, Not Determined. 
Isolatea 
ID 
NCBI Blast N,  
Closest match 
Nucleotide b  
identity (%) 
RDP,S_ab scorec 
(A seqmatch score ) Esculin Hippurate Inulin 
16S 
rRNA 
23S 
rRNA PauA 
2565-2 S. uberis HN1 100 1.000  S. uberis HN1 + + + + + +
2655-5 S. uberis HN1 100 1.000  S. uberis HN1 + + + + + +
2874-4 S. uberis HN1 100 1.000  S. uberis HN1 + + + + + +
2907-1 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
3133-3 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
3217-1 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
3217-2 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
3327-3 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
2042-5 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
2169-2 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
2285-1 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
2407-7 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
2481-1 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
2520-1 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
2530-2 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
2581-2 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
2690-2 S. uberis HN1  100 1.000  S. uberis HN1 + + - + + +
2730-5 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
2893-1 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
2956-4 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
2988-1 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
3064-1 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
3147-1 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
3147-4 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
3147-5 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
3209-4 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
3217-3 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
3217-5 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
3333-3 S. uberis HN1  100 1.000  S. uberis HN1 + + - + + +
796-2 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
684-1 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
684-6 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
684-9 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
816-5 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
816-2 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
883-4 S. uberis HN1  100 1.000  S. uberis HN1 + + + + + +
868-4 S. uberis HN1  100 1.000  S. uberis HN1 + + - + + +
796-3 S. uberis HN1 100 1.000  S. uberis HN1 + + + + + +
853-4 S. uberis HN1 100 1.000  S. uberis HN1 + + + + + +
5838-3 S. uberis HN1 100 1.000  S. uberis HN1 NDe NDe NDe + + +
5851 S. uberis HN1 100 1.000  S. uberis HN1 NDe NDe NDe + + +
5867 S. uberis HN1 100 1.000  S. uberis HN1 NDe NDe NDe + + +
6093 S. uberis HN1 100 1.000  S. uberis HN1 NDe NDe NDe + + +
6104 S. uberis HN1 100 1.000  S. uberis HN1 NDe NDe NDe + + +
686-5 S. uberis HN1 99.8 0.985  S. uberis HN1 + + + + + +
686-10 S. uberis HN1 99.6 0.975  S. uberis HN1 + + + + + +
815-5 S. pseudoporcinus 96.2 0.854  S. canis - + - + + -
2893-4 S. iniae 97.3 0.882  S. uberis HN1 + + - + + -
893-6 S. iniae 97.3 0.882  S. uberis HN1 + + + + + -
780-3 S. iniae 97.5 0.884  S. iniae + - - + + -
780-4 S. iniae 97.5 0.884  S. iniae + + - + + -
2407-5 S. parauberis SAP 100 1.000  S. parauberis + + + - + -
3162-1 Aerococcus 
viridans F01772 
99.6 0.974  A. viridians  
         M58797
+ + - - - - 
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3.3.2 16S rRNA gene sequencing analysis and 16S & 23S rRNA gene PCRs 
In total 53 isolates comprising 51 isolates biochemically identified as S. uberis (on 
the basis of the ability to hydrolyse of hippurate and esculin) and two isolates 
biochemically closely related to S. uberis (failed to hydrolyse either hippurate or 
esculin) were further analyzed by 16S rRNA gene sequencing analysis.  The 475 bp 
fragment of the 16S rRNA gene PCR product (534 bp) (Pullinger et al., 2006) 
including the V2 region of the 16S rRNA gene (Bentley and Leigh, 1995b) was 
analysed using both BLASTN in GenBank and Sequence Match in RDP-II.   
 
In total, 46 isolates were identified as S. uberis on the basis of 100% match to the 
reference S. uberis sequence (strain HN1 [AB023576.1]).  These isolates were all 
positive following the 16S and 23S rRNA gene PCR assays (Table  3-2), but three 
isolates, 2690-2, 3333-3 and 868-4, were inulin negative.  Two isolates (686-5 and 
686-10), showing 99.8% and 99.6% homology with the reference strain respectively, 
were identified as S. uberis on the basis of both biochemical profile, species-specific 
PCRs (Table  3-2) and the NJ tree phylogenetic analysis based on the 16S rRNA gene 
sequences (Figure  3-1).  Of interest, the chromatogram of 686-5 demonstrated two 
peaks at the variable site in the 16S rRNA gene sequence (Figure  3-2) whereas the 
16S rRNA gene sequence of 686-10 showed only one peak at each of the two 
variable sites. 
 
The remaining seven isolates were identified as Streptococcus iniae (n = 4), 
Streptococcus pseudoporcinus (n = 1), S. parauberis (n = 1) and Aerococcus viridans 
(n = 1) respectively (Table  3-2).  While isolates were identified as S. iniae (n = 4) and 
S. pseudoporcinus (n = 1) by BLASTN at NCBI, these differed from more than 2% 
nucleotide identity from the reference strains of each species, therefore they were 
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termed S. iniae-like and S. pseudoporcinus-like isolates.  It is important to note that 
five out of the seven non-S. uberis isolates were biochemically identified initially as 
S. uberis since both hydrolyzed esculin and hippurate.  The remaining two 
non-S. uberis isolates (815-1 and 780-3) were either esculin or hippurate negative, 
and these were subsequently identified as S. pseudoporcinus-like and S. iniae-like 
species following 16S rRNA sequence determination and analysis. 
 
The isolates identified as S. iniae-like (n = 4) and S. pseudoporcinus-like species 
(n = 1) were all positive using both the 16S and 23S rRNA gene PCR assays (Table 
 3-2).  The isolate 2407-5, identified as S. parauberis by the 16S rRNA sequencing 
analysis, was negative with the 16S rRNA gene PCR assay but positive with the 
23S rRNA gene PCR assay (Table  3-2).  The isolate 3162-1, identified as A. viridans 
by the 16S rRNA gene sequence analysis, was negative using both 16S and 23S 
rRNA PCRs (Table  3-2). 
 
The 16S rRNA gene sequences were further analyzed by RDP-II (Cole et al., 
2007), and the results were consistent with the analysis by BLASTN at NCBI except 
for isolates 815-5, 2893-4 and 893-6.  Isolate 815-5 showed the highest match with 
Streptococcus canis (S_ab, 0.854) and isolates 2893-4 and 893-6 showed the highest 
match with S. uberis (S_ab, 0.882) (Table  3-2). 
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Figure  3-1. NJ tree generated from 16S rRNA gene sequences. 
 
Phylogenetic analysis clearly demonstrated that the four S. iniae-like isolates (2893-4, 893-6, 780-3, 
and 780-4) were distributed between the S. uberis isolates and the S. iniae reference strains (S. iniae 
SCCS10 and ATCC29178) but were clearly separated from the two species. 
 
For the details of the isolate IDs and the reference strains used in this analysis refer to Table  3-3.  
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Figure  3-2. Chromatograms for the variable site in the 16S rRNA gene sequence of isolates 684-6 and 
686-5. 
 
The center of the chromatogram shows a polymorphism in the 16S rRNA gene sequence of isolate 
686-5 compared to isolate 684-6 which was 100% identical to the S. uberis reference strain HN1. 
 
The arrows indicate the variable nucleotide sequence site of 686-5 and the dual peaks indicate the 
occurrence of variant copies of the 16S rRNA gene in the S. uberis isolate 686-5. 
 
The two chromatograms, forward and reverse sequences, of each isolate were assembled by 
ChromasPro. 
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3.3.3 NJ tree based on the 16S rRNA gene sequences 
NJ tree phylogenetic analysis bootstrap analyses (1000 replications) based on 38 
16S rRNA gene sequences comprising representatives of S. uberis (n = 15) and 
non-S. uberis isolates (n = 8) from different farms; 13 reference strains including 
S. uberis and closely related Streptococcus spp. and two ATCC strains; S. uberis 
ATCC 700407 and S. parauberis ATCC 13386.  Details of the additional reference 
strains are given in Table  3-3. 
 
Phylogenetic analysis clearly demonstrated that the two isolates (686-5 and 
686-10) possessed 16S rRNA gene sequences which differed from those of the 
S. uberis reference strain by either one or two nucleotides and were only distantly 
related to S. parauberis and S. iniae, with S. uberis being the closest species (Figure 
 3-1). 
 
The four S. iniae-like isolates (2893-4, 780-3, 780-4 and 893-6) identified following 
16S rRNA sequence analysis were clustered between S. uberis and S. iniae 
reference strains (S. iniae SCCS10 and ATCC 29178) but were clearly separated 
from the two species (Figure  3-1).  Isolate 3162-2, identified by the sequence 
analysis as A. viridans, was clearly differentiated from the other isolates in the NJ tree.  
In addition, the NJ tree showed that S. iniae-like and S. pseudoporcinus-like isolates 
were more closely related to S. uberis than to S. parauberis (Figure  3-1).  
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Table  3-3. 16S rRNA gene sequence analyses of the reference strains 
 
Isolate IDa and strain name 
Nucleotide identity comparing with the 
consensus strain of each species based 
on NCBI BLASTN result 
Nucleotide identity comparing with the 
consensus strain of each species based on 
RDP-II,S_ab score  
R1, S. parauberis SAP 99c  Consensus S. parauberis strain  Consensus S. parauberis strain 
R2, S. parauberis 349 S. parauberis SAP 99, 100% 1.000  S. parauberis SAP 99 
R3, S. parauberis 332 S. parauberis SAP 99, 99% 1.000  S. parauberis SAP 99 
R4, S. parauberis DSM 6631 S. parauberis SAP 99, 99.8% 0.985  S. parauberis SAP 99 
R5, S. parauberis X89967 S. parauberis SAP 99, 99.8% 1.000  S. parauberis SAP 99 
R6, S. parauberis LMG 14376 S. parauberis SAP 99, 99.8% 0.985  S. parauberis SAP 99 
R1, S. iniae SCCSI10 Consensus S. iniae strain  Consensus S. iniae strain 
R2, S. iniae ATCC29178 S. iniae SCCSI10, 100% 1.000  S. iniae SCCSI10 
R1, S. dysgalactiae V26b Consensus S. dysgalactiae strainb Consensus S. dysgalactiae strainb 
R1, S. uberis NH1 Consensus S. uberis strain Consensus S. uberis strain 
R2, S. uberis JCM 5709 S. uberis HN1, 100% 1.000  S. uberis HN1 
R3, S. uberis U41048 S. uberis HN1, 100% 1.000  S. uberis HN1 
R4, S. uberis ATCC 27958 S. uberis HN1, 98% 0.951  S. uberis HN1 
R1, S. pseudoporcinus LQ 559-98 Consensus S. pseudoporcinus strain Consensus S. pseudoporcinus strain 
 
a Isolate identification.   
b S. dysgalactiae subsp. dysgalactiae V26. 
c R indicates reference strain followed by species and strain name.   
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3.3.3.1 Analysis of primer binding sites 
3.3.3.1.1 16S rRNA gene PCR for species identification 
Because of the number of false positive results obtained using the S. uberis 
species-specific PCR assays, the binding sites of the primers Ub-I and Ub-II were 
further analysed.  The binding sites of these primers on the 16S rRNA gene are 
shown in Figure  3-3. 
 
The primer binding site of the primer Ub-I was aligned with the 16S rRNA gene 
sequences used in the NJ tree analysis.  The primer Ub-I binds in the V2 region of 
16S rRNA gene and alignment demonstrated polymorphisms with most of the 
non-S. uberis reference strains (Figure  3-4).  However three nucleotides at the 3´ 
end of Ub-I matched with the sequence of three reference strains; R1_S. iniae 
SCCSI10, R2_S. iniae ATCC29178 and R1_S. pseudoporcinus LQ 559-98; four 
S. iniae-like isolates (2893-1, 893-6, 780-3, 780-4) and one S. pseudoporcinus-like 
isolate (815-5).  All of the S. uberis isolates and S. uberis reference strains were 
100% identical with the sequence of Ub-I (Figure  3-4).  This could account for the 
lack of specificity of the 16S rRNA gene-specific PCR. 
 
In contrast to primer Ub-I, three nucleotides at the 3´ prime end of Ub-II showed 
polymorphisms with the non-S. uberis reference strains of each species except for the 
reference strain, R1_S. pseudoporcinus LQ 559-98 (Figure  3-5).  However, the 
binding site of Ub-II was compared with only the reference strains since the binding 
region was outside of the region used for 16S rRNA gene sequence analysis (Figure 
 3-3). 
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Figure  3-3. Schematic showing primer binding regions on the 16S rRNA gene used for gene-specific 
PCR and nucleotide sequence determination. 
a, b primers for 16S rRNA gene PCR for species identification. 
c, d primers for 16S rRNA gene sequencing. 
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Figure 3-4-a. 
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Figure 3-4-b. 
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Figure 3-4-c. 
 
 
Figure  3-4 -a,b,c. Alignment of the 16S rRNA gene sequences (475bp) and Ub-I primer binding sites on 
the16S rRNA gene. 
 
16S rRNA gene sequences of the field isolates, reference strains including S. uberis and closely 
related Streptococcus spp. were aligned by CLUSTALW.  The primer binding site of Ub-I showed 
polymorphisms for most non S. uberis reference strains however the three nucleotides at the 3´ end of 
Ub-I matched with the reference strains, R1_S. iniae SCCSI10, R2_S. iniae ATCC 29178 and 
R1_S. pseudoporcinus LQ 559-98.  Sequences of the S. pseudoporcinus-like and the four S. iniae-like 
isolates matched with three nucleotides at the 3´ end of Ub-I.  Isolate ID starting with R indicates the 
reference strain.  The three nucleotides at the 3´ end of Ub-I indicates with an arrow with two vertical 
lines.  For the details of the isolate IDs and the reference strains refer to Table  3-3. 
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Figure  3-5. Ub-II binding site on the 16S rRNA gene. 
 
16S rRNA gene sequences of the reference S. uberis strains and closely related Streptococcus spp. 
were aligned by CLUSTALW.  The three nucleotides at the 3´ end of Ub-II showed polymorphisms 
with all reference strains with the exception of the reference strain R1_S. pseudoporcinus LQ 559-98.  
For details of the reference strains refer to Table  3-3.   
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3.3.3.1.2 23S rRNA gene PCR primer binding sites 
The 23S rRNA gene sequences of the reference S. uberis strains and closely 
related Streptococcus spp. were aligned using CLUSTALW.  The reference strains 
were as follows: S. uberis GI no. 433703; S. pyogenes M1 GAS GI no. 14286347; 
Streptococcus suis 98HAH33 GI no. 145690656; S. pyogenes M1 GAS GI no. 
14286347; Streptococcus procinus ATCC 43138 GI no. 45597362; S. parauberis GI 
no. 433515. 
 
While the primer binding site of Ub-23S-I showed polymorphisms for most 
non-S. uberis reference strains of each species examined, three nucleotides at the 3´ 
end of the primer matched with the sequences of reference strains of S. porcinus and 
S. pyogenes (Figure  3-6).  In contrast to primer Ub-23S-I, the sequence of primer 
Ub-23S-II matched with all the other non-S. uberis reference strains that were 
examined (Figure  3-6) and could account for the lack of specificity of the 23S rRNA 
gene PCR used. 
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Figure  3-6. Ub-23S-I and II binding sites on the 23S rRNA gene. 
 
23S rRNA gene sequences of S. uberis and closely related Streptococcus spp. aligned by CLUSTALW.  
The primer binding site of Ub-23S-I showed polymorphisms, however three nucleotides at the 3´ end of 
the primer matched with the reference strains of S. porcinus and the S. pyogenes whereas the primer 
binding site of Ub-23S-II was identical to all other reference strains of each species. 
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3.3.4 PauA gene PCR 
Of the 53 isolates morphologically resembling Streptococcus spp., seven were 
negative following PauA gene PCR and were identified as non-S. uberis species by 
16S rRNA gene sequence identification.  The remaining 46 isolates were all positive 
following PauA gene PCR (Table  3-2) and were confirmed as S. uberis following 16S 
rRNA gene sequencing. 
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3.4 Discussion 
Molecular identification methods have been increasingly applied to the diagnosis of 
human and animal disease.  In this study species identification PCRs and 16S rRNA 
gene sequence analysis were used for the identification of S. uberis isolates from milk 
samples.   
 
Of the 46 isolates confirmed to be S. uberis as determined by 16S rRNA gene 
sequencing analysis, two isolates (686-5 and 686-10) showed less than 0.5% 
nucleotide sequence diversity from the S. uberis reference sequence (Table  3-2). 
Isolates of the same species are permitted 1 to 1.5% intra-species nucleotide 
sequence genetic variability (Clayton et al., 1995; Fox et al., 1992).  Phylogenetic 
analysis demonstrated that the two isolates were only distantly related to 
S. parauberis and S. iniae with S. uberis being the closest species (Figure  3-1) and 
accordingly they were assigned as S. uberis.  Of interest, the 16S rRNA 
polymorphism observed in isolate 686-5, as demonstrated by the two peaks on the 
chromatogram (Figure  3-2), further suggests the existence of variant 16S rRNA gene 
alleles (Bentley and Leigh, 1995a). 
 
The 16S rRNA and 23S rRNA gene PCRs (Hassan et al., 2001) have been widely 
used in previous studies (Coffey et al., 2006; Field et al., 2003; Zadoks et al., 2005a).  
While these PCRs have been useful for primary identification of S. uberis and 
differentiation of S. uberis and S. parauberis, in the present study four S. iniae-like 
and one S. pseudoporcinus-like isolate were incorrectly assigned as S. uberis using 
either the 16S or 23S rRNA gene PCRs.  Specifically, isolate 2407-5, identified as 
S. parauberis by 16S rRNA gene sequence analysis, showed a false positive result 
with the 23S RNA gene PCR.  These results suggested the 16S and 23S rRNA gene 
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PCRs resulted in false positives (Table  3-2) explained by the lack of specificity of 
primer binding sites (Figure  3-4 and Figure  3-5). 
 
The primer binding site for Ub-I is within the V2 region of the 16S rRNA gene 
(Bentley and Leigh, 1995b) and has been demonstrated to have sufficient sequence 
variability to allow the differentiation of 31 species of the genus Streptococcus, 
including S. uberis and S. parauberis (Hassan et al., 2001), however, in the present 
study, primer Ub-1 binding site alignments (Figure  3-4 and Figure  3-5) demonstrated 
nucleotide sequence identity of three nucleotides at the 3´ end of the primer binding 
sites on S. iniae-like and S. pseudoporcinus-like isolates. 
 
In a analogous manner, the false positive results from 23S rRNA PCRs on six 
isolates, including S. iniae-like, S. pseudoporcinus-like and S. parauberis isolates, 
could be due to lack of specificity at the primer binding sites of Ub-23S-I and II.  
Specifically, the primer Ub-23S-II was identical and primer Ub-23S-I was highly 
homologous with all streptococcus reference strains analysed (Figure  3-6).  These 
findings clearly demonstrated that species-specific PCRs (Hassan et al., 2001) 
require supplemental data such as biochemical identification tests and 16S rRNA 
gene sequencing to confirm species identification. 
 
PauA is a putative virulence factor of S. uberis and encodes the plasminogen 
activator which converts plasminogen in blood plasma and tissues in cattle to plasmin 
(Leigh, 2000; Leigh et al., 1999), facilitating early colonization of the mammary gland 
prior to inflammation (Leigh, 1993; Rambeaud et al., 2004; Smith et al., 2002).  The 
PauA gene PCR performed in this study provided useful supplemental data to 
differentiate S. uberis from closely related species.   These results are in agreement 
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with an earlier study demonstrating that pauA appeared to be restricted solely to 
S. uberis and was absent in other Streptococcus spp. or other bacteria commonly 
associated with bovine mastitis (Ward and Leigh, 2004).  Although one S. uberis 
strain (SK888) possessed pauB instead of pauA at the same locus, the prevalence of 
pauB in S. uberis is very rare (Ward and Leigh, 2002).  Accordingly the PauA gene 
PCR could be used as an alternative species-specific PCR to differentiate S. uberis 
from closely related species. 
 
3.4.1 Phylogenetic analysis of closely related isolates  
NJ tree analysis showed that the four S. iniae-like isolates (2893-4, 780-3, 780-4 
and 893-6) clustered between S. uberis and the reference strain of S. iniae, but were 
clearly separated from the two species (Figure  3-1).  The S. iniae-like isolates were 
positive using the 16S and 23S rRNA PCRs and some of them fermented both esculin 
and hippurate.  Of interest, Sequence Match at RDP-II showed that the closest 
species to the two S. iniae-like isolates (2893-4 and 893-6) was S. uberis (Table  3-2 
and Table  3-3).  BLASTN and Sequence Match at RDP-II (Table  3-2 and Table  3-3) 
analyses suggest that these S. iniae-like isolates may belong to neither S. uberis nor 
S. iniae, since the differences between their sequences were either more than 5 to 15 
bp in the whole 16S rRNA gene sequence (Fox et al., 1992) or larger than 2.0% in 
sequence identity (Clarridge, 2004; Turenne et al., 2001). 
 
In an analogous manner, the S. pseudoporcinus-like isolate 815-5 may not belong 
to any known species since the closest matches with S. pseudoporcinus 16S rRNA 
sequences demonstrated only 96% nucleotide identity (Table  3-2).  These findings 
suggest that various species, closely related to S. uberis, co-colonize in dairy cows.  
These organisms not only share the same environment, but also possibly exchange 
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genetic material by homologous recombination.  Failure to differentiate such isolates 
could lead to errors in the interpretation of S. uberis epidemiological and clinical data. 
 
Of particular interest was that the NJ tree analysis demonstrated that a reference 
strain of S. iniae was more closely related to S. uberis than S. parauberis (Figure  3-1).  
S. iniae is a cause of septicaemia, meningoencephalitis, and death in farmed fish and 
a rare cause of cellulitis in humans exposed to them (Weinstein et al., 1997).  It is 
rarely isolated from milk of dairy cattle and seldom causes bovine mastitis.  A previous 
study reported that S. iniae has been mistakenly identified as S. uberis with 
commercially available biochemical identification systems (Weinstein et al., 1997), 
which further supports the high similarity between S. iniae and S. uberis. 
 
In the present study, a 534 bp fragment of the 16S rRNA gene was amplified by 
PCR (Pullinger et al., 2006) and a 475 bp region within this PCR fragment was 
sequenced.  Although the entire 1,500 bp region of 16S rRNA gene sequence is 
sometimes necessary to distinguish between particular taxa or strains (Sacchi et al., 
2002a; Sacchi et al., 2002b), the initial 500 bp sequence is widely considered to 
provide adequate sequence data to facilitate differentiation of most bacterial isolates 
of clinical importance (Clarridge, 2004).  Accordingly, the 475 bp nucleotide 
sequence of the 16S rRNA gene sequence used for analysis in the present study was 
considered sufficient for phylogenetic analysis (Clarridge, 2004). 
 
Possible discrepancies in sequence data available in GenBank were observed in 
this study e.g. the two 16S rRNA gene sequences of the same S. uberis strain ATCC 
27958 (accession numbers AB 002527 and U41048) in GenBank.  The former 
sequence (AB 002527) differed by five nucleotides from that of the reference S. uberis 
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strain HN1, whereas the latter (U41048) was 100% identical to that of the reference 
strain.  The reason underlying this discrepancy is as yet unknown.  According to 
Clarridge (2004), 16S rRNA gene sequences deposited in public databases such as 
GenBank, in the early 1990s have many more incorrect and indeterminate bases than 
more recently generated sequences (Clarridge, 2004) and one should be aware of the 
presence of incorrect sequences in public databases and exclude wherever possible 
such sequences from any subsequent analyses. 
 
In summary, of the 48 isolates that were morphologically similar to Streptococcus 
spp. and examined biochemically, 41 were confirmed to be S. uberis following 16S 
rRNA gene sequence analysis.  An additional five isolates included in this study that 
were obtained from the veterinary diagnostic lab were also additionally confirmed to 
be S. uberis following 16S rRNA gene sequencing analysis. 
 
In the present study, the species specific 16S and 23S rRNA gene PCRs (Hassan 
et al., 2001) were clearly demonstrated not to be capable of differentiating S. iniae-like 
and S. pseudoporcinus-like isolates from S. uberis.  Accordingly, to facilitate 
differentiation from closely related Streptococcus species, additional assays such as 
the PauA gene PCR (Zadoks et al., 2005a) should routinely be performed to provide 
additional confirmatory identification of S. uberis at the species level. 
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4 Chapter 4 PFGE Analysis 
4.1 Introduction 
The ability to control S. uberis mastitis depends on a detailed knowledge of the 
epidemiology of the organism and the management of the herd and its environment.  
Implicit to the epidemiology of S. uberis is the requirement of precise methods for the 
assignment of isolates at the subspecies level. 
 
Various subtyping methods have been developed to differentiate subspecies of 
S. uberis.  These methods are classified into two types; conventional subtyping and 
molecular based.  The conventional subtyping methods include serotyping 
(Groschup et al., 1991; Jayarao et al., 1991b; Khan et al., 2003; Lammler, 1991), 
biotyping (Jayarao et al., 1991b; Jayarao et al., 1991c; Lammler, 1991), antibiotic 
susceptibility typing (Jayarao et al., 1991c), phage typing (Hill and Brady, 1989; 
Phuektes et al., 2001b), and bacteriocin-like inhibitory substance fingerprinting 
(Jayarao et al., 1991c; Tagg and Vugler, 1986).  While conventional methods are 
useful for primary identification of subspecies, they may not provide sufficient 
resolution to differentiate species subtypes and often lack reproducibility.  For 
instance, serological tests are of little value for the differentiation of S. uberis subtypes 
since approximately 50% of isolates are serologically ungroupable (Roguinsky, 1971).  
Hill et al. (1989) suggested the possible application of phage typing since 
approximately 40% of S. uberis strains isolated from a single farm carried lysogenic 
phages, but this method lacked specificity and reproducibility (Hill and Brady, 1989). 
 
Molecular based subtyping methods based on restriction endonuclease 
fingerprinting have been developed and widely applied in many epidemiological 
studies of bacteria including S. uberis.  RFLP (Hill and Leigh, 1989; Jayarao et al., 
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1991c; Jayarao et al., 1993) and PFGE (Baseggio et al., 1997; Douglas et al., 2000; 
Gillespie et al., 1998; Khan et al., 2003; Phuektes et al., 2001b; Wang et al., 1999) 
were shown to be useful for the subtyping of S. uberis. 
 
Early studies by Jayarao et al. (1991) used an RFLP method based on the 
digestion of chromosomal DNA with Hind III to differentiate S. uberis subtypes.  
Forty-two S. uberis isolates, from 17 cows with clinical and subclinical mastitis in two 
herds collected at different periods of the lactation cycle, were successfully divided 
into 17 RFLP types (Jayarao et al., 1991c).  In a follow up study, Jayarao et al. 
(1993) differentiated 35 RFLP types in 50 isolates from nine herds with clinical and 
subclinical mastitis.  These studies demonstrated the occurrence of a broad 
spectrum of S. uberis RFLP types.  However, the observed RFLP diversity was less 
in isolates from cases of clinical mastitis than from non-clinical cases.  In addition, 
isolates with identical RFLP patterns were found within a herd, but similar RFLP 
patterns were not shared between isolates from different herds.  Although RFLP has 
high discriminatory power, it has several disadvantages.  It requires extracted DNA 
of high purity and physical integrity as degradation or incomplete digestion of the 
genomic DNA can lead to inconclusive results (Bai and Wong, 2004; Jayarao et al., 
1993). 
 
PFGE has several advantages over RFLP.  A great advantage of PFGE is the 
ability to separate large DNA fragments, up to 1,000,000 base pairs in length.  In 
addition, as the whole bacterial chromosome is subject to analysis by PFGE it has 
higher discriminatory power and is capable of the differentiation at subspecies level 
with high reproducibility (Agvald-Ohman et al., 2004; Bert et al., 1997; Tenover et al., 
1995).  For these reasons, PFGE has been applied extensively in many bacterial 
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epidemiological studies, and several investigators have used it to investigate the 
epidemiology of S. uberis (Douglas et al., 2000; McDougall et al., 2004; Phuektes et 
al., 2001b; Wang et al., 1999). 
 
Previous S. uberis epidemiological studies have demonstrated that many different 
PFGE types were present in each herd investigated (Douglas et al., 2000; McDougall 
et al., 2004; Phuektes et al., 2001b; Wang et al., 1999).  Phuektes et al. (2001) found 
a total of 62 different PFGE types among 138 isolates from four herds (Phuektes et al., 
2001b), and Douglas et al. (2000) identified 330 PFGE types from a total of 342 
S. uberis isolates collected from 15 farming regions in New Zealand and a single 
isolate from the US (Douglas et al., 2000).  These findings are in agreement with 
earlier RFLP studies and clearly demonstrate that S. uberis is a highly genetically 
diverse species (Jayarao et al., 1991c). 
 
In contrast, several studies have reported that chronically infected cows often 
harbour the same PFGE type of S. uberis from one milking period to the next 
(McDougall et al., 2004; Phuektes et al., 2001b; Pullinger et al., 2007; Wang et al., 
1999).  In addition, there are reports suggesting cow-to-cow transmission of a single 
clone (Baseggio et al., 1997; Phuektes et al., 2001b; Wang et al., 1999) and a single 
paper reported the presence of a predominant type being found in some herds 
(Phuektes et al., 2001b).  These observations strongly suggest that some S. uberis 
strains are either hyper-virulent or hyper-transmissible between cows and that a 
contagious route, such as via transmission of strains during milking, could play an 
important role in some dairy herds (Phuektes et al., 2001b; Wang et al., 1999; Zadoks 
et al., 2003). 
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While PFGE is recognized as the “Gold Standard” for the typing of many bacteria, 
there are some inherent difficulties with its use.  The most significant variable is the 
standardization of the assay, i.e. running conditions, preparation of samples and 
interpretation of PFGE band patterns (Tenover et al., 1995).  Standardized PFGE 
methods are available for common food-borne disease causing bacteria such as 
E. coli O157:H7, Salmonella, Shigella, Listeria, or Campylobacter at PulseNet 
(http://www.cdc.gov/pulsenet/index.htm) and are coordinated by the Center for 
Disease Control and Prevention (CDC) (Hedberg and Besser, 2006), however, no 
such standardized method is available for S. uberis, therefore inter-laboratory 
comparison of PFGE data is difficult and represents a significant impediment to 
worldwide epidemiological studies on S. uberis.  In addition, manual interpretation of 
PFGE profiles is highly subjective, particularly when comparing a large number of 
samples on multiple gel electrophoresis images.   
 
In order to improve on the reproducibility of PFGE assays, GelCompar II software 
(Applied Maths, Kortrijk, Belgium) has been applied to the analysis of Salmonella 
enteritidis, Bordetella pertussis and Moraxella catharrhalis PFGE profiles (Liebana et 
al., 2004; Peppler et al., 2003; Wolf et al., 2000).  GelCompar II software facilitates 
the standardization of gel electrophoresis images based on molecular weight 
markers, edits distortion and allows the comparison of PFGE patterns from multiple 
images with minimum operator subjectivity (Cardinali and Martini, 1999; Gerner-Smidt 
et al., 1998). 
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4.1.1 Aims 
The aim of this study was to determine the epidemiology of S. uberis based on 
PFGE types of 46 Australian isolates encompassing isolates from both clinical / 
subclinical mastitis and isolates from cows with low cell counts in their milk. 
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4.2 Methods  
4.2.1 Isolates 
In total, 46 S. uberis isolates were used, details of the isolates and related 
information such as SCC have been described earlier in Chapter 2.  These isolates 
were obtained from quarter milk samples of Victorian dairy cattle and confirmed as 
S. uberis as described in Chapter 3.  Twenty isolates were from cows with clinical 
mastitis, 16 from subclinical cases and 10 from cows with low SCC in their milk.  The 
geographic distribution of the samples was as follows: of the 46 isolates, 29 were from 
25 cows from a dairy farm in Newry (Eastern Victoria); 12 isolates from 6 cows in 
Timboon (Western Victoria) and 5 isolates from a centralized veterinary diagnostic 
laboratory (Gippsland Vetnostics, Traralgon, Victoria). 
 
4.2.2 PFGE 
PFGE was based on the methods described previously (Phuektes et al., 2001b; 
Smith and Cantor, 1987) with the following modifications.  S. uberis isolates were 
incubated in 10 ml of THB for 16 hrs at 37°C with gentle shaking.  Cells were 
harvested by centrifugation for 15 min at 3382 × g and resuspended in 1 ml Pett IV 
buffer.  An aliquot of the S. uberis suspension was then mixed with same volume of 
2.4% (w/v) low melting point agarose in Pett IV buffer and dispensed to plug moulds.  
Plugs were incubated at 37°C for 16 hrs in Lysis solution.  The plugs were 
subsequently incubated in ESP buffer for 16 hrs at 50°C, and then incubated in TE 
buffer with 1 mM PMSF for 2 hrs at 37°C, followed by four 15 min washes with TE 
buffer.  For restriction endonuclease digestion, plugs containing S. uberis genomic 
DNA were digested with 40 U of Sma I at 30°C overnight.  Sma I was chosen since it 
had been successfully used in earlier PFGE typing studies for other Gram positive 
cocci such as S. aureus (Anderson and Lyman, 2006) and group B streptococci 
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(Duarte et al., 2004).  In addition, Sma I is most suitable for the restriction 
endonuclease cleavage of genomes with a G+C content of 40% (Bert et al., 1997) 
which is close to that of S. uberis (36.63 %) (http://pubmlst.org/suberis). 
 
The plugs were then loaded into a 1% (w/v) SeaKem Gold Agarose gel and the 
Sma I digested DNA fragments were separated by PFGE using a CHEF DR-II 
chamber at 14°C in TBE buffer with pulse times of 5 s to 15 s for 7.7 h and 15 s to 
45 s for 9.5 h at 6 V/cm.  The Lambda Ladder PFG Marker was used as a molecular 
weight marker in the range 50 to 1000 kb and loaded at both ends of the gel and at 
every fifth well.  Gels were stained with ethidium bromide (0.5 μg/ml) and the DNA 
bands were visualized using the Gel Doc 2000 imaging system. 
 
GelCompar II software (Applied Maths, Kortrijk, Belgium) was used to perform 
cluster analysis and to construct a dendrogram using the unweighted pair group mean 
with arithmetic average (UPGMA) based on Dice coefficients using 0.75% 
optimization and 1% tolerance parameters.  While a large number of different 
algorithms such as Pearson correlation; cosine correlation; Dice; Nei and Li; Jaccard; 
Jeffrey's X and Ochiai can be used for GelCompar analysis, the Dice method was 
adopted in this study as this was the method of choice in the majority of previous 
studies and facilitated comparison with the greatest number of earlier studies (Fang et 
al., 2008; Liebana et al., 2004; Zarrilli et al., 2005).  PFGE patterns showing <80% 
similarity were assigned as different types and each PFGE type was designated using 
Arabic numerals e.g. 1, 2, 3, 4; PFGE patterns with similarity values >80% and <100% 
were assigned as subtypes and each subtype was designated by a letter e.g. a, b, c, 
d.  A group of isolates belonging to the same type, together with all subtypes were 
assigned to a cluster.  The use of an 80% cut-off for assignment of types has been 
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used in previous PFGE studies (Carrico et al., 2006; Fang et al., 2008; Gertz et al., 
2003; Giske et al., 2006; Liebana et al., 2004; Speijer et al., 1999; Zarrilli et al., 2005) 
facilitating the identification of clusters were four to six bands different fulfilling the 
criteria of Tenover et al. (1995) which is widely regarded as the “gold standard” for the 
assignment of PFGE types (Tenover et al., 1995).  In addition, other previous studies 
demonstrated that an 80% similarity value was useful and corresponded to the 
Tenover’s criteria as defining types by Dice/UPGMA dendrograms of SmaI profiles of 
S. pneumoniae (Carrico et al., 2006; Gertz et al., 2003).  Clusters are denoted by a 
bar in the dendrograms and given the Arabic numerals corresponding to their PFGE 
type.  The allocation of types and subtypes was additionally confirmed following 
visual inspection of the gels and application of the Tenover criteria (Tenover et al., 
1995), where indistinguishable profiles, those differing by up to three bands and 
profiles differing by more than three bands represented the same PFGE type, 
subtypes and different types respectively (Tenover et al., 1995). 
 
4.2.3 Data analysis 
The Simpson’s index of diversity (D), a measure of discriminatory power with 95% 
confidence intervals (95% CI), of the PFGE method used was determined using the 
following equations (Grundmann et al., 2001; Hunter and Gaston, 1988). 
 
 
and 
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Where N or n is the total number of strains in the sample population, s is the total 
number of types in the population, and nj is the number of strains belonging to the jth 
type. 
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4.3 Results 
4.3.1 PFGE analysis 
Sma I digestion of S. uberis chromosomal DNA generated 7 to 13 distinctive bands 
, with the majority of PFGE types consisting of more than 10 distinctive bands (Figure 
 4-1).  Analysis of the 46 Australian S. uberis isolates by PFGE demonstrated 
considerable genetic diversity and in total, 42 PFGE types (including subtypes) were 
identified (Figure  4-1).  Simpson’s index of diversity of the PFGE typing (D = 99.5%; 
95% CI, 97.8% to 100%) was comparable to that observed in a previous study using 
the same restriction enzyme (D = 98.9%) (Phuektes et al., 2001b).  
 
Two major clusters and five minor clusters were observed (Figure  4-1).  Cluster 
PFGE type 5 comprised four subtypes (a, b, c, d) identified from four cows on the 
Newry farm.  Cluster PFGE type 8 consisted of two subtypes (a, b) comprising four 
isolates from two different cows on the Timboon farm.  In contrast, three of the four 
isolates in Cluster PFGE type 8 had identical PFGE types.  The remaining five minor 
clusters, Cluster PFGE type 10, 11, 20, 23 and 31, consisted of two different PFGE 
subtypes with Clusters PFGE type 20 and 23 consisting of two identical PFGE types.  
In no instance were identical PFGE types observed from cows on different farms, but 
in one case, different subtypes of the same PFGE type (Cluster PFGE type 10, 
subtype 10a and 10b) were isolated from two different geographically distant farms 
(Timboon and Newry)(Figure  4-1). 
 
The distribution of PFGE types according to disease status is shown on the 
dendrogram (Figure  4-1).  Although isolates from cows with low cell counts were 
distantly related, these isolates were nevertheless clustered at the centre of the 
dendrogram (Figure  4-1).   
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Figure  4-1. Dendrogram of 46 Australian S. uberis isolates using UPGMA 
 
a Clusters are denoted by the bars and Arabic numbers which corresponded to the PFGE type.  
b The PFGE types and subtypes are represented with Arabic numbers and letters, respectively.   
c The disease status is indicated as C (clinical mastitis), S (subclinical), and L (low somatic cell count). 
d Isolate identification.  e N, Newry; T, Timboon; C, Camperdown; K, Korumburra; Moe, Moe; Maf, Maffra. 
f The global clonal complexes (GCCs) as subsequently assigned to the isolates in Chapter 5 are given.
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4.3.2 Standardization of inter-gel images using GelCompar II 
Multiple PFGE inter-gel electrophoresis images were standardized and combined 
using GelCompar II to generate the dendrograms (Figure  4-1).  GelCompar ll 
analysis facilitated the identification of two closely related PFGE types, from two 
different farms, which clustered in PFGE type 10 (Figure  4-1).  Manual assignment of 
these PFGE profiles on each different PFGE gel electrophoresis image may not 
correctly assigned them as subtypes according to Tenover’s criteria (Tenover et al., 
1995).  Another example was the two different isolates in Cluster PFGE type 20 
(Figure  4-1).  Manual observation of the two different gel electrophoresis PFGE 
images showed slight differences in the position of the bands (Figure  4-1).  However, 
after standardization of the two PFGE profiles with the position tolerance function 
implemented in the GelCompar II software, the two profiles were assigned as 
identical.  The assignment of these two isolates as identical PFGE types was 
subsequently confirmed following MLST analysis, which demonstrated that the two 
isolates belonged to same sequence type Sequence Type, (ST 258). 
 
GelCompar II analysis greatly facilitates inter-run comparison and assignment of 
the correct PFGE type.  For example, the two PFGE profiles (3217-2 and 3217-2#2) 
were generated from the same sample in two different PFGE gels using identical 
running conditions.  The GelCompar II comparison (Figure  4-2) highlighted that there 
were slight differences between the two PFGE profiles and suggested that the two 
samples were not identical.  However, subsequent re-analysis implementing the 
position tolerance function of GelCompar II correctly assigned both PFGE profiles as 
identical.  This highlights the importance of the implementation of the position 
tolerance function for all GelCompar II inter-run PFGE profile analysis. 
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Figure  4-2. Example of problem of standardization using GelCompar II. 
 
Two PFGE results (3217-2 and 3217-2#1) were generated by two different runs using an 
identical sample and the same conditions of PFGE. 
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4.4 Discussion 
Analyses of the 46 Australian isolates by PFGE demonstrated the occurrence of a 
genetically diverse population (Figure  4-1).  The Simpson’s index of diversity 
following PFGE typing (D = 99.5%; 95% CI, 97.8% to 100%) was comparable to that 
observed in a previous study (Phuektes et al., 2001b) further confirming the 
discriminatory power of PFGE typing as sufficient for subtyping of S. uberis 
populations.  The digestion of S. uberis chromosomal DNA by Sma I in most 
instances resolved at least 10 distinct fragments fulfilling PFGE guideline criteria 
(Tenover et al., 1995) and further supported the utility of Sma I as the restriction 
enzyme of choice for PFGE typing. 
 
No particular clone or PFGE type of S. uberis predominated in the Australian 
isolates.  Although PFGE type 8a had the highest prevalence (n = 3), it nevertheless 
comprised less than 10% of the total population.  Clustering analysis demonstrated 
the occurrence of seven clusters (Figure  4-1), which each consisted of only two to four 
isolates, with the clusters being highly divergent, differing from one another by more 
than 60% (Figure  4-1).  These findings were in agreement with most previous studies 
(Baseggio et al., 1997; Douglas et al., 2000; McDougall et al., 2004; Wang et al., 
1999), but contrast with a previous Australian study which, although also reported the 
occurrence of a genetically diverse population, demonstrated that two strains 
predominated at higher prevalence (>20%) in two of the four herds (Phuektes et al., 
2001b).  One possible explanation of the high prevalence of particular clones in the 
previous Australian study (Phuektes et al., 2001b) could be as a result of clonal 
expansion during an outbreak of S. uberis at that time. 
 
Chapter 4. PFGE analysis 
 
 
92 
The main source of S. uberis infection is believed to be the cows’ environment 
including their faeces (Douglas et al., 2000; McDougall et al., 2004; Zadoks et al., 
2003; Zadoks et al., 2005b).  Since in the earlier studies most of the PFGE patterns 
were only distantly related and lacked a predominate type, the results in the present 
study further substantiate that the main route of infections of S. uberis could be from 
the cow’s environment. 
 
Whilst in the present study there were a few cases of identical PFGE types isolated 
from different cows, suggesting possible transmission between cows or from a 
common source, these events seemed to be uncommon and are in agreement with 
previous studies (Baseggio et al., 1997; Douglas et al., 2000; McDougall et al., 2004; 
Phuektes et al., 2001b; Wang et al., 1999).  In addition, there was no evidence of an 
identical PFGE pattern observed in different herds which was consistent with most 
other PFGE-based S. uberis epidemiological studies (Baseggio et al., 1997; Douglas 
et al., 2000; McDougall et al., 2004; Wang et al., 1999). 
 
With regards to the possible route of infection, all of the isolates belonging to 
Cluster PFGE type 5, which were from four different cows with clinical mastitis, were 
closely related, but not identical types, suggesting they had not been acquired by 
cow-to-cow transmission in the recent past.  Nevertheless, it is unlikely that four 
different cows acquired the four closely related isolates from the environment 
simultaneously.  The origin of these isolates seemed to be neither contagious nor 
from the environment in this case.  One explanation for the occurrence of such 
closely related PFGE types could be that infection occurred from a common ancestor 
and subsequently became chronic.  This was followed by rearrangement of 
chromosomal DNA by recombination or transduction generating the four different 
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concurrent PFGE subtypes.  This hypothesis is further supported by previous 
studies.  The first study reported that two isolates, which differed by only 1 or 2 
bands, were isolated sequentially from chronically infected glands (McDougall et al., 
2004) while the second study reported eight of 20 cows harboured the same PFGE 
type for periods of up to five months, and generated PFGE subtypes during the 
course of chronic infection (Wang et al., 1999).  In addition, in the present study there 
was a single case of two closely related subtypes (8a and 8b) from different quarters 
of the same cow which possibly arose as a result of recombination during chronic 
infection. 
 
While PFGE studies have facilitated the investigation of some important aspects of 
S. uberis epidemiology, there has been no worldwide epidemiological study 
conducted using PFGE.  This has been largely due to the difficulties with regard to 
inter-laboratory comparison of PFGE results and lack of standardized methods.  The 
results of this study have demonstrated that the application of GelCompar II to PFGE 
analysis could significantly improve the standardization of PFGE-based 
epidemiological studies and facilitate intra-laboratory analysis.  However, to date, no 
S. uberis PFGE epidemiological studies have used GelCompar II (Baseggio et al., 
1997; Douglas et al., 2000; McDougall et al., 2004; Phuektes et al., 2001b; Wang et 
al., 1999). 
 
In this study, GelCompar II was successfully used to improve the standardization of 
PFGE analysis.  For example, as observed in the clustering of the two isolates 
originating from different farms (Cluster PFGE type 10, Figure  4-1), manual 
designation of PFGE type without GelCompar II standardization would have assigned 
these isolates as unrelated unless they had been run adjacent to each other on the 
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same gel.  However, after GelCompar II standardization of the two PFGE profiles, 
there were only three band differences (Figure  4-1) which assigned them as subtypes 
according to the Tenover’s criteria (Tenover et al., 1995).  Another example was the 
identification of clones in Cluster PFGE type 20 (Figure  4-1).  Manual observation of 
the two PFGE profiles without the GelCompar II standardization, revealed slight 
differences in the position of the bands (Figure  4-1), and these isolated would have 
been manually assigned to different PFGE types.  However, after the GelCompar II 
standardization of the two profiles, with the position tolerance function implemented in 
the software, these isolates were recognized as identical PFGE types (Figure  4-1).  
The designation of these isolated as identical PFGE types was further supported by 
subsequent MLST analysis which demonstrated that these two isolates belonged to 
the same Sequence Type (Chapter 5; Table  5-2).   
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4.5 Conclusions 
PFGE analyses of the Australian isolates provided useful information with regards 
to the epidemiology of S. uberis.  It was clear that PFGE is particularly useful for the 
analysis of a small number of genetically closely related isolates because of its high 
discriminatory power (Tenover et al., 1995).  However, the major disadvantage of 
PFGE is that it may not provide accurate phylogenetic analysis when dealing with a 
large number of distantly related isolates and in particular within a species such as 
S. uberis undergoing substantial recombination (Coffey et al., 2006; Tenover et al., 
1995; Zadoks et al., 2005a). 
 
The ultimate purposes of epidemiological data are to facilitate improvement of 
worldwide S. uberis infection control and vaccine development.  However to date, 
there has been no worldwide epidemiological study of S. uberis conducted using 
PFGE.  This is largely due to the difficulties associated with inter-laboratory 
comparison of PFGE results and lack of a standard method available for S. uberis.  
 
To overcome the inherent difficulties associated with the inter-laboratory 
comparison of PFGE data, an additional epidemiological tool is required.  In recent 
years, MLST has provided a means whereby unambiguous results can be generated 
for the typing of bacterial isolates (Feil and Enright, 2004).  Of particular significance, 
the availability of a web-based S. uberis MLST database which greatly facilitates 
inter-laboratory comparisons and the study of the global epidemiology of S. uberis 
(Coffey et al., 2006; Pullinger et al., 2007; Pullinger et al., 2006; Tomita et al., 2008). 
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5 Chapter 5 Multilocus Sequence Typing 
5.1 Introduction 
In the previous chapter it was shown that many different PFGE types of S. uberis 
were present on a single farm, suggesting that the species is behaving as an 
opportunistic pathogen.  There were three cases of an identical PFGE type being 
identified from different cows within the same farm and one case of different subtypes 
being isolated from different quarters of the same cow.  These findings suggest that 
cow-to-cow or quarter-to-quarter transmission of S. uberis occurred, and are in 
agreement with previous studies (Baseggio et al., 1997; Phuektes et al., 2001b; 
Zadoks et al., 2003). 
 
Chronically infected cows often harbour the same PFGE type from one milking 
season to the next (Pullinger et al., 2007; Wang et al., 1999).  The results of the 
present study detailed in Chapter 4 and earlier PFGE-based epidemiological studies 
(McDougall et al., 2004; Phuektes et al., 2001b; Pullinger et al., 2007; Wang et al., 
1999) suggest the possibility that some strains of S. uberis are either hyper-virulent 
and transmissible between cows, or able to survive in a host, for example by evading 
the host immune response.  However, it has not been conclusively proven, whether 
certain clones with enhanced virulence are responsible for mastitis.  In addition, 
despite numerous epidemiological studies using PFGE, no clear evidence with 
regards to the relatedness of S. uberis isolates from different herds has been reported 
in the literature.  As discussed previously, this lack of evidence can be attributed 
partly to the inherent difficulties associated with the inter-laboratory comparison of 
PFGE-based epidemiological studies. 
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Multilocus sequence typing (MLST) differs fundamentally from PFGE and most 
other molecular typing methods, as it is based on nucleotide sequence data from 
approximately 500 bp of multiple housekeeping genes.  The different sequences at 
each locus (the house keeping gene) are assigned different allele numbers, and each 
strain is defined by the alleles at multiple loci which is referred to as the allelic profile.  
Each unique allelic profile is assigned a sequence type (ST), which is an 
unambiguous notation of the individual strain and greatly facilitates inter-laboratory 
comparisons and the study of global epidemiology (Feil and Enright, 2004). 
 
MLST uses housekeeping genes that have been shown to accumulate sequence 
variation slowly, in contrast to PFGE which uses whole genomic DNA.  Accordingly 
MLST is much less affected by recent rearrangement of the genome by recombination.  
Consequently, MLST has greater utility for determining the recent ancestral linage 
and the relatedness of individual strains.  In addition, MLST utilizes multiple genes 
for analysis, which provides substantial discriminatory power for subtyping.  In some 
species, inclusion of one or more virulence-associated genes (multi-locus virulence 
sequence typing) can be used to further increase the discriminatory power (Lemee et 
al., 2005; Lemee et al., 2004; Tankouo-Sandjong et al., 2007; Zhang et al., 2004). 
 
MLST schemes are available for at least 48 species including bacteria and 
eukaryotes (at the PubMLST website [http://pubmlst.org/] and at the MLST home 
website [http://www.mlst.net/]), with at least 30 additional MLST schemes currently 
under development.  Examples of the MLST schemes available for common 
eukaryotes and bacteria are as follows: Candida albicans (Bougnoux et al., 2002), 
Candida krusei (Jacobsen et al., 2007), Neisseria meningitidis (Maiden et al., 1998), 
E. coli (Wirth et al., 2006), Campylobacter jejuni (Dingle et al., 2001), S. aureus and 
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S. epidermidis (Enright et al., 2000; Thomas et al., 2007), E. faecalis (Ruiz-Garbajosa 
et al., 2006), S. pyogenes (Enright et al., 2001), S. agalactiae (Jones et al., 2003) and 
S. uberis (Coffey et al., 2006). 
 
Analyses of isolates of several bacterial species by MLST (Enright et al., 2001; 
Maiden et al., 1998; Meats et al., 2003) demonstrated that a considerable proportion 
of a population belongs to a limited number of clusters of closely related genotypes 
referred to as a clonal complex (CC).  This clonal expansion results from the rise in 
frequency of a single highly adaptive genotype, which is generally regarded as the 
founder of a particular CC.  These ancestral genotypes subsequently diversify 
through recombination or mutation to produce minor clonal variants, which include 
single-locus variants (SLVs) and double-locus variants (DLVs), of the founder CC.  
SLVs or DLVs have allelic profiles that differ from those of the founder of a CC at only 
one or two of the MLST loci respectively (Feil et al., 2004; Feil and Spratt, 2001; Smith 
et al., 1993).  Isolates belonging to CC are epidemiologically significant, for instance 
previous studies have demonstrated that internationally disseminated MRSA isolates 
and several pandemic MRSA clones all belong to a single clonal complex; CC8 
(Crisostomo et al., 2001; Enright et al., 2002; Feil and Enright, 2004).   
 
Analysis, including the identification of CCs and the relatedness of a bacterial 
population, e.g. links between ancestors and descendents in the MLST dataset, can 
be determined by the program, “Based Upon Related Sequence Types” (BURST) and 
“enhanced Based Upon Related Sequence Types” (eBURST) analysis.  Although a 
clustering algorithm such as UPGMA is useful for examining the genetic relatedness 
of small numbers of isolates, dendrograms produced using larger datasets often lack 
accuracy as UPGMA is not based on an evolutionary model (Feil and Enright, 2004).   
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BURST and eBURST are web-implemented clustering algorithms designed for use 
on MLST datasets from bacterial pathogens.  BURST is implemented in the software, 
Sequence Type Analysis and Recombinational Tests, Version 2 (START2) (Jolley et 
al., 2001).  START2 also analyses the ratios of nonsynonymous to synonymous 
substitutions (dN/dS) that reflect the level of selection, the number of polymorphic 
nucleotide sites, the G+C ratios for each loci and the standardized index of 
association (ISA) (Haubold et al., 1998) which measures the degree of linkage 
equilibrium between allelic profiles and estimates the rate of recombination.  The 
eBURST program is available at the eBURST web site (http://eburst.mlst.net/) (Feil et 
al., 2004; Spratt et al., 2004). 
 
Both BURST and eBURST use the same algorithm.  These programs first 
subdivide large MLST data sets into CCs which are defined as a group of STs sharing 
at least five out of seven identical allelic profiles with at least one other member of the 
group.  This definition is the default setting for the BURST whereas six out of seven 
identical allelic profiles is the default setting of the eBURST.  Although these 
definitions are arbitrary and can be changed, e.g. to four out of seven loci, it is highly 
recommended to use the default settings to maintain the accuracy of results (Feil et 
al., 2004; Spratt et al., 2004).  Next, the programs identify a founder, which is the ST 
with the largest number of SLVs in a CC.  Once the founder of the CC has been 
identified, other strains within the CC are assigned according to their relationships with 
the founder, i.e. SLV and DLV, which represent likely patterns of descent within each 
CC. 
 
Although both programs use the same algorithm, there are some advantages of 
using eBURST over BURST.  The eBURST program uses a bootstrapping procedure 
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to determine the confidence level in the initial assignment of the founder in each CC 
(Feil et al., 2004).  In addition, eBURST attempts to link all STs in dataset by a line.  
Thereafter it follows a procedure of linking SLVs to DLVs and then to TLVs (triple 
locus variants) until all links have been made.  Accordingly eBURST can determine 
the relationship between different CCs and displays the overall structure of the 
population (Aanensen and Spratt, 2005), whereas BURST specifically examines the 
relationships between very closely related genotypes within CCs but not the 
relationships between different CCs (Feil et al., 2004). 
 
The relative contributions of recombination and mutation to clonal divergence can 
be determined by the molecular events that give rise to SLVs in a CC.  For instance, 
multiple nucleotide differences between a variant allele in a SLV (descendent allele) 
and the corresponding allele in the founder of a CC suggests that the new variant 
allele arose by recombination.  In contrast, a single nucleotide difference between a 
variant allele in a SLV and the corresponding allele in the founder of a CC suggests 
that the new variant allele arose as a result of point mutation (Feil et al., 2000b).  
Therefore, the rate of recombinational to mutational events can be determined 
empirically by counting the total number of variant alleles that arose by recombination 
or by point mutation in CCs (Feil et al., 2000b).  Furthermore, the per site ratio of 
recombination to mutation parameter can be calculated by counting the number of 
polymorphic sites that arose by recombination and the number of nucleotides that 
arose by mutation in variant alleles (Feil et al., 2000b).  Feil et al. (2000) elucidated 
the rate of recombinational to mutational events of N. meningitidis and S. pneumoniae, 
which are naturally transformable species, as 4:1 in N. meningitidis and 10:1 in 
S. pneumoniae.  In contrast, the per site ratio of recombination to mutation was at 
least 80:1 in N. meningitidis and 50:1 in S. pneumoniae.  These findings indicate that 
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recombination events, rather than mutational events, are more common in 
S. pneumoniae than in N. meningitidis, however, allele diversity was higher in 
N. meningitidis than in S. pneumoniae (Feil et al., 2000a). 
 
Two MLST schemes have been developed for the typing of S. uberis.  The initial 
MLST scheme (Zadoks et al., 2005a) used the pauA gene which encodes a virulence 
factor (plasminogen activator A) and the GapC gene which encodes a vaccine target 
(glyceraldehyde-3-phosphate dehydrogenase) (Fontaine et al., 2002).  The pauA 
gene has been shown to exhibit a high ratio of dN/dS (>1.0) (Zadoks et al., 2005a) 
indicating positive selection, and therefore may not facilitate accurate phylogenetic 
analyses (Coffey et al., 2006).  In addition, the initial MLST scheme (Zadoks et al., 
2005a) uses only six loci and as such may not provide sufficient resolution for large 
datasets compared with the seven loci used in the more recent MLST scheme (Coffey 
et al., 2006).  For these reasons I chose to use the MLST scheme developed by 
Coffey et al. (2006) for MLST analyses of Australian S. uberis isolates. 
 
5.1.1 Aims 
In the present study, MLST analyses were performed on a collection of Australian 
S. uberis isolates from cases of clinical and subclinical mastitis and from cows with 
low somatic cell counts in their milk.  The main aim of this study was to investigate 
the molecular epidemiology of S. uberis mastitis in Australia to ascertain whether 
there was any association of a particular MLST type with mastitis.  In addition, the 
evolutionary lineage of Australian isolates in relation to the S. uberis global population 
as a whole was investigated by comparing the MLST profiles of Australian isolates 
with those currently available on the MLST database from different countries. 
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5.2 Methods 
5.2.1 Bacterial isolates 
The 46 Australian S. uberis isolates, analysed previously by PFGE as described in 
Chapter 4, were used for MLST analysis. 
 
5.2.2 MLST analysis 
Multilocus sequence typing was performed using the primers described by 
Coffey et al. (2006).  Each PCR master mix contained 1 x PCR buffer, 0.2 mM each 
dNTP (dATP, dCTP, dGTP, dTTP), 0.4 µM of each set of primers, 1.25 U of Taq DNA 
polymerase, template genomic DNA (50 ng to 100 ng) and molecular grade water in a 
final reaction volume of 50 µl.  The PCR primers and cycling conditions used for 
each locus are detailed in Table  5-1.  The S. uberis reference strain, ATCC 700407, 
was used as a positive control.  The nucleotide sequence determination of individual 
MLST loci amplicons was performed as described in Chapter 3. 
 
The allelic profiles and STs of the individual isolates were determined using the 
query functions implemented in the S. uberis MLST database 
(http://pubmlst.org/suberis).  In this study, the CC for each ST in the MLST database, 
which had been assigned in advance by the database curator, is subsequently 
referred to as the global clonal complex (GCC). 
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Table  5-1. Primers and PCR conditions used for the S. uberis MLST scheme and hyaluronic acid gene[s] PCR 
 
Primer 
name Target gene Primer function (s) 
PCR 
product 
(bp) 
Primer sequence 
PCR 
cycling 
conditiona 
Reference 
ub-I 
ub-II 16S rRNA 
PCR 
(species identification) 445 
5'-CGCATGACAATAGGGTACA-3' 
5'-GCCTTTAACTTCAGACTTATCA-3' 
1 
 (Hassan et al., 2001) 
ub-23S-I 
ub-23S-II 23S rRNA 
PCR 
(species identification) 451 
5'-CGTATTTAAAATTGACTTTAGCC-3' 
5'-AATTTCTCCGCTACCCAC-3' 
1 
 (Hassan et al., 2001) 
16S forward 
16S reverse 16S rRNA 
PCR, sequencing 
(16S rRNA sequencing) 534 
5'-GAGAGTTTGATCCTGGCTCAGGA-3' 
5'-TTACCGCGGCTGCTGGCACGT-3' 
2 
 (Pullinger et al., 2006) 
arcC F 
arcC R arcC PCR, sequencing 518 
5'-GTTTGTGACGCAAAATCTTTATCGATAACA-3' 
5'-ACTCATGGTAACGGACCACAAGTTGGTAAC-3' 
3a 
 (Coffey et al., 2006) 
ddl F 
ddl R ddl PCR, sequencing 503 
5'-GTCTATATTGAAGGTAATGACTTGGAAGACTGT-3' 
5'-TACATGGACCACTGAGTGAATCCAGGCATAGTATTC-3' 
3b 
 (Coffey et al., 2006) 
gki F 
gki R gki PCR, sequencing 564 
5'-GACCGGACCCAAAACACAGTCACAGGTGCTTTT-3' 
5'-AAGAGAATCTGGATTTAGGATATTTGAAATATT-3' 
3a 
 (Coffey et al., 2006) 
recP F 
recP R recP PCR, sequencing 531 
5'-AATTCAGGTCACCCTGGCTTACCAATGGGTGCAGCC-3' 
5'-TGTGAAAGCCATTGATGTTGGACCATCAAGTGAAAT-3' 
3a 
 (Coffey et al., 2006) 
tdk F 
tdk R tdk PCR, sequencing 793 
5'-TATTTTCATTTCATAATAAGTTAGTGGATTTAGTAA-3' 
5'-TTGATCATATATATTCATGTTATGAATCGTTCTCCT-3' 
3a 
 (Coffey et al., 2006) 
tpi F 
tpi R tpi PCR, sequencing 471 
5'-GTTATTGGTCATTCAGAACGTCGTGATTACTTC-3' 
5'-GTCAAGTAATGCTAAGAAGCTATCTGCTTCAAGTGA-3' 
3a 
 (Coffey et al., 2006) 
yqiL F 
yqiL R yqiL PCR, sequencing 574 
5'-TTTCTTCTTTGAAACGATTATTTTTAAGTGCTTCAG-3' 
5'-CAAGCTCTAAGAACACCAATTGGTGCATTCGGAGGA-3' 
3a 
 (Coffey et al., 2006) 
yqiL in 2F 
yqiL in 2R yqiL 
PCR 
(additional primers for yqiL) 500 
5'-GCCTTTTGTTGACTATTGAATGC-3' 
5'-GCTTTTAAAGATGTTAATGCCGTTAC-3' 
3a 
 This study 
yqiL out 1F 
yqiL out 1R yqiL 
PCR 
(additional primers for yqiL) 772 
5'-CATTTCCAGCTGTAACAGTCC-3' 
5'-TTTCTATTTATGCAAAGGAGTCG-3' 
3a 
 This study 
hasA-for 
hasA-rev hasA PCR 319 
5'-GAAAGGTCTGATGCTGATG-3' 
5'-TCATCCCCTATGCTTACAG-3' 
1 
 (Field et al., 2003) 
hasC-for 
hasC-rev hasC PCR 225 
5'-TGCTTGGTGACGATTTGATG-3' 
5'-GTCCAATGATAGCAAGGTCAC-3' 
1 
 (Field et al., 2003) 
 
a
 PCR conditions were as follows: 
Condition 1:   5 min at 95°C; 28 cycles (1 cycle consisting of 30 s at 95°C, 30 s at 58°C, and 2 min at 72°C) and 5 min at 72°C 
Condition 2:   5 min at 94°C; 35 cycles (1 cycle consisting of 30 s at 94°C, 60 s at 56°C, and 90 s at 72°C) and 6 min at 72°C 
Condition 3a:  5 min at 95°C; 40 cycles (1 cycle consisting of 30 s at 95°C, 30 s at 55°C, and 45 s at 72°C) and 7 min at 72°C 
Condition 3b:  5 min at 95°C; 40 cycles (1 cycle consisting of 30 s at 95°C, 30 s at 63°C, and 45 s at 72°C) and 7 min at 72°C 
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5.2.3 Data analysis 
5.2.3.1 Simpson’s index of diversity (D) 
The Simpson’s index of diversity (D) using a 95% CI was determined as described 
previously in Chapter 4. 
 
5.2.3.2 MLST loci analysis 
The ratios of dN/dS that analyze the level of selection, the G+C ratios and the 
number and proportion of variable nucleotide sites for each of the seven loci were 
analysed using START2 (Jolley et al., 2001). 
 
5.2.3.3 Lineage analysis 
Lineage analyses of the 46 Australian S. uberis isolates were performed using an 
UPGMA-based dendrogram using START2 (Jolley et al., 2001).  The program 
eBURST version 3 (http://eburst.mlst.net/) was used to investigate the population 
structure of the Australian S. uberis and the relatedness of Australian isolates in the 
global population of S. uberis.  For eBURST analyses, an individual CC was defined 
as a group of isolates which shared alleles at 6 of the 7 MLST loci (Feil and Enright, 
2004; Feil et al., 2004; Spratt et al., 2004). 
 
5.2.3.4 Standardized index association 
The standardized index of association (ISA) (Haubold et al., 1998) was calculated 
using START2.  ISA measures the degree of linkage equilibrium between allelic 
profiles and estimates the rate of recombination (Koehler et al., 2003; Smith et al., 
1993; Suerbaum et al., 2001). 
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5.2.4 The ratio of recombinational to mutational events and the per site ratio of 
recombination to mutation 
The rates of recombination to mutation and the per site ratio of recombination to 
mutation parameter were determined as described by Feil et al. (2000b).  CCs and 
SLVs were identified among STs following BURST analysis (Jolley et al., 2001).  The 
rate of recombinational to mutational events was empirically determined by counting 
the total number of variant alleles that arose by recombination or by point mutation in 
the CCs.  Multiple nucleotide differences between a variant allele in a SLV 
(descendent allele) and the corresponding allele in the founder of a CC suggested the 
variant allele arose by recombination whereas a single nucleotide sequence 
difference was interpreted as arising by point mutation.  The per site ratio of 
recombination to mutation parameter was calculated by counting the number of 
polymorphic sites that arose by either recombination or mutation in variant alleles (Feil 
et al., 2000b). 
 
5.2.5 Statistical analysis 
Statistical analyses were performed using Chi-square tests using SPSS 13.0 
software (SPSS Inc., Chicago, US). 
 
5.2.6 Investigation of yqiL-negative Australian isolates 
In an attempt to amplify the yqiL gene of the four Australian isolates which were 
PCR negative using the original primers (Coffey et al., 2006), two additional primer 
pairs for the yqiL gene were designed using Primer3 (Rozen and Skaletsky, 2000).  
The primer specifications and amplification conditions used are detailed in Table  5-1 
and the binding sites of these additional primers are detailed in Figure  5-1.   
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To further confirm the absence of the yqiL gene in these isolates, Southern blot 
hybridization was performed.  For Southern blot hybridization, 1 µg of genomic DNA 
was digested with Hind III and separated by agarose gel electrophoresis at 80V for 
90 min in a 1.5% (w/v) agarose gel.  The DNA fragments were subsequently 
transferred by Southern blotting to a positively charged Hybond N+ nylon membrane, 
and hybridized with a yqiL gene probe using standard procedures as described in 
section  6.2.2.3.  A randomly-primed Digoxigenin-11-dUTP (DIG)-labelled yqiL gene 
probe was prepared using a yqiL PCR product generated from a reference 
yqiL-positive S. uberis isolate as described in section  6.2.2.1. 
 
The flanking region of the yqiL gene was further investigated to determine whether 
a possible virulence factor gene or surface protein gene was adjacent.  Any such 
association would place the locus under high selective pressure making it unsuitable 
for MLST.  The yqiL flanking region of the S. uberis genome sequence obtained from 
the S. uberis genome project (http://www.sanger.ac.uk./Projects/S_uberis/) was used 
for this analysis.   
 
The S. uberis yqiL gene was queried against the S. uberis genome sequence using 
BLASTN and BLASTX to ascertain whether possible yqiL homologues, that could 
possibly complement in yqiL-negative isolates, were present. 
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Figure  5-1. Primer binding sites of yqiL primers on the S. uberis genome.  
 
Numbers in the figure correspond to the position of nucleotide and starts at the 5´ end of the yqiL ORF 
(975 bp).  Small arrows with red color indicate the primers.  Numbers adjacent to the small red 
arrows refer to the nucleotide position of the 3´ end of primers on the yqiL gene.  The yqiL allele (439 
bp) starts at 430 bp and ends at 868 bp.  Additional primers, yqiL IN 2F and 2R bind 38 bp and 26 bp 
inside of the original primers, yqiL F and R respectively.  Other additional primers, yqiL OUT 1F and 
1R bind 147 bp and 64 bp outside of the original primers, yqiL F and R.  Numbers between primer 
pairs indicate the size of PCR products. 
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5.2.7 Detection of HasA and HasC genes by PCR and Southern blot 
hybridization 
Amplification of the capsular genes, hasA and hasC, was performed using a 
modification of a previously described method (Field et al., 2003).  The HasA or 
HasC gene PCR master mix contained 1 x PCR buffer, 0.2 mM each dNTP (dATP, 
dCTP, dGTP, and dTTP), 0.3 µM of each set of primers, 1.25 U of Taq DNA 
polymerase, 50 ng of genomic DNA template and molecular grade water to a final 
reaction volume of 25 µl.  The PCR conditions and the primers used are listed in 
Table  5-1. 
 
The isolates that were negative for hasA by PCR and the strains that were positive 
for hasA by PCR (control strains) were further examined by Southern blot 
hybridization using a randomly-primed DIG-labelled hasA gene probe generated from 
a reference S. uberis strain as described in section  6.2.2.1. 
 
5.2.8 Nucleotide sequence accession numbers 
The nucleotide sequences of the MLST alleles from the 46 Australian S. uberis 
isolates have been deposited in GenBank as a dataset with the Accession Numbers 
EF672733 to EF672747. 
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5.3 Results 
5.3.1 MLST analysis 
5.3.1.1 MLST analysis of Australian isolates 
MLST revealed 33 STs and four yqiL-negative isolates in the 46 Australian 
S. uberis isolates (Table  5-2).  Whilst five of the STs consisted of multiple isolates, 
the remaining 28 STs and the four yqiL-negative isolates consisted of single isolates.  
The Simpson’s index of diversity of the Australian MLST dataset (D = 98.6%; 95% CI, 
97.1% to 100%) was comparable to that observed previously using PFGE typing 
(D = 99.5%; 95% CI, 97.8% to 100%). 
 
The most common GCC was GCC ST143 (26%), followed by GCC ST5 (13%) and 
GCC ST86 (9%); 24 of the isolates (52%) were not assigned to a specific GCC (Table 
 5-2).  Thirty-one out of 33 STs, 4 yqiL-negative isolates and 15 of the alleles had not 
been previously recorded in the MLST database and were identified in Australia for 
the first time. 
 
The STs with the largest number of isolates were ST60 and ST155, both consisting 
of four isolates (8.7 %) (Table  5-2).  All four ST60 isolates had different PFGE types 
(including subtypes), whereas three ST155 isolates had an identical PFGE type 
(PFGE type 8a) and the fourth was a different subtype (type 8b) (Table  5-2).  The 
four Australian ST60 isolates had an identical ST to isolates originally identified in the 
UK (Pullinger et al., 2007) and one ST184 isolate had a MLST profile identical to a 
isolate from New Zealand (Pullinger et al., 2006).  In addition, the two ST194 isolates 
recovered from different farms located 100 km apart in Victoria were shown by PFGE 
analysis not to be identical strains. 
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Statistical analysis based on the geographic origin of the samples against types of 
global clonal complex (GCC) demonstrated that whilst more than 50% of the samples 
were isolated from the farm in Newry, there was no significant difference (P = 0.57) in 
the distribution of strains by geographic location of sampling against types of GCC. 
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Table  5-2. MLST profiles of 46 Australian isolates 
 
Allelec PCRg Farm  
location ST
a Isolate
b 
ID arcC ddl gki recP tdk tpi yqiL 
Global 
clonal 
complexd 
Disease
statuse 
PFGE 
Typef HasC HasA 
Newry 60 2907-1 1 1 2 2 7 1 3 5 C 3 + -(+) 
Newry 60 2481-1 1 1 2 2 7 1 3 5 C 5-b + +(+) 
Newry 60 2956-4 1 1 2 2 7 1 3 5 C 5-c + + 
Newry 60 3209-4 1 1 2 2 7 1 3 5 C 6 + + 
Timboon 153 796-2 9 1 2 2 25(N) 1 3 143 SC 2 + + 
Timboon 155 684-1 1 19(N) 2 2 17 4 3 143 SC 8-a + + 
Timboon 155 684-6 1 19(N) 2 2 17 4 3 143 SC 8-b + + 
Timboon 155 684-9 1 19(N) 2 2 17 4 3 143 SC 8-a + + 
Timboon 155 816-5 1 19(N) 2 2 17 4 3 143 SC 8-a + + 
Newry 156 2893-1 18 1 2 2 7 3 3 143 C 28 + +(+) 
Newry 184 2874-4 1 1 2 2 17 1 3 143 C 31-a + -(+) 
Newry 194 2042-5 32(N) 1 20(N) 1 17 1 3 - SC 4 + + 
Korumburra 194 5838-3 32(N) 1 20(N) 1 17 1 3 - C 24 + + 
Newry 216 2407-7 1 1 20(N) 2 17 1 3 143 SC 7 + + 
Newry 217 2655-5 3 2 21(N) 3 3 2 3 86 SC 22 + -(-) 
Timboon 251 796-3 1 1 5 2 3 1 3 - SC 13 + + 
Timboon 252 853-4 9 12 4 2 17 1 3 - C 30 + + 
Timboon 253 816-2 4 1 5 1 17 1 3 - SC 23 + + 
Timboon 253 883-4 4 1 5 1 17 1 3 - C 23 + + 
Timboon 254 868-4 37(N) 2 4 1 13 12(N) 26(N) - SC 1 + + 
Newry 255 2690-2 3 19(N) 3 2 36(N) 3 3 - SC 27 + + 
Newry 256 3147-4 1 1 13 4 2 3 3 - L 11-a + + 
Newry 257 3217-1 19 1 5 2 8 8 19 - L 15 + -(-) 
Newry 258 2581-2 19 1 5 2 37(N) 1 3 - SC 20 + + 
Newry 258 3333-3 19 1 5 2 37(N) 1 3 - L 20 + + 
Newry 259 3327-3 3 1 3 2 6 1 3 86 L 32 + -(-) 
Newry 260 3147-1 4 1 4 3 13 4 3 - L 21 + + 
Newry 261 3147-5 1 1 13 4 17 3 13 - L 16 + + 
Newry 262 3217-2 3 2 3 3 13 4 3 86 L 18 + -(-) 
Newry 263 3217-5 3 2 3 3 5 1 3 86 L 31-b + +(+) 
Newry 264 3133-3 3 2 3 2 17 4 3 143 L 17 + -(-) 
Moe 272 5851 18 1 2 1 13 1 3 5 C 33 + + 
Camperdown 273 5867 20 1 2 2 7 1 3 143 SC 9 + + 
Maffra 275 6104 1 1 5 2 4 2 3 - C 35 + + 
Newry 276 2565-2 4 4 4 2 17 1 10 - C 29 + -(+) 
Newry 277 2169-2 1 1 13 2 7 3 3 - C 11-b + + 
Newry 278 2285-1 1 1 2 2 4 1 3 5 C 5-a + + 
Newry 279 2520-1 18 1 2 2 7 1 3 143 C 26 + + 
Newry 280 2530-2 1 1 3 4 17 1 13 - C 10-b + + 
Newry 281 2730-5 1 1 3 2 7 3 3 - C 25 + + 
Newry 282 2988-1 1 1 13 2 17 3 3 143 C 5-d + + 
Maffra 283 6093 9 1 2 1 40(N) 3 7 - C 34 + + 
Newry 594h 3064-1 1 1 3 2 1 1 -i - C 12 + + 
Newry 595h 3217-3 3 2 28(N) 2 6 4 -i - L 19 + + 
Timboon 596h 686-5 6 14 4 15(N) 22 13(N) -i - SC 14 + -(-) 
Timboon 597h 686-10 21 21 18 11 41(N) 6 -i - SC 10-a + -(-) 
 
a ST, sequence type.  b Isolate ID, isolate identification. 
c (N), new allele that had not been previously recorded in the MLST database and was identified in Australia for the first time. 
d GCC for each ST has been assigned by the S. uberis MLST database. -, does not belong to any GCC. 
e Disease status is indicated as follows: C, clinical mastitis; SC, subclinical mastitis; L, low somatic cell count. 
f PFGE type and subtype are represented with Arabic numbers and letters. 
g PCR results for hasC and hasA genes are shown as follows: +, positive by PCR; -, negative by PCR; (+), positive by Southern 
blotting; (-), negative by Southern blotting. 
h The yqiL-negative isolates have yet to be assigned a ST by the MLST database and are indicated by their strain IDs in the ST 
column. 
i _, yqiL negative. 
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5.3.1.2 Loci analysis of Australian isolates 
Analysis of the STs (n = 33) identified in the Australian isolates (excluding the four 
yqiL-negative isolates as START2 cannot perform loci analysis using partial allelic 
profiles), showed the dN/dS ratios for each locus were substantially <1.0, ranging 
from 0.000 (gki) to 0.139 (tpi).  The G+C ratios for each locus ranged from 35.7% 
(tdk) to 45.6% (recP).  The average number of alleles at each locus was 7.1 and the 
proportion of variable nucleotide sites in the each locus ranged from 1.1% (recP) to 
4.4 % (tdk).  The dN/dS, the G+C ratios, the proportion of variable nucleotide sites 
were comparable to that reported in a previous study (Coffey et al., 2006). 
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5.3.1.3 Lineage analysis using UPGMA and eBURST 
The majority of the Australian isolates (85%) were resolved (<0.3 linkage distance) 
into three clusters (Figure  5-2).  A linkage distance of 0.3 was set arbitrarily and 
although this is not an absolute limit, it facilitated the identification of two main 
clusters, and an association between GCC and disease status.  Cluster I (n = 31) 
consisted of two thirds of the Australian isolates and 90% of the isolates in this cluster 
were from either clinical or subclinical mastitis cases.  There were two possible 
clonal complexes in Cluster I identified following eBURST analysis and these were 
termed local clonal complex ST60 (LCC ST60) and ST277 (LCC ST277) (Figure  5-3).  
ST60 was the founder of LCC ST60; which consisted of 7 isolates; 4 SLVs and 2 
DLVs while LCC ST277 consisted of 3 isolates and 2 SLVs (Figure  5-3).  The 
majority of STs (80%) belonging to the two LCCs belonged to GCC ST5 and GCC 
ST143 (Figure  5-2). 
 
In contrast, Cluster III consisted of six isolates, which mainly obtained from cows 
with low cell counts (n = 4) and a few (n = 2) were from cases of subclinical mastitis 
(Figure  5-2).  Notwithstanding the fact that the number of isolates in Cluster III was 
small, all of the GCC ST86 isolates identified in this study belonged to Cluster III. 
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Figure  5-2. Dendrogram showing genetic relatedness of 46 Australian S. uberis isolates as determined 
using UPGMA. 
 
Clusters are denoted by the bars and Roman numerals.  Strains belonging to local clonal complexes 
are indicated with a bar and by the ST which corresponded to the founder of the LCC.  The disease 
status is indicated as C (clinical mastitis), S (subclinical), and L (low somatic cell count). 
 
The global clonal complexes assigned to the isolates are given.  The PFGE types and subtypes are 
represented with Arabic numbers and letters, respectively.  The number of isolates, if more than one, 
is given in parentheses. 
 
The countries of origin of previously reported STs are listed as United Kingdom (UK) and New Zealand 
(NZ).  The yqiL-negative [yqiL (-)] isolates (which have yet to be assigned a ST by the MLST database) 
are indicated in the Note column and by their strain identifications in the sequence type column. 
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Figure  5-3. eBURST analysis of 46 Australian S. uberis isolates. 
 
The founder of a clonal complex is situated at the center of the chart.  Disease status was indicated as 
C (clinical mastitis) and SC (subclinical mastitis) above numbers which correspond to ST.  
Single-locus variants are joined by lines. 
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5.3.1.4 Association between disease status and GCCs 
All six isolates in the GCC ST5 and approximately 90% of the isolates of GCC 
ST143 were associated with clinical and subclinical mastitis (Table  5-3).  In contrast, 
none of isolates of GCC ST86 were associated with clinical mastitis and 75% of these 
isolates were associated with cows with low cell counts.  Chi-square analysis on the 
association of disease status and GCC found that it was statistically significant 
(P = 0.006) (Table  5-3). 
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Table  5-3. Association between disease status and global clonal complexesa 
 
Number (%) of isolates in GCC Disease 
Statusb ST5 ST143 ST86 Otherc Total 
C 6 (100) 4 (33) 0 10 (42) 20 (43) 
SC 0 7 (58) 1 (25) 8 (33) 16 (35) 
L 0 1 (8) 3 (75) 6 (25) 10 (22) 
Total no. 
of 
isolates 
6 12 4 24 46 
 
a Chi-square analysis showed statistical significance (P = 0.006) for the association between 
disease status (C, SC or L) and GCCs. 
b C, clinical mastitis; SC, subclinical mastitis; L, low somatic cell count. 
c Isolates not belonging to any GCC. 
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5.3.1.5 eBURST analysis of Australian isolates and all isolates in the S. uberis 
MLST database (n = 593) 
The three GCCs (ST5, ST143, ST86) and the Australian cluster are shown by light 
shaded ovals in Figure  5-4.  Australian isolates belonging to LCCs were distributed 
between GCC ST5 and GCC ST143 and eBURST analysis clearly demonstrated that 
GCC ST86 was distantly related to GCC ST5 and GCC ST143 (Figure  5-4). 
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Figure  5-4. Snapshot of global population structure of S. uberis generated by eBURST. 
 
The three GCCs (ST143, ST5, and ST86) and the Australian cluster are represented by light shaded 
ovals.  The Australian isolates are indicated by numbers corresponding to their ST.  The sizes of the 
dots are in direct proportion to the size of the population.  Single-locus variants are joined by lines. 
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5.3.2 Recombination analysis 
5.3.2.1 Standardized index of association (ISA) 
An ISA analysis performed on 42 Australian isolates (excluding the four 
yqiL-negative isolates) demonstrated linkage disequilibrium (ISA = 0.0981; P < 0.001).  
The ISA of all isolates in the S. uberis MLST database as of February 2007, was 
comparable (n = 593; ISA = 0.0995; P < 0.001) to that observed in the Australian 
isolates. 
  
5.3.2.2 Ratio of recombinational to mutational events and the per site ratio of 
recombination to mutation parameter 
All of the MLST STs available as of February 2007 in the S. uberis MLST database 
(n = 593) were used for this analysis.  A total of nine possible CCs and 60 SLVs were 
identified following BURST analysis (Figure  5-5).  Whilst 59 of the SLVs arose by 
recombination, surprisingly, only one variant yqiL allele arose by point mutation (rate 
of recombinational to mutational events = 59:1) (Figure  5-5, Table  5-4).  While 21 
variant alleles differed at a single nucleotide position from corresponding alleles in 
founders of the CCs, 20 of these were assigned as arising by recombinational events 
since the variant alleles were present in unrelated STs, which differed at three or more 
loci, in the S. uberis MLST database (Figure  5-5, Table  5-4) (Feil et al., 2000b). 
 
 Of the 60 SLVs, a total of 226 nucleotide sequence differences arose by 
recombination with only one base pair change arising by point mutation.  The per-site 
ratio of recombination to mutation parameter was 226:1 (Figure  5-5, Table  5-4). 
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Figure  5-5. Assignment of single-locus variants and clonal complexes by BURST for empirical 
estimation of rate of recombination to mutation. 
 
The founder of a CC is shown in the center circle, and SLVs are in the outer circle.  Small circles with a 
black background indicate that the SLV arose by recombination, whereas a circle with a white 
background indicates that the SLV arose by point mutation.  The numbers in the small circles show 
the number of nucleotide differences between a variant allele of the SLV and the corresponding allele 
of the founder. 
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Table  5-4. Ratio of recombinational to mutational events and the per site ratio of recombination to 
mutation parameter 
 
 No. of SLVs arising by: No. of polymorphisms arising by: 
 Recombination (r) 
Point  
mutation  
(m) 
r / mb 
Recombination Point  mutation 
Per site r / m parameterc 
ST143 11 (5)a 0 11/0 41 0 41/0 
ST233 8 (4) 0 8/0 20 0 20/0 
ST112 7 (2) 0 7/0 22 0 22/0 
ST86 7 (2) 0 7/0 38 0 38/0 
ST6 7 (2) 0 7/0 17 0 17/0 
ST241 5 (1) 0 5/0 41 0 41/0 
ST161 4 (1) 1 4/1 18 1 18/1 
ST89 5 (1) 0 5/0 13 0 13/0 
ST69 5 (2) 0 5/0 16 0 16/0 
       
Total 59 (20) 1 59/1 226 1 226/1 
 
a The number of SLVs that arose by recombination with a single-nucleotide change in a variant allele is 
shown in parentheses. 
b Ratio of recombinational to mutational events = total number of SLVs that arose by recombination (r) / 
total number of SLVs that arose by point mutation (m). 
c Per site r / m parameter = total number of polymorphisms that arose by recombination / total number 
of polymorphisms that arose by point mutation. 
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5.3.3 Investigation of yqiL-negative isolates 
All of the 46 Australian isolates yielded a PCR product for at least six of the seven 
loci following PCR (Coffey et al., 2006).  However, PCR for the four isolates, 686-5, 
686-10, 3064-1 and 3217-3, was unsuccessful with the original primers for the yqiL 
gene (Coffey et al., 2006), and also with a new primer set designed to confirm this 
result.  The new yqiL primers successfully amplified yqiL from the control S. uberis 
and subsequent Southern blot analysis confirmed that these isolates lacked the yqiL 
gene (data not shown). 
 
BLASTN and BLASTX analyses of the yqiL gene against the S. uberis genome 
sequence in the Sanger Institute database identified a single yqiL homologue which 
exhibited 38% amino acid (57/148) and 57% nucleotide sequence identity (171/299) 
with the S. uberis yqiL allele 1.  This open reading frame (ORF) was located at the 
1795067bp to 1796317bp region of the genome of S. uberis strain 0140J, 400 kb 
distant from yqiL.  On further analysis using Basic Local Alignment Search Tool for 
proteins (BLASTP), the yqiL ORF homologue exhibited extensive identity with both 
the thiolase B gene from Oceanobacillus iheyensis (46% amino acid identity 
[186/404]) (Takami et al., 2002) and the acetyl-CoA acetyltransferase gene from 
Clostridium difficile (46% amino acid identity [186/402]) (Sebaihia et al., 2006).  A 
search of the Conserved Domain Database at NCBI (Marchler-Bauer et al., 2005) 
showed that the S. uberis yqiL ORF homologue, and both the thiolase B and the 
acetyl-CoA acetyltransferase genes contained several conserved domains 
characteristic of enzymes involved in the synthesis of acetoacyl-CoA (cd00751) (Igual 
et al., 1992; Yang et al., 1990).   
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Using ORF finder (NCBI, http://www.ncbi.nlm.nih.gov/gorf/gorf.html) and BLASTX 
(NCBI, http://www.ncbi.nlm.nih.gov/blast), a putative penicillin binding protein gene 
was identified at 15kb upstream of the yqiL in the S. uberis genome sequence. 
 
5.3.4 HasA and HasC gene PCRs 
Whilst all of the 46 Australian isolates possessed the hasC gene, only 39 (85%) of 
them possessed the hasA gene (Table  5-2).  Three of the ten HasA gene PCR 
negative and the positive control isolates (n = 3) were positive by Southern blot using 
the hasA probe.  Chi-square analysis of the association between disease status and 
the presence of hasA was statistically significant (P = 0.014; Table  5-5).  In addition, 
Chi-square analysis of the association between GCCs and the presence of hasA was 
statistically significant (P = 0.005; Table  5-6). 
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Table  5-5. Association between disease status and the presence of hasAa 
 
Number (%) of isolates and disease statusb 
hasA 
C SC L 
Total no. (%) 
of isolates 
Present 20 (100) 13 (81) 6 (60) 39 (85) 
Absent 0 3 (19) 4 (40) 7 (15) 
Total no. of isolates 20 16 10 46 
 
a Analysis with the Chi-square test showed statistical significance (P = 0.014) for the association between disease status and the 
presence of hasA. 
b C, clinical mastitis; SC, subclinical mastitis; L, low somatic cell count. 
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Table  5-6. Association between the global clonal complexes and the presence of hasAa 
 
Number (%) of isolates in GCC 
hasA 
ST5 ST143 ST86 
Otherb 
Total no. (%) 
of isolates 
Present 6 (100) 11 (92) 1 (25) 21 (87.5) 39 (85) 
Absent 0 1 (8) 3 (75) 3 (12.5) 7 (15) 
Total no. of isolates 6 12 4 
 
24 46 
 
a Analysis with the Chi-square test showed statistical significance (P = 0.005) for the association between GCC and the presence 
of hasA. 
b Isolates not belonging to any GCC. 
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5.4 Discussion 
Analysis of the Australian collection of S. uberis isolates by MLST clearly 
demonstrated a genetically diverse population, with no predominating ST.  These 
findings were consistent with the PFGE analysis performed previously in this study 
and are in agreement with other S. uberis epidemiological studies using PFGE 
(Baseggio et al., 1997; Phuektes et al., 2001b; Wang et al., 1999) and using MLST 
(Coffey et al., 2006; Pullinger et al., 2007; Pullinger et al., 2006). 
 
The data presented in this study strongly suggests that the isolates in Cluster I, in 
particular those belonging to GCC ST5 and GCC ST143, were highly associated with 
clinical and subclinical mastitis.  The dendrogram derived following UPGMA for 
lineage analysis (Figure  5-2) clearly distinguished a cluster of isolates associated with 
clinical and subclinical mastitis (Cluster I) from a cluster of isolates from cows with low 
cell counts (Cluster III).  Specifically, 90% of isolates belonging to Cluster I were from 
cows with clinical and subclinical mastitis.  The vast majority (94 %) of the Australian 
isolates belonging to the GCC ST5 and GCC ST143 were distributed in Cluster I and 
there was a statistically significant association between GCC type and disease status 
(P = 0.006; Table  5-3).  In addition, eBURST analysis (Figure  5-3) identified two 
possible LCCs in Cluster I, suggesting the presence of genetically closely related 
strains in the cluster.  These results are in agreement with a previous study that 
demonstrated low levels of heterogeneity in isolates from clinical mastitis (Jayarao et 
al., 1993).   
 
The isolates belonging to GCC ST5 and GCC ST143 may possess virulence 
factors promoting invasion of host tissue, survival in the host environment, evasion of 
the host immune response and internalization in the mammary gland cells 
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(Tamilselvam et al., 2006).  This hypothesis was further supported by hasA analysis 
of the Australian S. uberis isolates.  In this study, 95% of the isolates in GCC ST5 
and GCC ST143 possessed hasA whereas only 25% of the isolates in GCC ST86 
possessed hasA gene with Chi-square analysis demonstrating a significant link 
between the possession of hasA and GCC types (P = 0.005) (Table  5-6).  These 
results are in agreement with previous studies (Coffey et al., 2006; Pullinger et al., 
2006), which suggested a link between both GCC ST5s and GCC ST143s with hasA.  
Although hasA is not thought to be directly involved in the pathogenicity of S. uberis 
(Field et al., 2003), it nevertheless could represent a virulence marker gene. 
 
In contrast, Cluster III, which was genetically distinct from Cluster I (Figure  5-2), 
consisted of isolates mainly from cows with low cell counts and comprised all of the 
isolates belonging to GCC ST86.  This finding was further corroborated following 
eBURST analysis (Figure  5-4).  These observations suggest that isolates in GCC 
ST86, although forming a clonal complex in the global S. uberis population, were not 
associated with mastitis.  Accordingly, it is possible that these isolates may have the 
ability to colonize their host but lack pathogenicity, behaving like a commensal 
species.  This hypothesis is further supported by the results of a recent study which 
demonstrated that most of the isolates in GCC ST86 were less associated with clinical 
mastitis (Pullinger et al., 2006). 
 
There was an inconsistency in Cluster III where one isolate (ST264) belonging to 
GCC ST143 grouped with GCC ST86s (Figure  5-2).  This could be due to the 
assigning system used by the MLST database which differs from UPGMA which was 
used in Figure  5-2 (Coffey et al., 2006).  ST264 shares four out of seven allelic 
profiles with both ST143 and ST86 and therefore could be assigned either to GCC 
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ST143 or to GCC ST86 in the database, however, ST264 also shares five of seven 
profiles with its nearest neighbour (ST262), and should possibly be assigned to GCC 
ST86 by the MLST database (Figure  5-2).   
 
Australian LCCs were distributed between GCC ST5 and GCC ST143 in the global 
population of S. uberis (Figure  5-4) suggesting that these isolates were closely 
associated with both GCC ST5 and ST143.  This is in contrast to a previous study 
which demonstrated that STs identified in UK and New Zealand were clearly 
separated into two GCC types, GCC ST5 and ST143 (Pullinger et al., 2006). 
 
ST60, the founder of LCC ST60, was initially identified in the UK and has not been 
found in any other country.  In a similar manner, ST184 was originally identified in 
New Zealand and neither of these STs has been demonstrated outside their country 
of origin.  Accordingly, the detection of both ST60 and ST184 in the Australian 
isolates represents the first report of the occurrence of identical STs in different 
countries (New Zealand) and continents (UK).  These findings support the 
hypothesis that ancestors of Australian S. uberis are related to isolates in the UK and 
New Zealand.  Specifically, the eBURST results (Figure  5-4) suggest ST60 or ST184 
could represent a recent ancestor of Australian isolates highly associated with mastitis 
and may represent key pathogenic lineages in the Australian S. uberis population. 
 
It should be noted that not all STs belonging to the three major GCCs (Table  5-2) 
are represented in Figure  5-4.  Five STs (ST153, ST217, ST259, ST264 and ST272) 
do not appear in Figure  5-4.  These apparent inconsistencies were due to the 
assigning system used by the MLST database which differs from the eBURST 
analysis (Coffey et al., 2006; Pullinger et al., 2006).  To avoid any possible confusion, 
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the classification of GCC for each STs by the MLST database was used for all 
analyses. 
 
The ISA analyses for both of the Australian isolates and all isolates in the MLST 
database demonstrated linkage disequilibrium, suggesting a clonal population 
structure, but the low ISA also implied that substantial recombination had occurred in 
the S. uberis population.  A comparison of the ISA between other species 
demonstrated that the ISA of S. uberis was lower than that observed in N. meningitidis 
(ISA = 0.14) and C. jejuni (ISA = 0.256) which are known for their high rate of inter- and 
intra-species recombination (Feil et al., 2000a; Feil et al., 1999; Koehler et al., 2003; 
Suerbaum et al., 2001).  These results are in agreement with earlier S. uberis MLST 
studies using maximum likelihood tree analysis which demonstrated substantial 
recombination in the evolutionary history (Coffey et al., 2006) and significant reticulate 
evolution detected between the loci used for MLST (Zadoks et al., 2005a). 
 
In addition, empirical recombination analysis demonstrated a substantial 
recombination rate among the entire MLST database including the Australian isolates.  
The ratio of recombinational to mutational events (59:1) was at least 5 times higher 
than the rate reported for N. meningitidis and S. pneumoniae (Feil et al., 2000b).  
This finding further supports the occurrence of substantial recombination in the 
S. uberis population. 
 
In a previous study, S. uberis was shown to possess phages (Hill and Brady, 1989) 
and although transduction could be responsible for recombination, the exact 
mechanisms of recombination in S. uberis are still unknown.  However, given the 
substantial recombination observed in both the Australian and the global S. uberis 
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population, it is possible that frequent recombination of genomic DNA between 
isolates could lead to the genetic diversity as demonstrated by the MLST and PFGE 
results in this and previous studies (Douglas et al., 2000; Phuektes et al., 2001b; 
Wang et al., 1999).  Consequently, frequent recombination would render 
phylogenetic analysis using PFGE data of very little significance unless the samples 
were very closely related.  In addition, it has been demonstrated that frequent 
recombination within a bacterial population decreased the accuracy of eBURST 
analysis for identification of links between ancestor and descendents in a population, 
suggesting additional analyses should be used in conjunction with eBURST to confirm 
the validity of the inferred relationships (Turner et al., 2007).   
 
The yqiL locus is commonly used in MLST assays for various bacteria including 
S. aureus (Enright et al., 2000), S. epidermidis (Thomas et al., 2007), S. pyogenes 
(Enright et al., 2001), E. faecalis (Ruiz-Garbajosa et al., 2006) and S. uberis (Coffey et 
al., 2006).  Of the four isolates in the Australian collection shown to lack yqiL, two 
had identical 16S rRNA gene sequences to the reference sequence whereas the 
other two yqiL-negative isolates only differed at 1 or 2 nucleotides.  Phylogenetic 
analysis demonstrated that they were only distantly related to S. parauberis and 
S. iniae with S. uberis being the closest species as described earlier in Chapter 3.  It 
is therefore highly unlikely that the Australian yqiL-negative isolates represent 
different species.  This was further substantiated insofar as all of the other species 
identification tests such as PCRs (Hassan et al., 2001), biochemical tests and API 
Strep 20 performed on the yqiL-negative isolates were consistent with S. uberis as 
described earlier in Chapter 3. 
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The investigation of the flanking region of the S. uberis yqiL gene revealed a 
putative penicillin binding protein gene 15 kb upstream of the yqiL locus.  Since this 
gene was more than 6 kb distant from yqiL gene, it fitted criteria for locus selection 
(Curran et al., 2004) and would not be expected to affect the selection of the yqiL 
locus.  While the mechanisms of yqiL deletions are unknown, it is possible that, given 
the high rate of recombination observed in the S. uberis population in both this and 
previous studies (Coffey et al., 2006), the deletion of the yqiL gene may have occurred 
by recombination.  This is further substantiated by the occurrence of non-standard 
yqiL alleles (yqiL alleles 4, 11, 23 which possess a 1 nucleotide deletion within the 
yqiL locus) in the S. uberis MLST database.  Furthermore, strains of S. pyogenes 
lacking yqiL have been reported (Perez-Trallero et al., 2007; Robinson et al., 2006) 
and recorded in the S. pyogenes MLST database as non-standard alleles 
(http://spyogenes.mlst.net/misc/info.asp). 
 
The occurrence of yqiL-negative isolates remains enigmatic and it is still unknown 
how the four yqiL-negative Australian strains could survive without what is considered 
a housekeeping gene.  The identification of a yqiL homologue with homology to 
similar genes also involved in the synthesis of acetyl-CoA, from diverse species of 
bacteria (Igual et al., 1992; Yang et al., 1990), suggests that the four yqiL-negative 
Australian isolates might utilize such a homologue to replace yqiL function.  Since 
yqiL is absent from some strains of S. uberis its status as a housekeeping gene is now 
in doubt. 
 
While MLST greatly facilitated the investigation of the epidemiology of S. uberis, it 
nevertheless has its limitations with regard to its power of discrimination.  In the 
present study, although the Simpson’s index of diversity of MLST was comparable to 
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PFGE, PFGE demonstrated greater discriminatory power resolving four ST60s and 
four ST155s into 4 PFGE types and two PFGE types respectively.  In addition, two 
isolates from two different farms, which had an identical ST (ST194), were resolved 
into two different PFGE types.  Therefore identical STs are not always identified as 
clones following PFGE analysis.  Although there are inherent difficulties associated 
with the use of PFGE for epidemiological studies, its high discriminatory power can 
nevertheless be used to further enhance and refine MLST-based studies to resolve 
isolates with the same STs. 
 
More recently Dopfer et al., report (2006) that suggests that 10 to 20 colonies from 
each sample are needed to detect all strains of S. uberis that are present in a sample 
with 95% certainty (Dopfer et al., 2008).  While in this study we did not test 10 to 20 
colonies from each sample, all colonies from each sample with different morphology 
were tested.  In addition, earlier MLST and PFGE studies have been conducted 
using a single colony of each different morphological colony (Baseggio et al., 1997; 
Coffey et al., 2006; Douglas et al., 2000; Gillespie et al., 1998; Khan et al., 2003; 
Phuektes et al., 2001b; Pullinger et al., 2006; Wang et al., 1999).  Nevertheless, one 
should be aware of that the sampling size could potentially impact typing results 
including the PFGE and MLST analyses which may demonstrate further genetic 
diversity in the Australian S. uberis population.   
 
5.4.1 Conclusions 
In conclusion, MLST analysis of the 46 Australian isolates has clearly identified a 
cluster of STs highly-associated with clinical and subclinical mastitis and a cluster of 
STs associated with cows with low cell counts in their milk.  Specifically, particular 
groups of STs; GCC ST5 and GCC ST143, were highly associated with clinical and 
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subclinical mastitis.  It is therefore postulated that such STs may represent a lineage 
of virulent S. uberis.  In contrast, all of the isolates belonging to GCC ST86 were 
associated with cows with low cell counts and may represent a less virulent lineage. 
 
The use of MLST has greatly facilitated inter-laboratory comparison and has 
identified specific STs that were initially characterized in different countries and 
continents, currently present in the Australian S. uberis population.  As four of the 
Australian isolates were shown to lack yqiL, this locus should perhaps be removed 
from future MLST studies of S. uberis.  The current MLST assay has nevertheless 
facilitated the identification of possible highly virulent STs amongst the genetically 
diverse population of S. uberis both within Australia and in the global population as a 
whole. 
 
The use of MLST will greatly facilitate the identification and characterization of 
pathogenic S. uberis isolates and the identification of specific STs that can be 
exploited for further research and vaccine development. 
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6 Chapter 6 S. uberis Virulence Factors 
6.1 S. uberis virulence factors 
In Chapter 5, a group of STs within GCC ST5 and GCC ST143, which may 
represent a lineage of virulent S. uberis and a group within GCC ST86s, which may 
represent a less virulent ST lineage, were identified.  The pathogenesis of S. uberis 
is not fully understood and remains a major obstacle for the development of strategies 
for the control of mastitis; however several possible S. uberis virulence factors have 
been postulated.  The plasminogen activator is considered to be one of the most well 
characterized virulence factors (Johnsen et al., 1999; Leigh, 1993; Rosey et al., 1999; 
Ward et al., 2003).  Additional virulence factors such as hyaluronic acid (Ward et al., 
2001), CAMP factor (Hassan et al., 2000; Jiang et al., 1996; Skalka et al., 1980), 
hyaluronidase (Khan et al., 2003; Schaufuss et al., 1989), lactoferrin binding protein 
(Lbp) (Moshynskyy et al., 2003) and S. uberis adhesion molecule (SUAM) (Almeida et 
al., 2006) have also been proposed. 
 
6.1.1 Streptokinase or plasminogen activator (PauA) 
Bacteria that have a limited capacity to synthesize amino acids exhibit a reduced 
ability to grow in milk (Leigh and Lincoln, 1997).  To overcome this deficiency, some 
bacteria such as S. uberis utilize host proteolytic enzymes e.g. plasmin to digest the 
casein in milk.  In the animal host, plasmin is generated from plasminogen following 
cleavage by plasminogen activators that are present in blood plasma and tissues 
(Leigh and Lincoln, 1997).  Certain streptococci are capable of producing a 
plasminogen activator which can also cleave plasminogen to plasmin (Leigh and 
Lincoln, 1997).  For example, streptokinase from S. equisimilis (Lancefield group C) 
activates both human and feline plasminogen, whereas that from a Lancefield group E 
Streptococcus activates only porcine plasminogen.  The S. uberis streptokinase, 
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known as PauA, has been shown to specifically activate both bovine (Rosey et al., 
1999) and ovine plasminogen (Kliem and Hillerton, 2002).   
 
Accordingly, it has been hypothesized that growth of S. uberis in milk could depend 
on the activation of plasminogen by PauA (Leigh, 2000; Leigh et al., 1999) and this 
could facilitate early colonization of the mammary gland prior to inflammation (Leigh, 
1993; Rambeaud et al., 2004; Smith et al., 2002).  However, in a more recent study, 
mutational analysis of pauA gene has demonstrated that the activation of 
plasminogen by PauA does not play a major role in the ability of S. uberis to either 
grow in milk or infect the bovine mammary gland (Ward et al., 2003).  Nevertheless, 
vaccination with PauA not only induced a neutralizing antibody response but also 
reduced the rate of colonization and resulted in a decreased incidence of disease 
following experimental challenge with homologous and heterologous strains of 
S. uberis (Leigh, 1999). 
 
6.1.2 Hyaluronic acid 
Hyaluronic acid production is a well-known characteristic of S. uberis and is 
controlled by the hasA, hasB and hasC encoded hyaluronate synthase, UDP-glucose 
dehydrogenase and UDP-glucose pyrophosphorylase respectively (Ward et al., 
2001).  These genes catalyze the assembly of hyaluronic acid from 
N-acetylglucosamine and glucuronic acid (Scott et al., 2003).  A mutagenesis study 
of S. uberis has demonstrated that the presence of both hasA and hasC are essential 
for the production of a hyaluronic acid capsule with isolates possessing hasC, but 
lacking hasA, unable to produce a capsule (Ward et al., 2001). 
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The hyaluronic acid present in the streptococcal capsule is similar to that in animal 
connective tissues, which contain glycans with ß-glycosidic linkages (Almeida and 
Oliver, 1993).  Mammalian enzymes are thought to be incapable of breaking these 
linkages (Scott et al., 2003).  It is believed that hyaluronic acid wraps and covers 
bacterial cells, probably stabilizing chains of bacteria (Bisno, 2003).  However 
hyaluronic acid is also involved in S. pyogenes virulence via an antiphagocytic effect 
(Almeida and Oliver, 1993). 
 
In an analogous manner, the possession of a hyaluronic acid capsule may enhance 
the virulence of S. uberis.  For example, 48% of macrophages ingested 
encapsulated S. uberis with a killing rate of 35% whereas 77% of macrophages 
ingested non-encapsulated S. uberis with a killing rate of 75% (Field et al., 2003).  
Accordingly it has been hypothesized that the capsule may protect S. uberis from 
phagocytosis via the direct interaction of capsular material with macrophages (Field et 
al., 2003).  An additional study demonstrated that 98.7% of S. uberis sampled from 
cases of clinical mastitis had hasA whereas only 83.5 % of S. uberis from the 
environmental sources possessed the gene, indicating an association between hasA 
and clinical mastitis (Field et al., 2003).  Nevertheless, Field et al. (2003) also 
demonstrated that mutant S. uberis which lacked hasA were able to withstand the 
bactericidal effect of bovine neutrophils and induce mastitis in dairy cows (Field et al., 
2003).  Thus, although hasA may not be directly involved in the pathogenicity of 
S. uberis (Coffey et al., 2006; Pullinger et al., 2006), it nevertheless appears to be a 
virulence marker gene (Leigh, 1993; Tomita et al., 2008). 
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6.1.3 CAMP factor 
The CAMP factor was first described by Christie et al. in 1944 (Christie, 1944) 
following the observation that group B streptococci (S. agalactiae) produced a distinct 
zone of complete haemolysis on a blood agar plate near the diffusion zone of the 
S. aureus beta-toxin.  This phenomenon was called the CAMP reaction and the 
compound responsible, an extracellular protein with a molecular weight of 23.5 kDa, 
was termed the CAMP factor.  The CAMP reaction has since been observed in many 
other bacteria including Listeria monocytogenes, Listeria seeligeri, Aeromonas spp., 
Rhodococcus equi and S. uberis (Figura and Guglielmetti, 1987; Fraser, 1961; Jiang 
et al., 1996; Jurgens et al., 1987; Rocourt and Grimont, 1983; Skalka and Smola, 
1981; Valanne et al., 2005). 
 
The CAMP factor of S. uberis has been shown to be a 28 kDa protein (Jiang et al., 
1996) which exhibits greater than 60% protein sequence identity with that of 
S. agalactiae, with CAMP-specific antisera cross-reacting between both species 
(Fontaine et al., 2002).  While a specific role for the CAMP factor in S. uberis 
pathogenesis has yet to be determined, analogy with S. agalactiae CAMP factor 
which binds immunoglobulin IgG and IgM, suggests possible CAMP factor 
involvement in resistance to phagocytosis (Fontaine et al., 2002; Jurgens et al., 1987).  
However, the S. uberis CAMP factor may not represent a highly significant virulence 
factor since a previous study demonstrated that only five out of the 130 S. uberis 
isolates characterized were CAMP reaction and CAMP factor PCR positive (Khan et 
al., 2003). 
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6.1.4 GapC 
GapC encodes the streptococcal surface dehydrogenase protein which possesses 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity and is one of the 
surface proteins in streptococci (Goji et al., 2004; Perez-Casal et al., 2004).  
Although GapC was initially identified in S. pyogenes, GapC-like cell surface proteins 
with GAPDH activity are also present in S. aureus, S. epidermidis, S. dysgalactiae, 
S. agalactiae, and S. uberis (Perez-Casal et al., 2004).  Specifically, the GapC genes 
of S. dysgalactiae, S. agalactiae, and S. uberis exhibit >90% nucleotide sequence 
identity (Goji et al., 2004).  While GapC gene is generally believed to be a 
housekeeping gene, it has also been demonstrated to bind plasmin (Jiang et al., 
1996) suggesting a possible role in a S. uberis virulence factor.  This hypothesis has 
since been supported following the demonstration that vaccination using the S. uberis 
GapC protein conferred protection against heterologous S. uberis experimental 
challenge in dairy cows (Fontaine et al., 2002). 
 
6.1.5 Lactoferrin binding protein 
Bovine lactoferrin is a 92.1 kDa iron-binding glycoprotein found in milk.  The 
biological roles of bovine lactoferrin include amplification of the inflammatory response 
by promoting adhesion and aggregation of polymorphonuclear leukocytes to the 
endothelial surface and stimulation of macrophages (Moshynskyy et al., 2003).  The 
concentration of bovine lactoferrin in bovine milk increases up to 30-fold during acute 
mastitis (Moshynskyy et al., 2003; Smith and Oliver, 1981).  Lactoferrin also has a 
powerful inhibitory effect on bacterial growth via iron chelation.  However some 
bacteria including S. aureus, coagulase negative staphylococci, S. agalactiae, 
S. dysgalactiae ssp. dysgalactiae, Haemophilus influenzae and Neisseria meningitidis 
possess lactoferrin-specific receptors on their surface and are able to use lactoferrin 
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directly as an iron source (Moshynskyy et al., 2003; Park et al., 2002).  It has been 
postulated therefore that a lactoferrin-specific receptor, termed Lactoferrin binding 
protein (Lbp), could be an important virulence factor (Moshynskyy et al., 2003). 
 
A previous study characterized Lbp from five S. uberis isolates obtained from cows 
with clinical and subclinical mastitis (Fang and Oliver, 1999).  Although active Lbp 
was expressed on the S. uberis cell wall (Fang and Oliver, 1999; Moshynskyy et al., 
2003) and possessed a similar structure to the M-like protein in S. pyogenes 
(Moshynskyy et al., 2003), mutational analysis has demonstrated that the S. uberis 
Lbp was not responsible for adhesion to host epithelial cells (Almeida and Oliver, 
1993). 
 
6.1.6 S. uberis adhesion molecule (SUAM) 
A recent study has identified a possible new virulence factor, SUAM, which also 
has an affinity for bovine lactoferrin and could represent a different type of Lbp 
(Almeida et al., 2006).  Antibodies against SUAM inhibited adherence and 
internalization of S. uberis (Almeida et al., 2006) suggesting a role for SUAM in the 
colonization of bovine mammary epithelial cells.  
 
6.1.7 Hyaluronidases 
Hyaluronidase is an enzyme that degrades hyaluronic acid and increases tissue 
permeability.  Hyaluronidases are present in many bacterial species (Canard et al., 
1994; Starr and Engleberg, 2006) and are thought to facilitate bacterial dissemination 
by degrading host hyaluronic acid (Canard et al., 1994; Kreil, 1995). 
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S. pyogenes produces hyaluronidase and antibodies to hyaluronidase can be 
found in the majority of patients following infection (Halperin et al., 1987).  Although it 
is assumed that the S. pyogenes hyaluronidase is also involved in the spread of 
infections (Hynes, 2004; Starr and Engleberg, 2006), S. pyogenes itself produces a 
hyaluronic acid capsule which is structurally identical to mammalian hyaluronic acid 
and also degraded by hyaluronidase (Sandson et al., 1968; Starr and Engleberg, 
2006).  Indeed, hyaluronidase degradation of the S. pyogenes hyaluronic acid 
capsule can be used as a carbon source during the periods of nutrient deprivation 
(Starr and Engleberg, 2006). 
 
Three hyaluronidase genes have been identified in S. pyogenes; one encodes a 
secreted hyaluronidase, hylA, and two, hylP and hylP2, are associated with 
bacteriophage but these are not homologous to hylA at the nucleotide or amino acid 
level.  Extracellular hyaluronidase activity relies on the hylA gene product, HylA, 
whereas HylP and its analogues are believed to facilitate penetration of the capsule 
by streptococcal phages (Hynes et al., 2000; Hynes et al., 1995).  
 
A S. uberis 54 kDa extracellular protein with hyaluronidase activity has been 
characterized (Schaufuss et al., 1989), and hyaluronidase enzyme activity was 
observed in 47 of 135 S. uberis isolates (Khan et al., 2003).  Although the role of 
hyaluronidase activity in the pathogenesis of mastitis is unknown, in a manner 
analogous to S. pyogenes, this enzyme could be involved in bacterial spread (Leigh, 
1999) and represent an additional potential S. uberis virulence factor. 
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6.1.8 Investigation of S. uberis virulence factors 
Although some antigens derived from potential S uberis virulence associated gene 
products such as PauA and GapC have been used in vaccine trials, such vaccines did 
not fully protect cows from S. uberis challenge (Moshynskyy et al., 2003) which 
strongly suggests that key S uberis virulence factors remain to be determined. 
 
Subtractive hybridization has been successfully used for the identification of 
genomic differences, for instance virulence factors, pathogenicity islands or mobile 
genetic elements, between closely related strains of Helicobacter pylori (Akopyants et 
al., 1998), C. jejuni (Hepworth et al., 2007), S. pneumoniae (Suzuki et al., 2005) and 
Burkholderia pseudomallei (Brown et al., 2000).  The underlying rationale behind any 
subtractive hybridization approach is based on the assertion that if a particular gene 
sequence is only present in a virulence strain but not present in non-virulence strains, 
it is highly likely that the gene sequence could represent a virulence factor (Brown et 
al., 2000). 
 
In addition to a subtractive hybridization approach, the complete genome sequence 
of the bacterial strain S. uberis O140J, that can be searched and downloaded from 
the Sanger Institute, greatly facilitates the identification of possible virulence factors in 
this species. 
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6.1.9 Aims 
A primary objective of this study was to investigate the presence of as yet 
uncharacterized S. uberis virulence factors utilizing comparative genome analyses 
between an isolate associated with clinical mastitis and an isolate from a cow with a 
low cell count using a subtractive hybridization approach.  In an earlier study, STs 
highly-associated with clinical and subclinical mastitis in the S uberis population were 
identified (Tomita et al., 2008).  To further investigate the possible occurrence of 
unique S uberis virulence factors, a potentially virulent strain belonging to ST143 and 
a potentially non-virulent strain belonging to ST86 from a cow with a low somatic cell 
count (Coffey et al., 2006; Pullinger et al., 2006; Tomita et al., 2008) were selected as 
targets for subtractive hybridization. 
 
The distribution of subtracted tester-specific gene sequences was subsequently 
analyzed using DNA dot blotting, Southern blotting and gene-specific PCR to further 
investigate whether there was any association between individual subtracted DNA 
sequences and disease status or GCC type in the collection of Australian S. uberis 
isolates. 
 
The secondary objective of this Chapter was to investigate the distribution of 
previously proposed S. uberis virulence-associated factors in the Australian isolates 
using Southern blotting and PCR.  The virulence-associated genes investigated were 
as follows: C5a peptidase, PauA, HasA, SUAM, Lbp, CAMP factor and GapC genes. 
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6.2 Methods 
6.2.1 Subtractive hybridization 
6.2.1.1 S. uberis isolates selected as sources of tester DNA and driver DNA 
S. uberis 2893-1 was isolated from a cow with clinical mastitis and was thought to 
represent a possible hyper-virulent strain whereas S. uberis 3217-2 was isolated from 
a cow with low cell counts and could be a non-virulent strain (Tomita et al., 2008).  
Accordingly, S. uberis 2893-1 was selected as the source of genomic tester DNA and 
S. uberis 3217-2 was selected as the source of genomic driver DNA for subtractive 
hybridization. 
 
6.2.1.2 S. uberis genomic DNA isolation 
S. uberis genomic DNA was extracted from the cells using a Wizard® Genomic 
DNA Purification Kit in accordance with the manufacturer’s instructions (Promega, 
1999).  S. uberis isolates were grown in 10 ml of THB for 16 hrs at 37°C with gentle 
shaking.  Each THB overnight culture was centrifuged at 3382 × g for 15 min at 4°C.  
The supernatant was then discarded and the pellet resuspended in 1 ml of 50 mM 
EDTA and transferred to a new centrifuge tube.  The pellet was centrifuged at 
16,100 × g for 3 min, the supernatant discarded and the pellet again resuspended in 
1 ml of 50 mM EDTA and centrifuged at 16,100 × g for 3 min and the resultant pellet 
resuspended in 380 µl of 50 mM EDTA.  Sixty microliters of 10 mg/ml lysozyme was 
added to each sample and the bacterial suspensions gently mixed.  The samples 
were then incubated at 37°C for 60 min prior to the addition of 600 µl of Nuclei lysis 
solution and incubation at 80°C for 5 min.   After cooling to room temperature, 1.5 µl 
of RNase solution (10 mg/ml) was added to each cell lysate and each sample mixed 
by inverting 25 times prior to incubation at 37°C for 30 min.  The samples were then 
cooled to room temperature, 200 µl of Protein precipitation solution was added, and 
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the samples vortexed vigorously for 20 s and incubated on ice for 5 min prior to 
centrifugation at 16,100 x g for 3 min.  The supernatant containing the extracted 
genomic DNA (approximately 600 µl) was transferred to a clean 1.5 ml 
microcentrifuge tube containing an equal volume of room temperature isopropanol. 
 
The samples were gently mixed by inversion and then incubated for 15 min at room 
temperature prior to centrifugation at 16,100 x g for 10 min.  The supernatants were 
carefully removed and 600 µl of 70% cold ethanol was added and each sample gently 
mixed by inverting several times.  The samples were centrifuged at 16,100 x g for 
10 min, the supernatants aspirated, and the DNA pellets air dried for 15 min.  The 
DNA pellets were resuspended following the addition of 100 µl of DNA rehydration 
solution and the samples were incubated at 65°C for 60 min, or at 4°C overnight.  
The S. uberis genomic DNA samples were stored long-term at -20°C. 
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6.2.1.3 Spectrophotometric determination of genomic DNA concentration 
The concentration and purity of genomic DNA extracts were determined by 
measuring their absorbance (A) at 260 nm (A260nm) and 280 nm (A280nm) using a 
UV-Visible Recording Spectrophotometer UV-160.  For quantification, one A260nm unit 
is equivalent to 50 ng/µl of double-stranded DNA.  The purity of DNA was determined 
from A260nm/A280nm ratio where pure DNA has an A260nm/A280nm ratio of 1.8 to 2.0 
(QIAGEN, 2003).  Stock solutions of S. uberis genomic DNA were diluted and stored 
at a final concentration of 200 ng/µl. 
 
6.2.1.4 Subtractive hybridization overview 
A subtracted library of cloned tester strain-specific DNAs, representing an enriched 
population of S. uberis gene sequences from an isolate highly-associated with 
mastitis (Tomita et al., 2008), was generated following subtractive hybridization using 
the S. uberis isolate 2893-1 (tester DNA; Isolate highly-associated with mastitis) and 
S. uberis isolate 3217-2 (driver DNA; Isolate associated with a cow with a low cell 
count) using a PCR-Select™ Bacterial Genome Subtraction Kit in accordance with the 
manufacturer’s instructions (BD Biosciences, 2002). 
 
An overview of the protocols used, which entailed Rsa I digestion and Adaptor 
ligation of tester DNA (S. uberis 2893-1), a two-round subtractive hybridization and 
PCR enrichment using Rsa I digested driver DNA (S. uberis 3217-2) are presented in 
Figure  6-1 and Figure  6-2.  
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Figure  6-1. Overview of subtractive hybridization.   
 
The chart above was adapted from PCR-Select™ Bacterial Genome Subtraction Kit (Clontech, 2005).   
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6.2.1.4.1 Restriction enzyme digestion 
Both tester and driver DNAs were digested using the tetra-nucleotide restriction 
endonuclease Rsa I.  Three micro gram of tester or driver DNA was mixed with 5 µl 
of 10X NEBbuffer 1, 15 U of Rsa I and made up to a final reaction volume of 50 μl with 
molecular grade water.  The reaction mixture was incubated at 37°C for 16 hrs prior 
to the digestion products being cleaned using a QIAquick PCR Purification Kit in 
accordance with the manufacturer’s instructions. 
 
6.2.1.4.2 Adaptor ligation 
Prior to use in subtractive hybridization, the digested and purified tester DNA was 
subdivided into two equal portions (tester 1-1 and tester 1-2) and subsequently ligated 
at their 5´ ends to Adaptor 1 or Adaptor 2R respectively (Figure  6-1).  Each ligation 
reaction mixture contained the digested tester DNA (100 ng), 1 µl of T4 DNA ligase 
(400 Cohesive End Ligation Units equivalent to 6 Weiss Units), 1 µl of 10 x Ligation 
buffer, 0.5 µl of ATP (20 mM) and either 2 µM of Adaptor 1 or Adaptor 2R (Table  6-1) 
in a final reaction volume of 10 µl.   
 
Prior to overnight ligation, 1.5 µl of each tester DNA ligation reaction (tester 1-1 and 
1-2) were combined and ligated for use as a control for unsubtracted hybridization 
(tester control 1-c).  After ligation at 16°C for 16 hrs, 1 µl of 0.2 M EDTA was added 
to stop the ligation reaction and the samples heated to 72 oC for 5 min to inactivate the 
ligase.  One microliter of unsubtracted tester control (tester control 1-c) was diluted 
to 1 ml using molecular grade water and stored at -20 oC until use. 
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Table  6-1. Sequence of adaptors and primers used for subtractive hybridization 
 
Adaptor / Primer name Adaptor / Primer sequence 
Adaptor 1a 5'-CTA ATA CGA CTC ACT ATA GGG CTC GAG CGG CCG CCC GGG CAG GT-3' 
  
Adaptor 2Ra 5'-CTA ATA CGA CTC ACT ATA GGG CAG CGT GGT CGC GGC CGA GGT-3' 
  
Primer 1b 5'-CTA ATA CGA CTC ACT ATA GGG C-3' 
  
Nested PCR primer 1c 5'-TCG AGC GGC CGC CCG GGC AGG T-3' 
 
Nested PCR primer 2Rc 
 
5'-AGC GTG GTC GCG GCC AGG T-3' 
 
a Underlined bases indicate the binding sites of Primer 1 on the Adaptor 1 and 2R, and shaded 
areas indicate the binding sites of Nested PCR primer 1 and 2R on the Adaptor 1 and 2R 
respectively.  Adaptors and primers were designed by Clontech™ (BD Biosciences, 2002). 
 
b Used for Primary PCR.  Primer 1 is underlined to indicate the corresponding binding sites of the 
Adaptor 1 and 2R. 
 
c Used for Secondary PCR.  Nested PCR primer 1 and 2 are shaded to indicate the 
corresponding binding sites of the Adaptor 1 and 2R. 
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6.2.1.4.3 First round subtractive hybridization 
An excess of driver DNA (2 µl) was added to 1 µl of each tester DNA (tester 1-1 
and 1-2) and then 1 µl of 4x Hybridization buffer (Clontech) was added.  The 4 µl 
subtractive hybridization samples were heat denatured at 98°C for 2 min and then 
allowed to anneal at 60°C for 90 min using a PCR machine heat block.  The 
hybridization temperature for subtractive hybridization requires optimization 
depending on the GC content of a particular genome.  The optimal hybridization 
temperature for genomic DNA with an average GC content or 40-50% such as E. coli, 
Y. enterocolitica, S. typhimurium, and D. nodosus (Hacker et al., 1997) is 63°C.  
However, when the GC content of the genomic DNA is low such as is the case for 
C. perfringens (26.5%) or as in this study S. uberis (36.63%), the hybridization 
temperature can be reduced to 60°C. 
 
The resultant DNA forms; Types a, b, c and d molecules are illustrated 
diagrammatically in Figure  6-2.  Following subtractive hybridization, because of the 
excess of driver DNA, the single-stranded Type a DNAs were dramatically enriched 
for tester-specific sequences (Clontech, 2005).   
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6.2.1.4.4 Second round subtractive hybridization 
For second round subtractive hybridization, the two samples (tester 1-1 and 1-2) 
from the first hybridization reactions were mixed together, and additional denatured 
driver DNA was added to further enrich for tester-specific Type a sequences following 
hybridization.  The combined reaction mixture was incubated at 60°C for 16 hrs and 
following incubation, 200 µl of Dilution buffer (Clontech) was added to the reaction 
mixture.  This overnight incubation resulted in the formation of a new hybrid type; 
Type e which originated following hybridization of single-stranded Type a molecules 
from the two tester DNA 1-1 and 1-2 forms (Figure  6-2).   
 
The resultant double-stranded Type e molecules contained tester-specific 
sequences with two different annealing sites for Nested PCR primers at their 5´ and 3´ 
ends which facilitated subsequent selective amplification following a two-step nested 
PCR (Clontech, 2005). 
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Figure  6-2. Schematic diagram of BD PCR-Select bacterial genome subtractive hybridization protocol. 
 
Type e molecules are formed only if the sequence is present in the tester DNA, but absent in the driver 
DNA.  Solid lines represent the Rsa I-digested DNAs.  Solid boxes represent the outer part of the 
Adaptor 1 and 2R overhanging strands and the corresponding PCR Primer 1 sequence.  Clear boxes 
represent the inner part of Adaptor 1 and the corresponding Nested Primer 1 sequence.  Shaded 
boxes represent the inner part of Adaptor 2R and the corresponding Nested Primer 2R sequence 
(Clontech, 2005). 
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6.2.1.5 Amplification of subtracted DNA fragments 
6.2.1.5.1 Primary PCR 
In order to enrich for subtracted tester-specific DNA fragments both a primary and 
secondary PCR was performed.  The primary PCR was performed in accordance 
with the manufacturer’s instructions (Clontech, 2005) in a PCR master mix containing 
1 x Expand Long Template buffer 3, 0.35 mM each dNTP (dATP, dCTP, dGTP, 
dTTP), 0.4 µM of Primer 1 (Table  6-1), 2.5 U of Expand Long Template Enzyme mix 
and 1 µl of the diluted subtracted tester-specific DNA fragments in a final reaction 
volume of 25 µl.  To fill in overhangs of the Adaptor 1 and 2R (Table  6-1) ligated to 
subtracted tester-specific DNA fragments, the primary PCR mixture was incubated at 
72°C for 10 min.  The reaction mixture was then subjected to PCR amplification using 
94°C, 5 min followed by 30 cycles of: 95°C, 30 s; 59°C, 30 s; 72°C, 2 min, and a final 
elongation step at 72°C for 10 min.  Following amplification, the primary PCR 
amplicons were diluted 1 in 40 using molecular grade water and 1 µl used for 
secondary PCR. 
Chapter 6. S. uberis virulence factors 
 
 
154 
6.2.1.5.2 Secondary PCR 
Secondary PCR was performed using 1x Expand Long Template buffer 3, 0.35 mM 
each dNTP (dATP, dCTP, dGTP, dTTP), 0.4 µM of Nested PCR primer 1 and Nested 
PCR primer 2R (Table  6-1), 2.5 U of Expand Long Template Enzyme mix and 1 µl of 
the diluted primary PCR product in a final reaction volume of 50 µl.  The amplification 
conditions were as follows: 94°C, 3 min followed by 13 cycles of: 95°C, 30 s; 67°C, 
30 s; 72°C, 2 min, and a final elongation at 72°C for 10 min. 
 
6.2.1.6 Cloning using TOPO TA Cloning® Kits 
PCR products generated by the secondary PCR were cloned into pCR®2.1-TOPO® 
vector using the TOPO TA Cloning® Kit in accordance with the manufacturer’s 
instructions. 
 
Briefly, individual TOPO TA cloning reaction mixtures contained 2 to 4 µl (10 to 
20 ng) of the secondary PCR product, 1 µl of Salt solution, 1 µl of pCR®2.1-TOPO® 
vector and water to a final reaction volume of 6 µl and incubated for 30 min at room 
temperature. 
 
Two microliter of each cloning reaction was subsequently used to transform one 
vial of One Shot® TOP10F´ chemically competent E. coli following incubation on ice 
for 30 min.  The cells were then heat-shocked for 30 s at 42°C and immediately 
transferred to ice prior to the addition of 250 µl of room temperature S.O.C. medium 
and incubated at 37°C for 1 hr with shaking at 200 rpm.  Fifty microliters of each 
transformation reaction was then plated onto LB agar plates containing ampicillin 
(50 µg/ml), pre-treated with 40 µl of 40 mg/ml X-gal and 40 µl of 100 mM IPTG per 
plate, and the plates incubated overnight at 37°C.  Selected transformants, white 
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colonies (approximately 20 per transformation), were then sub-cultured in 10 ml LB 
broth containing ampicillin (50 µg/ml) prior to plasmid DNA extraction and purification. 
 
6.2.1.7 Plasmid DNA extraction and purification using the alkaline lysis method 
One point five ml of each overnight culture was centrifuged at 16,100 x g for 3 min 
and the supernatant aspirated.  The bacterial pellet was then washed with 1 ml TEG 
buffer and the bacterial suspension centrifuged at 16,100 x g for 3 min and the 
supernatant again discarded.  The pellet was then resuspended in 100 µl of TEG/ 
lysozyme (6 µg/µl), mixed vigorously by vortexing, and the suspension incubated for 
5 min at room temperature.  The bacterial suspension was then lysed following the 
addition of 200 µl of NaOH/SDS (0.2M NaOH, 1% SDS) and mixed by inverting the 
tube rapidly two or three times.  The lysate was then neutralized following the 
addition of 150 µl of cold 3M potassium acetate (pH 5.2) and incubated on ice for 
5 min.  The suspension was then clarified following centrifugation at 16,100 x g for 
5 min, and the supernatant was transferred to a clean microcentrifuge tube.  The 
extracted plasmid DNA was subsequently precipitated following the addition of 1/10 
volume of 3M sodium acetate (pH 5.2) and 2.5 volumes of 100% cold ethanol and 
incubated at -20°C for 30 min.  The plasmid DNA was recovered by centrifugation at 
16,100 x g for 20 min, the supernatant carefully aspirated, and the plasmid DNA pellet 
air dried for 15 min at room temperature.  Plasmid DNAs were then resuspended in 
100 µl DNA rehydration solution and stored at -20°C until subsequent use. 
 
6.2.1.8 Analysis of plasmid library following EcoR I digestion 
Plasmids containing tester-specific inserts were characterized following restriction 
endonuclease digestion with EcoR I.  The reaction mixture contained 1 µl of isolated 
plasmid (200 ng/µl), 0.5 µl of EcoR I, 1 µl of Buffer H, 0.1 µl of BSA (10 μg/μl) and 
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molecular grade water to a final reaction volume of 10 µl.  The reaction mixture was 
incubated at 37°C for 16 hrs prior to insert size estimation following agarose gel 
electrophoresis. 
 
6.2.1.9 M13 PCR for insert amplification and sequence-specific probe 
production 
Insert-specific amplicons were amplified from individual pCR®2.1-TOPO® clones 
using M13 universal primer-based PCR prior to nucleotide sequence determination 
and for the generation of sequence-specific probes for subsequent dot blot analysis. 
 
The M13 universal primer-based PCR master mix contained 1 x PCR buffer, a final 
concentration 3 mM MgCl2, 0.3 mM each dNTP (dATP, dCTP, dGTP, dTTP), 0.5 µM 
of the forward and reverse M13 primers, 2.5 U of Taq DNA polymerase, 50 ng of 
plasmid DNA and made up to a final reaction volume of 50 µl with molecular grade 
water.  The specifications of the M13 primers and the PCR cycling conditions used 
are detailed in Table  6-2.  Prior to nucleotide sequence determination or for the 
production of randomly-primed DIG-labeled probes, all M13 PCR amplicons were gel 
purified using a Qiagen Gel Extraction Kit in accordance with the manufacturer’s 
instructions. 
 
6.2.1.10 Nucleic acid sequence determination 
The nucleotide sequences of the M13 PCR-amplified tester-specific inserts were 
determined in both directions using BigDye® Terminator v3.1 as described previously 
(section  3.2.6). 
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6.2.1.11 Nucleotide sequence analysis 
Following nucleotide sequence determination, homology searches of tester-specific 
sequences were performed using the BLASTN (http://www.ncbi.nlm.nih.gov/BLAST/) 
and ORF finder with BLASTP (http://www.ncbi.nlm.nih.gov/gorf/gorf.html) programs at 
the NCBI web site. 
 
In addition, tester-specific clone sequences were queried against the S. uberis 
strain 0140J genome sequence database at the Sanger Institute, 
(http://www.sanger.ac.uk./Projects/S_uberis/) using BLASTN and BLASTX to search 
for possible homologues present in the S. uberis strain 0140J genome sequence. 
 
6.2.1.11.1 Statistical analysis 
Statistical analyses of the distribution of tester-specific sequences and GCC type or 
disease status were performed using Chi-square tests using SPSS 13.0 software 
(SPSS Inc., Chicago, US). 
 
6.2.2 Preparation of virulence associated gene-specific and tester-specific DIG 
labelled probes for Southern and dot blot assays. 
Probes were prepared as follows, using either randomly-primed or PCR 
amplification techniques. 
 
6.2.2.1 Randomly-primed DIG-labelled probe preparation 
M13 PCR products comprising the subtracted DNA sequences from 20 randomly 
chosen clones from the tester-specific clone libraries were labelled with DIG using the 
randomly-primed method in accordance with the manufacturer’s instructions. 
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Briefly, 15 µl of purified tester-specific M13 PCR products containing 500 ng of 
DNA was heat-denatured in a boiling water bath for 10 min, and quickly chilled on ice 
for 5 to 10 min.  Following denaturation, 2 µl of hexanucleotide mixture (10 x), 2 µl 
dNTP DIG labeling mixture (10 x) and 1 µl Klenow enzyme was added and the 
reaction mixture incubated at 37°C overnight.  Two microliters of EDTA was 
subsequently added to each reaction to stop the labeling reaction. 
 
6.2.2.2 PCR DIG labelling 
Following nucleotide determinations and analyses of sequences from the 20 
randomly selected clones and initial screening of tester-specific sequences in the 
Australian S. uberis isolates (n = 40) using the randomly-primed DIG-labelled probes, 
five tester-specific sequences encoding six ORFs (T2-01 ORF1, T4-01 ORF1, T4-15 
ORF1, T4-17 ORF1, T4-17 ORF2 and T4-19 ORF1) were selected for further 
analyses since these ORFs representing putative virulence factors and positive 
association with clinical / subclinical mastitis detailed in section  6.3.3 and  6.3.4.  
ORF-specific DIG-labelled probes were generated using a PCR DIG labeling Kit in 
accordance with the manufacturer’s instructions.  Each ORF-specific PCR mixture 
contained a final concentration of 1 x PCR buffer, 1.5 mM MgCl2, 0.2 mM of PCR DIG 
Labeling Mix (containing 2 mM dATP, dCTP, dGTP, 1.9 mM dTTP, and 0.1 mM 
DIG-dUTP), 0.2 µM of the respective ORF-specific primer pair, 1.25 U of Taq DNA 
polymerase, 50 ng of purified M13 PCR product as template DNA and molecular 
grade water in a final reaction volume of 50 µl.  The PCR cycling conditions and 
specification of primers for each ORF are detailed in Table  6-2.  Following 
amplification, the ORF-specific DIG-labelled amplicons were purified using a QIAquick 
Gel Extraction Kit in accordance with the manufacturer’s instructions and stored at 
-20°C until used. 
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6.2.2.3 Southern blotting 
To confirm the absence of the hasA in the PCR negative Australian S. uberis 
isolates and to investigate the copy number of the tester-specific transposon-like 
sequence (T4-19), genomic DNA from representative Australian S. uberis isolates 
were digested by Hind III prior to Southern blot hybridization using either a hasA or a 
T4-19 randomly-primed DIG-labelled “whole insert” probe.  Each 20 µl of restriction 
digestion reaction contained 1 x restriction enzyme buffer E, 0.2 µl of BSA (10 μg/μl), 
5 U of Hind III and 1 µg of respective genomic DNA.  The reaction mixture was 
incubated for 16 hrs at 37°C prior to the reaction being terminated by the addition of 
1 µl of 200 mM EDTA.   
 
To each restriction endonuclease reaction 4 µl of loading dye was added, and the 
digested genomic DNA samples was loaded onto a 1.5% agarose gel and 
fractionated at 80 V for 90 min.  Following agarose gel electrophoresis, the gel was 
stained with ethidium bromide (0.5 µg/ml) for 3 min, followed by distaining for 20 min 
in running tap water.  The fractionated digested genomic DNA was then visualised 
using the Gel Doc 2000 imaging system to confirm complete digestion of genomic 
DNA. 
 
Prior to Southern blot transfer, the gel was submerged in Denaturation solution for 
2 x 15 min at room temperature, with gentle shaking then rinsed with sterile, double 
distilled water (ddH2O).  The gel was then submerged in Neutralization solution for 
2 x 15 min at room temperature then equilibrated for at least 10 min in 20 x SCC prior 
to Southern blot transfer onto a positively charged Hybond N+ nylon membrane using 
standard procedures (Sambrook, 2001).  Following disassembly, the membrane was 
washed once in 2 x SSC prior to UV cross-linking for 5 min using a UV 
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transilluminator.  The blot was then air dried and stored at room temperature prior to 
subsequent use. 
 
6.2.2.4 Dot blotting 
The presence or absence of each individual tester-specific sequence was evaluated 
among the 40 S. uberis Australian isolates by dot blot hybridization as described 
previously (Hepworth et al., 2007; Pettigrew and Fennie, 2005; Winstanley and Hart, 
2000).  Genomic DNA from each S. uberis isolate was extracted using a Wizard® 
Genomic DNA Purification Kit as described earlier in section  6.2.1.2.  Two different 
concentrations of genomic DNA (200 ng and 20 ng) from each isolate were blotted 
onto Hybond N+ nylon membranes using a Bio-Dot microfiltration apparatus in 
accordance with the manufacturer’s instructions. 
 
All target DNAs were denatured prior to dot blot application onto nylon membranes.  
The DNA dilutions were denatured by heating to 100°C for 10 min in a final 
concentration of 0.4 M NaOH and 10 mM EDTA followed by neutralization by the 
addition of an equal volume of cold 2 M ammonium acetate, pH 7.0.  The Bio-Dot 
apparatus was assembled with a membrane (size 7.5 cm x 11.5 cm), 500 μl of ddH2O 
was added to each well to rehydrate the membrane and the vacuum applied until the 
ddH2O in each well was aspirated.  One hundred microliter aliquots of the denatured 
DNAs, which contained either 20 or 200 ng of genomic DNA, were applied to 
individual wells and the samples bound onto the nylon membrane following the 
application of a gentle vacuum.  Following an additional denaturation step, using 
500 µl of 0.4 M NaOH in each well, the dot blot apparatus was disassembled and the 
membrane rinsed in 2 x SCC.  The bound genomic DNA samples were subsequently 
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cross-linked to the membrane following exposure on a UV illuminator for 5 min.  The 
membrane was then air dried and stored at room temperature until hybridization. 
 
6.2.2.5 Hybridization of Southern and dot blots with a DIG-labelled probe 
Pre-hybridization and hybridization steps were performed using a Hybaid 
hybridization oven.  Southern or dot blots were pre-hybridized in Standard 
hybridization solution for 2 hrs at 68°C followed by overnight hybridization at 68°C in 
Standard hybridization solution containing 25 ng/ml of the individual DIG-labelled 
probes.  Prior to addition to the Standard hybridization solution, the DIG-labelled 
probe was boiled for 10 min, and then chilled immediately on ice for 5 min.  When 
reused, following storage at -20°C, Standard hybridization solution with a DIG-labelled 
probe was boiled for 10 min, and then chilled immediately in ice water bath for 10 min 
prior to reuse in hybridization.  Post-hybridization, the blot was washed twice for 
5 min in 2 x SSC Wash solution then washed twice for 20 min in 0.5 x SSC Wash 
solution.  All washing steps were performed at 68°C. 
 
6.2.2.6 Development of blots 
All detection steps for both Southern and dot blots were performed at room 
temperature.  The blots were equilibrated in Washing buffer for 1 min then blocked in 
Blocking buffer for 60 min with gentle shaking.  The blots were then incubated in 
30 ml of fresh Blocking buffer, containing 6 µl of Anti-Digoxigenin-AP for 30 min with 
gentle shaking.  The blots were then washed twice for 15 min with 100 ml of Washing 
buffer, and then equilibrated in 20 ml of Detection buffer for 2 min.  The Detection 
buffer was discarded and the blots were subsequently incubated in 10 ml Detection 
buffer containing 200 µl of the alkaline phosphatase substrate (NBT/BCIP) in the dark 
with no shaking for colour development.  Colour development was allowed to 
Chapter 6. S. uberis virulence factors 
 
 
162 
proceed for three to four hours and once the control bands or dots were visible, the 
colour development reaction was terminated by the addition of TE buffer or water. 
 
6.2.3 Prevalence of previously characterized virulence-associated genes in 
Australian isolates using gene-specific PCRs or dot blots 
6.2.3.1 C5a peptidase, PauA, HasA, SUAM, Lbp, CAMP factor and GapC gene 
PCRs 
C5a peptidase, PauA and HasA gene PCRs were performed using a modification 
of the methods described previously (Dmitriev et al., 2004; Field et al., 2003; Zadoks 
et al., 2005a).  The HasA gene PCR (Field et al., 2003) was described in section 
 5.3.4. 
 
Virulence-associated gene-specific PCRs (C5a peptidase, SUAM, Lbp, CAMP 
factor and GapC gene) were performed using primers designed during the course of 
this study.  Primers were designed using Primer3 (Rozen and Skaletsky, 2000) 
based on the C5a peptidase ScpB gene (Accession Number, YP_329932) in the 
S. agalactiae strain A909 (Tettelin et al., 2005); the SUAM gene (Accession Number, 
DQ232760) identified in the S. uberis strain UT888 (Almeida et al., 2006); the Lbp 
gene (Accession Number, BD023108) (Moshynskyy et al., 2003); the CAMP factor 
gene (Accession Number, U34322)(Jiang et al., 1996) and the GapC gene (Accession 
Number, AF421900) identified in the S. uberis strain ATCC 9927 (Fontaine et al., 
2002). 
 
A PCR master mix for SUAM, Lbp, CAMP factor and GapC gene PCRs containing 
a final concentration of 1 x PCR buffer, 0.3 mM each dNTP (dATP, dCTP, dGTP, 
dTTP), 0.5 µM of the virulence associated gene-specific primer pair, 1.25 U of Taq 
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DNA polymerase and 50 ng of each individual S. uberis genomic DNA in a final 
reaction volume of 25 µl.  Details of the primers and the amplification conditions used 
are given in Table  6-2.   
 
In the case of C5a peptidase gene PCR, the presence of the gene among the 40 
Australian S. uberis isolates was further examined following dot blot analysis.  As a 
positive control, a randomly-primed DIG-labelled probe, generated from C5a 
peptidase PCR product of S. agalactiae strain RO799, was used.  Probe generation, 
purification, dot blot processing and analysis were performed as described in section 
 6.2.2. 
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Table  6-2. List of primers used in Chapter 6 
 
Primer name 
Target 
Primer pair 
function(s) 
PCR 
product 
(bp) 
Primer sequence 
PCR 
cycling 
condition 
M13 Forward 
M13 Reverse 
PCR 
Sequencing n/a 
5'- GTA AAA CGA CGG CCA G-3' 
5'- CAG GAA ACA GCT ATG AC-3' 1 
T2-01 ORF1 F 
T2-01 ORF1 R 
T2-01 ORF1specific 
PCR 216 
5'-TCC ACT TCC TCA ACC CAG AC-3' 
5'-TAC CAT CAC GAC CTG GCA TA-3' 2 
T4-01 ORF1 F 
T4-01 ORF1 R 
T4-01 ORF1 specific 
PCR 183 
5'-CGT CTG CAA TTG CCT CAA TA-3' 
5'-GTT TGC AAG TGG CAG AGG AT-3' 2 
T4-15 ORF1 F 
T4-15 ORF1 R 
T4-15 ORF1 specific 
PCR 177 
5'-CAA CAT GCT TTT GAC GAT GG-3' 
5'-GGT GCG GAC TAA GGT AGC AA-3' 2 
T4-17 ORF1 F 
T4-17 ORF1 R 
T4-17 ORF1 specific 
PCR 245 
5'-TGC ATC AAT CCT TTT CTC TTG A-3' 
5'-TCG CCC TTA TGA AAT CTT TTG-3' 2 
T4-17 ORF2 F 
T4-17 ORF2 R 
T4-17 ORF2 specific 
PCR 168 
5'-AAC GAT GGC GTA GAA GAT GG-3' 
5'-TGC AGA AGT AAA GAA CGC TTC A-3' 2 
T4-19 IN F 
T4-19 IN R 
T4-19 ORF1 specific 
PCR 305 
5'-ATG AAG CCC CTA TTC CCA AC-3' 
5'-GAT TCC AAA GGC TTC CAA CA-3' 2 
T1-15 F 
T1-15 R Sequencing n/a 
5'-TCT CCT GAG CCA CCT ACA CC-3' 
5'-CCG GTG GTA TTA GAG CGA AC-3' 3 
T4-15 L 267 Sequencing n/a 5'-AAT ATT TTG CCG GGC TTC TT-3' 3 
T4-25 F Sequencing n/a 5'-GGG ACA GAG GCG AAT ATC AC-3' 3 
SUAM F 
SUAM R SUAM 357 
5'-TGA CGT CAG CAA TCA CAA CA-3' 
5'-TTG CTG GGG CAT TAT TTT TC-3' 4 
Suc 1BF 
Suc 2Rb C5a peptidase 2643 
5'-GGG ATC TTG TCA GGA AAT GC-3' 
5'-ACC TGG TGT TTG ACC TGA ACT A-3' 5 
pauA for 
pauA rev PauA 976 
5'-TTC ACT GCT GTT ACA TAA CTT TGT G-3' 
5'-CCT TTG AAA GTG ATG CTC GTG-3' 6 
tcamp I 
tcamp II CAMP factor 613 
5'-CAA GTG TCC AAG CAA ATC AA-3' 
5'-CCT ACT GCA TGT GTG ATA GC-3' 7 
GapC2 F 
GapC2 R GapC 423 
5'-CAG GTG CTT CAT GTA CTA CT-3' 
5'-CGT AAG CCA TAC CGA TGA TA-3' 8 
Lbp1 F 
Lbp1 R Lbp 570 
5'-TGA CCG AAG AAC GTG ATG-3' 
5'-AGA GAC CAC TTG CCA CTA-3' 8 
 
a1. 95ºC, 5 min; 25x (95ºC, 1 min; 55ºC, 1 min; 72ºC, 2 min); 72ºC, 5 min 
2. 94°C 3 min; 25x (94°C, 30 s; 60°C, 30 s; 72°C, 45 s); 72°C 5 min. 
3. 96ºC, 1 min; 25x (96ºC, 20 s; 50ºC, 10s; 60ºC, 4 min) 
4. 95ºC, 5 min; 30x (95ºC, 1 min; 55ºC, 1 min; 72ºC, 3 min); 72ºC, 5 min 
5. 95ºC, 5 min; 35x (94ºC, 1 min; 55ºC, 1 min; 68ºC, 3 min); 68ºC, 15 min 
6. 94°C 5 min; 35x (94°C, 30 s; 55°C, 60 s; 72°C, 60 s); 72°C 5 min. 
7. 95°C 5min; 30x (92°C, 60 s; 54°C, 90 s; 72°C, 90 s); 72°C 5 min. 
8. 95°C 5 min; 30x (94°C, 60 s; 55°C, 90 s; 72°C, 90 s); 72°C 5 min. 
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6.3 Results 
6.3.1 Subtractive hybridization 
The two S. uberis isolates (2893-1, as the tester DNA and 3217-2, as the driver 
DNA) were used for subtractive hybridization.  The results obtained following primary 
and secondary PCR enrichment are shown in Figure  6-3.  As anticipated, the 
secondary PCR products generated from the unsubtracted genomic DNA control 
resulted in the most intense bands following agarose gel electrophoresis, and the 
tester-specific secondary PCR products from the subtracted genomic DNA 
demonstrated weaker bands than those observed in the unsubtracted genomic DNA 
control (Figure  6-3).   
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Figure  6-3. Primary and secondary PCR products generated following tester-specific and control 
subtractive hybridization. 
 
M1. 100 bp molecular weight ladder ranging from 100 to 1000 bp. 
1. Primary PCR product generated from the tester 1-1. 
2. Primary PCR product generated from the tester 1-c (unsubtracted control). 
M2. Lambda DNA digested by Pst I (molecular weight range 250 to 11,000 bp). 
3. Secondary PCR product generated from the tester 1-1. 
4. Secondary PCR product generated from the tester 1-c (unsubtracted control)  
Numbers adjacent to molecular markers indicate sizes of DNA fragments. 
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6.3.2 TOPO TA cloning 
After subtractive hybridization and amplification of subtracted tester-specific 
sequences, a library of S. uberis 2893-1 tester-specific sequences was obtained 
following cloning of the secondary PCR products into the vector pCR2.1-TOPO.  In 
total, 114 E. coli transformants (Figure  6-4) were obtained from a total of four (T1-T4) 
independent cloning experiments generating the tester-specific S. uberis libraries T1 
(Clones T1; 1-13); T2 (T2; Clones 1-8); T3 (T3; Clones 1-35) and T4 (T4; Clones 
1-68).  Twenty of the recombinants from the libraries T1-T4 were chosen at random 
for further characterization.  Following recombinant pCR2.1-TOPO plasmid 
extraction and EcoR I digestion, the linearized vector generated a band of the 
expected size (3973 bp).  Tester-specific insert sequences ranged in size from 700 
to 1150 bp (Figure  6-5). 
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Figure  6-4. Example of a typical pCR®2.1-TOPO® transformation of E. coli TOP-10F´ cells following 
selection on LB agar with ampicillin plates using X-Gal / IPTG selection for the generation of 
tester-specific plasmid libraries. 
 
White colonies indicate transformed E. coli containing tester-specific DNA inserts whereas blue 
colonies have no insert in the plasmid. 
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Figure  6-5. Example of results following EcoR I digestion of selected pCR®2.1-TOPO® clones. 
 
a Linearized pCR®2.1-TOPO® vector (3973 bp) following EcoR I digestion. 
b Tester-specific inserts excised following EcoR I digestion of a selection of clones from the libraries 
T2-02 to 08 and T3-01 to 03.  
 
M. 10 µl of Lambda DNA digested by Pst I (Molecular weight range 250 to 11,000 bp) 
1. T2-02 
2. T2-03 
3. T2-04 
4. T2-05 
5. T2-06 
6. T2-07 
7. T2-08 
8. T3-01 
9. T3-02 
10. T3-03 
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6.3.3 Initial screening of tester-specific sequences in Australian isolates 
An initial screening to investigate the distribution of tester-specific nucleotide 
sequences in the 40 Australian isolates was performed using DNA dot blot analyses 
using randomly-primed DIG-labelled “whole insert” probes generated from the M13 
PCR amplified fragment of each tester-specific insert.  Initially, 20 inserts from the 
tester-specific clone libraries were selected at random, however clone T2-01 and 
T4-08 comprised a duplicate set of sequences as identified subsequently following 
sequence determination of the inserts.  Only clone T2-01 was included in 
subsequent analyses.  Accordingly, 19 tester-specific inserts were subsequently 
used for DNA dot blot analyses.  The dot blots were scored as positive if an intense 
dot was observed and negative if a weak dot or no dot was observed.  A 
diagrammatic representation outlining the initial and final screening rationale and 
subsequent dot blot results obtained using a combination of both randomly-primed 
“whole insert” and ORF-specific PCR probes are shown in Figure  6-6.   
 
Initial screening of the Australian isolates revealed that 7 of the “whole insert” 
probes (T2-01, T2-03, T2-06, T2-08, T3-03, T3-05 and T4-20) bound to both the tester 
(2893-1) and the driver (3217-2) genomic DNAs (Table  6-3).  Probes from the 
remaining 12 clones (T1-15, T1-16, T3-02, T3-06, T4-01, T4-06, T4-15, T4-16, T4-17, 
T4-18, T4-19 and T4-25) were tester-specific since these DIG-labelled probes 
specifically bound only to the genomic DNA of the tester strain 2893-1 and not the 
driver strain 3217-2 genomic DNA (Table  6-3 and Figure  6-7).  Faint dots were 
observed for the inserts T4-15 and T4-19 and these were scored as negative (Table 
 6-3).  
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Figure  6-6. Overview of DNA dot blot screening. 
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Table  6-3. DNA dot blot results of initial screening of 40 Australian S. uberis isolates using “whole insert” randomly-primed DIG-labelled probes 
 
 Diseasea
status 
Farm 
location 
Isolateb 
ID 
STc 
 
GCCd
 
T2-01 T2-03 T2-06 T2-08 T3-03 T3-05 T4-20 T4-06 
 
T4-25
 
T3-02
 
T4-17 T4-19 
 
T4-15
 
T3-06
 
T4-01 
 
T1-16
 
T4-18
 
T1-15
 
T4-16 
 
Total 
 
Tester C Newry 2893-1 156 143 + + + + + + + + + + + + + + + + + + + 18 
 C Newry 2730-5 281 + + + + + + + + + + + +/- + + + + + + 16 (1) 
 C Moe 5851 272 5 + + + + + + + + + + + +/- + + + + + +  16 (1) 
 C Korumburra 5838-3 194 + + + + + + + + + + + +/- + + + + +  15 (1) 
 C Timboon 853-4 252 + + + + + + + + + + + +/- + + + + +  15 (1) 
 C Newry 3064-1 594 + + + + + + + + + + + +/- + + + + +  15 (1) 
 C Timboon 883-4 253 + + + + + + + + + + + +/- + + + +  14 (1) 
 C Newry 2481-1 60 5 + + + + + + + + + + + + + +  13 
 C Newry 2907-1 60 5 + + + + + + + + + + + + +  12 
 C Newry 2956-4 60 5 + + + + + + + + + + + + +  12 
 C Newry 2169-2 277 + + + + + + + + + + + + +  12 
 C Newry 2285-1 278 5 + + + + + + + + + + + + +  12 
 C Newry 2520-1 279 143 + + + + + + + + + + + + +  12 
 C Newry 2988-1 282 143 + + + + + + + + + + + +/- +  11 (1) 
 C Maffra 6093 283 + + + + + + + + + + + +/- +  11 (1) 
 C Newry 2874-4 184 143 + + + + + + + + + + + +/-  10 (1) 
 C Maffra 6104 275 + + + + + + + + + + +/-  9 (1) 
 C Newry 2565-2 276 + + + + + + + + + + +/-  9 (1) 
 C Newry 2530-2 280 + + + + + + +  + +/- + +  9 (1) 
 SC Newry 2042-5 194 + + + + + + + + + + + +/- +/- + + + + +  15 (2) 
 SC Timboon 686-5 596 + + + + + + + + + + + + + +  13 
 SC Camperdown 5867 273 143 + + + + + + + + + + + + +  12 
 SC Newry 2407-7 216 143 + + + + + + + + + + + + +  12 
 SC Timboon 796-3 251 + + + + + + + + + + + + +/-  11 (1) 
 SC Timboon 868-4 254 + + + + + + + + + + + + +/-  11 (1) 
 SC Timboon 684-1 155 143 + + + + + + + + + + + +  11 
 SC Timboon 796-2 153 143 + + + + + + + + + + +/-  9 (1) 
 SC Newry 2581-2 258 + + + + + + + + + + +/-  9 (1) 
 SC Timboon 686-10 597 + + + + + + +  + + +  9 
 SC Newry 2655-5 217 86 + + + + + + + + + +/-  8 (1) 
 SC Newry 2690-2 255 + + + + + + +  +/-  6 (1) 
 N Newry 3147-4 256 + + + + + + + + + + + +  11 
 N Newry 3217-1 257 + + + + + + + + + + + +/-  10 (1) 
 N Newry 3147-5 261 + + + + + + + + + + + +/-  10 (1) 
 N Newry 3147-1 260 + + + + + + + + + + +/- +  10 (1) 
 N Newry 3217-5 263 86 + + + + + + +  +/- + +  8 (1) 
 N Newry 3327-3 259 86 + + + + + + + + + +/-  8 (1) 
 N Newry 3133-3 264 143 + + + + + + +  + +/- +/-  7 (2) 
 N Newry 3217-3 595 + + + + + + +  +/- +/- +  7 (2) 
Driver N Newry 3217-2 262 86 + + + + + + +  +/- +/-  6 (2) 
    Total 40 40 40 40 40 40 40 33 32 26 20 20 (7) 16(24) 15 12 10 10 8 2  
a Disease status is indicated as follows: C, clinical mastitis; SC, subclinical mastitis; L, low somatic cell count.  b Isolate identification.  c Sequence type. 
d Global clonal complex (GCC) for each ST has been assigned by the S. uberis MLST database.  Blank, does not belong to any GCC. 
Shaded area indicates non-tester-specific inserts since both tester (2893-1) and driver (3217-2) were positive following with the DNA dot blot analysis using a “whole insert” randomly-primed DIG-labelled 
probe.  For the purpose of clarity, a negative dot blot result is indicated by a blank entry.  +/- indicates a faint cross reaction.   
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Figure  6-7. An example of a typical DNA dot blot result using a tester-specific DIG-labelled probe.   
 
This blot was obtained following probing of genomic DNA from the Australian S. uberis isolates using a 
clone T3-06 “whole insert” randomly-primed DIG-labelled probe.  A key detailing the position of each 
of the genomic DNAs used is given below.  Genomic DNA from each isolate was dotted at two 
different DNA concentrations (200 and 20ng) on columns 1-2, 3-4, 5-6, 7-8, 9-10 and 11-12 
respectively.  As positive and negative controls, genomic DNA from the tester strain 2893-1 (Position; 
G11-12; 200ng and 20ng) and the driver strain 3217-2 (Position; H11-12; 200ng and 20ng) were 
included. 
 
 
Column 1-2 
  
A1-2 (2481-1) 
B1-2 (2907-1) 
C1-2 (2956-4) 
D1-2 (2530-2) 
E1-2 (3064-1) 
F1-2 (6104) 
G1-2 (5867) 
H1 (WCH59) 
H2 (RO800) 
Column 3-4 
 
A3-4 (2169-2) 
B3-4 (2285-1) 
C3-4 (2520-1) 
D3-4 (2730-5) 
E3-4 (5851) 
F3-4 (6093) 
G3-4 (Blank) 
H3-4 (2407-7) 
Column 5-6 
 
A5-6 (2874-4) 
B5-6 (2893-1) 
C5-6 (2988-1) 
D5-6 (3133-3) 
E5-6 (3217-3) 
F5-6 (5660-4) 
G5-6 (684-1) 
H5-6 (796-2)  
Column 7-8 
 
A7-8 (2042-5) 
B7-8 (2565-2) 
C7-8 (2581-2) 
D7-8 (2690-2) 
E7-8 (3147-5) 
F7-8 (3147-4) 
G7-8 (3147-1) 
H7-8 (RO799) 
Column 9-10 
 
A9-10 (3217-1) 
B9-10 (5838-3) 
C9-10 (686-10) 
D9-10 (796-3) 
E9-10 (853-4) 
F9-10 (868-4) 
G9-10 (883-4) 
H9-10 (VW921) 
Column 11-12 
 
A11-12 (2655-5) 
B11-12 (3217-5) 
C11-12 (3217-2) 
D11-12 (3327-3) 
E11-12 (Blank) 
F11-12 (686-5) 
G11-12  
(Positive control,  
tester, 2893-1) 
H11-12  
(Negative control, 
driver, 3217-2) 
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6.3.4 Sequencing results of subtracted sequences from tester-specific clone 
libraries 
6.3.4.1 Tester-specific S. uberis 2893-1 sequences 
Following initial dot blot screening, 12 tester-specific sequences which encoded 18 
ORFs or partial ORFs (Table  6-3) were selected for further analysis.  Subsequent 
BLASTP analyses of the 18 ORFs revealed their possible functions as follows: mobile 
genetic elements were encoded by five ORFs (T1-16 ORF1 [transcriptional regulator 
Cro/ CI family], T4-01 ORF1 [bacteriophage 10750.4], T4-17 ORF1 [IS1193 
transposase], T4-19 ORF1 [putative transposase OrfB] and 2 [putative transposase 
OrfA]); outer membrane proteins or membrane-associated proteins were encoded by 
four ORFs (T1-15 ORF1 [reticulocyte binding protein], T3-02 ORF1 [putative acyl-CoA 
synthetase], T3-06 ORF1 [collagen-like surface protein] and T4-17 ORF2 [alpha-like 
protein 1]); proteins involved in metabolism were encoded by seven ORFs (T3-02 
ORF1 [putative acyl-CoA synthetase], T4-06 ORF1 [phosphotransferase system 
mannose/ fructose/ N-acetylgalactosamine-specific component IIC] and 2 
[phosphotransferase system mannose/ fructose/ N-acetylgalactosamine-specific 
component IID], T4-15 ORF1 [acetyltransferase GNAT family] and 2 [putative 
hydrolase, NUDIX family], T4-25 ORF1 [ribose5-phosphate isomerase RpiB] and 2 
[tagatose-6-phosphate kinase]) and two unidentified proteins were encoded by two 
ORFs (T4-16 ORF1 [conserved hypothetical protein] and T4-18 ORF1 [hypothetical 
protein LEUM_1012]).  The BLASTP results for each ORF are detailed in Table  6-4.   
 
Of the four ORFs which exhibited protein sequence identity with outer membrane 
proteins, a collagen-like surface protein was encoded by the tester-specific sequence 
T3-06 ORF1 (collagen-like surface protein).  The remaining outer membrane protein 
homologues were reticulocyte binding protein, myosin X and alpha-like protein 1 
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which were identified in inserts T1-15 ORF1 (reticulocyte binding protein),, T4-01 
ORF2 (myosinX isoform CRA_c) and T4-17 ORF2 (alpha-like protein 1) respectively. 
 
BLASTP analysis identified two types of transposon-like proteins and 
bacteriophage-related proteins encoded by the five ORFs; T4-17 ORF1 (IS1193 
transposase), T4-19 ORF1 (putative transposase OrfB) and 2 (putative transposase 
OrfA), T4-01 ORF1 (bacteriophage 10750.4) and T1-16 ORF1 (transcriptional 
regulator Cro/ CI family) which exhibited 28 to 98% amino acid sequence identity with 
homologues in S. agalactiae, S. pyogenes and S. thermophilus.  The T4-19 ORF1 
(putative transposase OrfB) and 2 (putative transposase OrfA) exhibited 98 and 92% 
protein sequence identity with the putative transposase of S. agalactiae O90R. 
 
Of the 7 tester-specific ORFs which exhibited protein sequence identity with 
enzymes involved in metabolism, four ORFs (T4-06 ORF1 [phosphotransferase 
system mannose/ fructose/ N-acetylgalactosamine-specific component IIC], ORF2 
[phosphotransferase system mannose/ fructose/ N-acetylgalactosamine-specific 
component IID] and T4-25 ORF1 [ribose5-phosphate isomerase RpiB] and ORF2 
[tagatose-6-phosphate kinase]) encoded proteins involved in carbohydrate 
metabolism.  The T3-02 ORF1 (putative acyl-CoA synthetase) encoded a long-chain 
fatty acid-CoA ligase homologue (Covault et al., 2004; Tauch et al., 2005).  Finally, 
the T4-15 insert encoded 2 ORFs (ORF1 [acetyltransferase GNAT family] and ORF2 
[putative hydrolase, NUDIX family]) which exhibited protein sequence identity with 
acetyltransferase and NADH pyrophosphatase respectively (Dos Vultos et al., 2006). 
 
With the exception of T3-02 ORF1 (putative acyl-CoA synthetase), the nucleotide 
sequence of the seven metabolism-related ORFs exhibited >89% nucleotide 
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sequence identity and concomitant higher protein sequence identity (ranging from 89 
to 100%), with gene homologues in the reference S. uberis strain 0140J genome 
available in the Sanger S. uberis database (Table  6-4). 
 
The 11 ORFs encoded by 9 clones (T1-15 ORF1 [reticulocyte binding protein], 
T1-16 ORF1 [transcriptional regulator Cro/ CI family], T3-02 ORF1 [putative acyl-CoA 
synthetase], T3-06 ORF1 [collagen-like surface protein], T4-01 ORF1 [bacteriophage 
10750.4] and 2 [myosinX isoform CRA_c], T4-17 ORF1 [IS1193 transposase] and 2 
[alpha-likeprotein1], T4-19 ORF1 [putative transposase OrfB], T4-16 ORF1 
[conserved hypothetical protein], T4-18 ORF1 [hypothetical protein LEUM_1012]), 
with the exception of T4-19 ORF2 (putative transposase OrfA), were very divergent 
(<63% nucleotide sequence identity) from gene homologues present in the reference 
S. uberis strain 0140J genome database (Table  6-4).   
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Table  6-4. Database analysis of the 12 tester-specific DNA sequences 
 
BLASTP result vs non-redundant protein database  BLASTN vs S. uberis 0140J Clonea 
ID 
Size 
(bp)b ORF
c Size (aa)d Putative protein [Species/ strain name] (accession number) Expecte Amino acids
f 
Identities (%)  Expect
e Nucleotides
f 
Identities (%) 
T1-15 1342 1, Partial 432 Reticulocyte binding protein [S. agalactiae CJB111] (ZP_00787477) 5e-97 194/412(47)  2.5 135/217 (62) 
T1-16 1052 1 ,Full 326 Transcriptional regulator Cro/ CI family [S. pyogenes MGAS6180] (YP_280786) 0.0 317/326(97)  1.8 342/605 (56) 
T3-02 909 1, Partial 296 Putative acyl-CoA synthetase [Carnobacterium sp. AT7] (ZP_02183824) 2e-72 129/294 (43)  1.40E-38 554/919 (60) 
T3-06 1016 1, Partial 338 Collagen-like surface protein putative [S. agalactiae A909] (YP_329350) 1e-54 136/332(40)  4 151/270 (55) 
T4-01 1297 1, Full 195 Hypothetical protein MGAS10750_Spy1915 [Bacteriophage 10750.4] (YP_603409) 4e-14 55/193(28)  0.013 260/463 (56) 
  2, Full 116 MyosinX isoform CRA_c [Homo sapiens] (NP_036466) 3e-06 34/99(34)  3.8 120/205 (58) 
T4-06 928 1, Full 188 Phosphotransferase system mannose/ fructose/ N-acetylgalactosamine-specific component IIC 
 [S.suis 05ZYH33] (YP_001197817) 2e-63 124/197(62)  2.60E-123 566/567 (99) 
  2, Partial 119 Phosphotransferase system mannose/ fructose/ N-acetylgalactosamine-specific component IID 
[S. suis 98HAH33] (YP_001199998) 6e-56 103/119(86)  9.40E-77 359/359 (100) 
T4-15 1610 1, Full 142 Acetyltransferase GNAT family [S. agalactiae CJB111] (ZP_00787020) 2e-43 76/138(55)  3.80E-21 126/141 (89) 
  2, Full 164 Putative hydrolase (NUDIX family) [Lactobacillus delbrueckii subsp. bulgaricus ATCC 11842] 
(YP_618599) 1e-05 87/157 (55)  9.80E-87 444/495 (89) 
T4-16 751 1, Full 158 Conserved hypothetical protein [L. lactis subsp. cremoris MG1363] (CAL97806) 8e-05 33/151(21)  0.028 138/218 (63) 
T4-17 1097 1, Full 134 IS1193 transposase [S. thermophilus LMG18311] (YP_139512) 1e-41 87/133(65)  6.9 139/239 (58) 
  2, Partial 120 Alpha-like protein 1 [S. agalactiae] (AAR08145) 2e-07 52/161(32)  2.2 168/295 (56) 
T4-18 738 1, Partial 239 Hypothetical protein LEUM_1012 
[Leuconostocmes enteroides subsp. mesenteroides ATCC8293] (YP_818485) 2e-14 45/121(37)  3.3 156/277 (56) 
T4-19 919 1, Partial 205 Putative transposase OrfB [S. agalactiae] (AAL12831)  3e-112 202/206(98)  4 111/188 (59) 
  2, Partial 82 Putative transposase OrfA [S. agalactiae] (AAL12830) 3e-27 63/68(92)  7.10E-42 206/220 (93) 
T4-25 1328 1, Partial 83 Ribose5-phosphate isomerase RpiB [S. suis 05ZYH33] (ABP90008) 1e-33 68/83(81)  2.30E-51 249/252 (98) 
  2, Full 323 Tagatose-6-phosphate kinase [S. agalactiae A909] (YP_330483) 5e-103 192/311(61)  2.20E-214 970/972 (99) 
 
a Clone identification. 
b Base pair. 
c Open reading frame; Partial, partial ORF; Full, full ORF. 
d Amino acid. 
e e-value.  Expectation value, the lower the e-value, the more significant the score. 
f e.g. 194/412  (47%) = % amino acid or nucleotide sequence identity over region of comparison.  
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6.3.4.2 Non-tester-specific S. uberis 2893-1 sequences 
In total, initially seven non-tester-specific sequences were identified following the 
initial screening using DNA dot blot analyses.  ORF analysis using ORF finder of the 
seven non-tester-specific sequences identified 12 ORFs or partial ORFs.  
Subsequent BLASTP analyses of the 12 ORFs revealed their possible function[s] and 
are detailed in Table  6-5.   
 
Following nucleotide sequence determination, these sequences exhibited high 
(>90%) nucleotide sequence identity with housekeeping genes in the genome of the 
reference S. uberis strain 0140J (Table  6-5). 
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Table  6-5. Database analysis of the seven non-tester-specific DNA sequences 
 
BLASTP result vs non-redundant protein database  BLASTN vs S. uberis 0140J Clonea 
ID 
Size 
(bp)b ORF
c Size (aa)d Putative protein [Species/ strain name] (accession number) Expecte Amino acids
f 
Identities (%) Expect
e Nuceotides
f 
Identities (%) 
T2-01 1250 1, Full 165 Collagen-like surface protein [S. pyogenes MGAS10394] (YP_060115) 3e-30 74/181(40)  3.9e-60 307/334 (91) 
  2, Full 131 CobB/ CobQ-like glutamine amidotransferase domain  
[S. pyogenes MGAS10270] (YP_598485) 3e-61 110/130(84) 
 
1.5E-74 370/396 (93) 
T2-03F 640 1, Partial 188 Histidine kinase [S. pneumoniae R6] (NP_359485) 7e-26 63/152 (41)  9.6e-114 536/566 (94) 
T2-03R 700 1, Full 100 Response regulator [S. pneumoniae SP19-BS75] (ZP_01833086) 2e-21 53/92 (57)  5.2e-57 284/303 (93) 
T2-06 1006 1, Partial 282 Sulfatase family protein [S. pyogenes MGAS10750] (YP_602203) 1e-137 243/280 (86)  1.2e-185 846/849 (99) 
T2-08 982 1, Partial 324 Bacterial Peptide Chain Release Factor 3 [S. pyogenes MGAS10394] 
(AAT87316) 
3e-169 292/325 (89)  3.2e-211 964/976 (98) 
T3-03 1040 1, Full 259 Glutathione S-transferase [S. thermophilus LMD-9] (ABJ66040) 3e-95 165/262 (62)  5.1e-171 778/780 (99) 
T3-05F 531 1, Full 47 Succinate-semialdehyde dehydrogenase (NADP+)  
[S. pyogenes MGAS10750] (YP_602432) 
7e-18 42/47 (89)  3.4e-28 144/144 (100) 
  2, Full 47 Predicted hydrolases of the HAD superfamily 
[Yersinia bercovieri ATCC 43970] (ZP_00823468) 
4e-06 25/46 (54)  8.6e-28 143/144 (99) 
T3-05R 652 1, Full 87 Excinuclease ABC subunit C [S. agalactiae A909] (YP_329921) 3e-39 79/88 (89)  1e-54 263/265 (99) 
  2, Full 100 Haloacid dehalogenase-like hydrolase 
[Streptococcus gordonii str. Challis substr. CH1] (YP_001449606) 
7e-19 
 
43/99 (43) 
 
 6.9e-63 300/303 (99) 
T4-20 759 1, Partial 250 Agglutinin-like protein ALS2 [Candida albicans SC5314]  
(XP_712109 XP_442551) 
0.003 36/105 (34)  2.4e-161 742/753 (98) 
 
a Clone identification. 
b Base pair. 
c Open reading frame; Partial, partial ORF; Full, full ORF. 
d Amino acid. 
e e-value.  Expectation value, e-value is lower, the score is more significant. 
f e.g. 194/412  (47%) = % amino acid or nucleotide sequence identity over region of comparison.  
 
 
 
Chapter 6. S. uberis virulence factors 
 
 
180 
6.3.5 Additional dot blot analysis using ORF-specific DIG-labelled probes 
Although all 12 clones selected for subsequent use were initially demonstrated to 
be tester-specific, using the “whole insert” probes, they represented a library of 
nucleotide sequences that encompassed specific individual tester-specific ORFs.  
Dot blot analyses were further refined and their power of discrimination enhanced by 
the use of ORF-specific probes for the four tester-specific sequences encoding the 
five ORFs (T4-01 ORF1 [bacteriophage 10750.4]; T4-15 ORF1 [acetyltransferase 
GNAT family]; T4-17 ORF1 [IS1193 transposase] and 2 [alpha-like protein 1]; T4-19 
ORF1 [putative transposase OrfB]).  These ORFs in the four tester-specific 
sequences were identified to be virulence-associated factors or virulence-associated 
genes following nucleotide sequence determination and sequence analysis (Table 
 6-4). 
 
In addition, T2-01 ORF1 (collagen-like surface protein) in the non-tester-specific 
sequence (T2-01) was included in the additional dot blot analysis since this ORF 
encoded a homologue of a collagen-like surface protein in S. pyogenes, which could 
also be a putative virulence-associated factor in S. uberis (Table  6-5).   
 
A synopsis of the results following dot blot analysis using both clone specific “whole 
insert” and the six ORF-specific probes on the Australian S. uberis isolates were as 
follows. 
 
6.3.5.1 Dot blot analysis using a T4-01 ORF1 (bacteriophage 10750.4)-specific 
probe 
The results obtained using a T4-01 “whole insert” DIG-labelled probe demonstrated 
that homologous sequences were present in 12 of the 40 Australian S. uberis isolates 
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(Table  6-3).  However, when a T4-01 ORF1-specific probe was used, T4-01 ORF1 
homologous sequences were demonstrated in only five of the 12 T4-01 “whole insert” 
positive isolates (Table  6-7). 
 
6.3.5.2 Dot blot analysis using a T4-15 ORF1 (acetyltransferase GNAT 
family)-specific probe 
The dot blot analyses using a T4-15 “whole insert” probe demonstrated that 
homologous sequences were present in 16 of the 40 Australian S. uberis isolates 
(Table  6-3).  The remaining 24 S. uberis isolates, including the driver strain (3217-2), 
demonstrated only very weak cross-reaction on the initial screening using DNA dot 
blot (Table  6-3).  However, when a T4-15 ORF1-specific probe was used a positive 
result was observed in only 13 of the 16 T4-15 “whole insert” positive isolates (Table 
 6-7). 
 
6.3.5.3 Dot blot analysis using a T4-17 ORF1 (IS1193 transposase) or 2 
(alpha-like protein 1)-specific probe 
The dot blot analyses using a T4-17 “whole insert” probe demonstrated that 
homologous sequences were present in 20 of the 40 Australian isolates (Table  6-3).  
Although the results obtained using a T4-17 ORF1-specific probe demonstrated the 
occurrence of homologous sequences (T4-17 ORF1) in 20 of the 20 T4-17 positive 
isolates (Table  6-7), when a T4-17 ORF2-specific probe was used, homologous 
sequences (T4-17 ORF2) were demonstrated in only 8 of the 20 T4-17 positive 
isolates (Table  6-7). 
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6.3.5.4 Dot blot analyses using both T4-19 ORF1 (putative transposase 
OrfB)-specific probe 
The dot blot analyses using a T4-19 “whole insert” probe demonstrated that 
homologous sequences were clearly present in 20 of the 40 Australian S. uberis 
isolates.  However, faint dots were observed in seven isolates including the driver 
strain (3217-2) (Table  6-3).  Such faint cross-reactions were to be expected given the 
anticipated transposon-like function of this gene and this was investigated further 
using a combination of both T4-19 ORF1-specific PCR and Southern blotting. 
 
When a T4-19 ORF1-specific probe was used, homologous sequences were 
demonstrated in 19 of the 20 T4-19 positive isolates (Table  6-6).  Whilst a faint 
cross-reaction using a T4-19 ORF1-specific probe was observed with seven isolates, 
the driver strain (3217-2) was clearly negative (Table  6-6). 
 
Accordingly, the weakly cross reactive T4-19 ORF1 isolates were further 
investigated using a T4-19 ORF1-specific PCR and the copy number of this 
transposon-related gene estimated following Southern blot analysis.   
 
All isolates which exhibited a faint dot blot cross-reaction using either a T4-19 
“whole insert” probe or the T4-19 ORF1-specific probe were confirmed as negative 
using a T4-19 ORF1-specific PCR (Table  6-6).   
 
6.3.5.5 Southern blotting using a T4-19 (putative transposase OrfB and OrfA) 
“whole insert” randomly-primed DIG-labelled probe 
To further investigate the occurrence of the T4-19 transposon-like sequence in the 
Australian S. uberis isolates, 13 isolates were further analysed by Southern blotting 
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following Hind III digestion of genomic DNA and probing using a T4-19 “whole insert” 
DIG-labelled probe.  The results demonstrated that seven of the isolates (2956-4, 
6104, 2169-2, 2285-1, 6093, 2893-1, 5660-4) produced two bands consisting of one 
intense band and one weak band; three of the isolates (3147-1, 3327-3 and 3217-2) 
produced only a single weak band and no bands were observed in the three isolates; 
2530-2, 2690-2 and 3217-5 (Table  6-6 and Figure  6-8). 
 
Specifically, only isolates 2956-4, 6104, 2169-2, 2285-1, 6093, 2893-1, and 5660-4 
were positive using a T4-19-specific PCR and these isolates also elicited an intense 
signal following dot blot analysis using a T4-19 ORF1-specific probe (Table  6-6).  
However, isolates 3147-1, 3327-3 and 3217-2, although PCR negative, elicited a faint 
cross-reaction following the dot blot analysis using a T4-19 ORF1-specific probe 
(Table  6-6).  Isolates 2530-2, 2690-2 and 3217-5 were clearly both PCR and dot blot 
negative using a T4-19 ORF1-specific probe (Table  6-6).  Accordingly the higher 
molecular weight T4-19 Hind III band most likely represents a T4-19 sequence 
homologue (Figure  6-8).  The lower molecular weight T4-19 Hind III band most likely 
represents the T4-19 sequence and the differences in the intensity of this lower 
molecular weight band can be considered indicative of the copy number of this 
transposase-like sequence in the respective genomic DNAs (Figure  6-8).   
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Table  6-6. Distribution of insert T4-19 and T4-19 ORF1 homologous sequences  
in Australian S. uberis isolates 
 
Diseasea 
status 
Farm 
location 
Isolateb  
ID 
STc 
 
GCCd 
 
T4-19e 
Dot blot 
T4-19f 
ORF1-sp. 
Dot blot 
T4-19g 
ORF1-sp. 
PCR 
T4-19h 
Southern 
blotting 
C Newry 2893-1 156 143 + + + ++ 
C Newry 2730-5 281  +/- +/-  + 
C Moe 5851 272 5 +/- +/-  + 
C Korumburra 5838-3 194   +/-  ND 
C Timboon 883-4 253   +/-  ND 
C Newry 3064-1 594  + +/-  ND 
C Newry 2481-1 60 5 + + + ++ 
C Timboon 853-4 252  +/- +/-  ND 
C Newry 2907-1 60 5 + + + ++ 
C Newry 2956-4 60 5 + + + ++ 
C Newry 2169-2 277  + + + ++ 
C Newry 2285-1 278 5 + + + ++ 
C Newry 2520-1 279 143 + + + ++ 
C Newry 2988-1 282 143 + + + ND 
C Maffra 6093 283  + + + ++ 
C Newry 2874-4 184 143 + + + ND 
C Maffra 6104 275  + + + ++ 
C Newry 2565-2 276     ND 
C Newry 2530-2 280     - 
SC Newry 2042-5 194  +/- +/-  + 
SC Camperdown 5867 273 143 + + + ND 
SC Timboon 686-5 596     - 
SC Timboon 684-1 155 143 + + + ND 
SC Newry 2407-7 216 143 + + + ND 
SC Timboon 796-3 251  + + + ND 
SC Timboon 868-4 254  + + + ND 
SC Timboon 796-2 153 143 + + + ND 
SC Newry 2655-5 217 86    ND 
SC Newry 2581-2 258     ND 
SC Newry 2690-2 255     - 
SC Timboon 686-10 597     ND 
N Newry 3147-4 256  + + + ND 
N Newry 3217-1 257     ND 
N Newry 3147-5 261  + + + ND 
N Newry 3147-1 260     + 
N Newry 3217-5 263 86    - 
N Newry 3327-3 259 86    + 
N Newry 3133-3 264 143 +/-   + 
N Newry 3217-3 595  +/-   + 
N Newry 3217-2 262 86 +/-   + 
    Total 20 (7) 19 (7) 19 ++ 9 
+ 8 
- 4 
 
a Disease status is indicated as follows: C, clinical mastitis; SC, subclinical mastitis; L, low somatic cell 
count. 
b Isolate identification. 
c Sequence type. 
d Global clonal complex (GCC) for each ST has been assigned by the S. uberis MLST database.  
Blank, does not belong to any GCC. 
e DNA dot blotting assay result using randomly DIG-labelled probe generated from the insert T4-19. 
f DNA dot blotting assay result using T4-19 ORF1-specific PCR DIG-labelled probe. 
g T4-19 ORF1-specific PCR result. 
h Southern blotting assay result using randomly T4-19 ORF1-specific PCR Dig labelled probe.  ++, + 
and - indicate a number of bands, two, one and nill, on the result of the Southern blot respectively.   
For the purpose of clarity, a negative dot blot result is indicated by a blank entry. 
+/- indicates a faint cross reaction.   
ND, not determined. 
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Figure  6-8. Prevalence of T4-19 transposon-like and T4-19 homologue sequences in 13 Australian 
S. uberis isolates as determined by Southern blotting. 
 
The higher molecular weight T4-19 Hind III band (T4-19 homologue; upper arrow) most likely 
represents a T4-19 transposon-like sequence homologue. 
 
The lower molecular weight T4-19 Hind III band (T4-19; lower arrow) represents the T4-19 
transposon-like sequence. 
 
T4-19 ORF1-specific PCR results, DNA dot blot results using a T4-19 ORF1-specific probe and a 
T4-19 “whole insert” probe for each of the 13 selected S. uberis isolates are shown inserted in the 
Southern blot Figure above.  The symbols “+”, “+/-“ and “-“ indicate a positive result, a faint cross 
reaction and a negative result respectively.    
 
Lanes. Isolate ID in the Australian S. uberis isolates 
1. 2956-4 
2. 6104 
3. 2169-2 
4. 2285-1 
5. 6093 
6. 2893-1 
7. 5660-4 
8. 2530-2 
9. 2690-2 
10. 3147-1 
11. 3217-5 
12. 3327-3 
13. 3217-2. 
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6.3.5.6 Dot blot analysis using a T2-01 ORF1 (collagen-like surface 
protein)-specific probe 
The dot blot analyses using a T2-01 “whole insert” probe demonstrated that 
homologous sequences were present in all of the 40 S. uberis isolates including the 
driver strain (3217-2) (Table  6-3).  However, 37 out of the 40 Australian isolates 
demonstrated positive results using a T2-01 ORF1-specific probe (Table  6-7) and a 
homologous sequence (T2-01 ORF1) was not observed in the driver strain (3217-2) 
confirming the tester-specificity of the T2-01 ORF1. 
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6.3.6 Summary of dot blot results using a combination of “whole insert” and 
ORF-specific DIG-labelled probes 
In summary, the earlier results obtained using tester-specific “whole insert” probes 
from clones T4-06, T4-25, T3-02, T3-06, T1-16, T4-18, T1-15, T4-16 (Table  6-3) have 
been further refined by the inclusion of results obtained following tester-specific ORF 
probing of a set of 40 Australian S. uberis isolates using probes generated from T2-01 
ORF1; T4-01 ORF1; T4-15 ORF1; T4-17 ORF1; T4-17 ORF2 and T4-19 ORF1 (Table 
 6-7). 
 
Clone T2-01 was initially considered to be non-tester-specific (Table  6-3).  
However, subsequent dot blot analysis using a T2-01 ORF1-specific probe clearly 
demonstrated that T2-01 ORF1, encoding collagen-like surface protein, was absent in 
the genomic DNA of the driver DNA.  Accordingly the result obtained using the T2-01 
ORF1-specific probe has been included in Table  6-7. 
 
Thirteen out of the 20 randomly selected clones from the tester-specific clone 
libraries were tester-specific.  Dot blot analyses using eight “whole insert” and six 
ORF-specific probes demonstrated that the distribution of each homologous 
sequence of the whole insert or ORF in the 40 Australian S. uberis isolates ranged 
from two (5%) to 37 isolates (92.5%) (Table  6-7).  More tester-specific “whole 
inserts” and ORFs were distributed in the isolates associated with clinical / subclinical 
mastitis than in those associated with cows with low cell counts (Table  6-7). 
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Table  6-7. Distribution of tester-specific inserts, ORFs and known putative virulence factors in Australian S. uberis isolates 
 
Disease
a status 
Farm 
location 
Isolateb 
ID 
STc 
 
GCC
d 
T2-01e
ORF1 
T4-06
 
T4-25
 
T3-02
 
T4-17e 
ORF1 
T4-19
ORF1
T3-06
 
T4-15
ORF1
T1-16
 
T4-18 
 
T4-17e 
ORF2
T1-15
 
T4-01
ORF1
T4-16
 
Total
 
HasA
 
Lbp 
 
CAMP PauA
 
SUAM
 
GapC C5a 
C Newry 2893-1 156 143 + + + + + + + + + + + + + + 14 + + + +  
C Newry 2730-5 281  + + + + + + + + + + + + 12 + + + +  
C Moe 5851 272 5 + + + + + + + + + + + 11 + + + + +  
C Korumburra 5838-3 194  + + + + + + + + + + 10 + + + +  
C Newry 3064-1 594  + + + + + + + + + + 10 + + + + +  
C Timboon 883-4 253  + + + + + + + + + 9 + + + + +  
C Timboon 853-4 252  + + + + + + + + + 9 + + + + +  
C Newry 2481-1 60 5 + + + + + + +  + 8 + + + + + +  
C Newry 2907-1 60 5 + + + + + + +  7 + + + + + +  
C Newry 2956-4 60 5 + + + + + + +  7 + + + + + +  
C Newry 2169-2 277  + + + + + + +  7 + + + + + +  
C Newry 2285-1 278 5 + + + + + + +  7 + + + + + +  
C Newry 2520-1 279 143  + + + + + +  6 + + + + +  
C Newry 2988-1 282 143 + + + + + +  6 + + + + + +  
C Maffra 6093 283  + + + + +  + 6 + + + + +  
C Newry 2874-4 184 143  + + + +  4 + + + + +  
C Maffra 6104 275  + + + +  4 + + + + +  
C Newry 2565-2 276  + + + +  4 + + + + + +  
C Newry 2530-2 280  + + +  3 + + + + + +  
SC Newry 2042-5 194  + + + + + + + + + + 10 + + + +  
SC Camperdow 5867 273 143 + + + + + + +  7 + + + + +  
SC Timboon 686-5 596  + + + + + + + 7 + + + +  
SC Newry 2407-7 216 143 + + + + + + +  7 + + + + +  
SC Timboon 684-1 155 143 + + + + + +  6 + + + + +  
SC Timboon 796-3 251  + + + + + +  6 + + + + +  
SC Timboon 868-4 254  + + + + + +  6 + + + + +  
SC Timboon 796-2 153 143 + + + +  4 + + + + +  
SC Newry 2581-2 258  + + + +  4 + + + + + +  
SC Newry 2655-5 217 86 + + +  3 + + + +  
SC Timboon 686-10 597  + + +  3 + + + +  
SC Newry 2690-2 255  +  1 + + + + + +  
N Newry 3147-4 256  + + + + + +  6 + + + + +  
N Newry 3217-1 257  + + + + +  5 + + + +  
N Newry 3147-5 261  + + + + +  5 + + + + +  
N Newry 3147-1 260  + + + +  4 + + + + +  
N Newry 3217-5 263 86 + + + 3 + + + + + +  
N Newry 3327-3 259 86 + + +  3 + + + +  
N Newry 3133-3 264 143 + +  2 + + + + +  
N Newry 3217-3 595  +  + 2 + + + + +  
N Newry 3217-2 262 86   0 + + + + +  
  Total 37 33 32 26 20 19 15 13 10 10 8 8 5 2 33 37 13 40 40 40 0 
 
a Disease status is indicated as follows: C, clinical mastitis; SC, subclinical mastitis (shaded area); L, low somatic cell count.  b Isolate identification. c Sequence type. 
d Global clonal complex (GCC) for each ST has been assigned by the S. uberis MLST database.  Blank, does not belong to any GCC. 
e Results based on ORF-specific probe for each of the inserts.  For the purpose of clarity, a negative dot blot result is indicated by a blank entry. 
+/- indicates a faint cross reaction.   
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6.3.7 Virulence factor PCRs 
6.3.7.1 C5a peptidase PCR and DNA dot blot analysis 
A C5a peptidase-specific PCR was performed on both the tester strain (2893-1) 
and driver strain (3217-1) DNAs.  Both were negative with only the positive control, 
S. agalactiae, strain RO799, giving a positive result.  Accordingly, C5a 
peptidase-specific PCR was not performed on any other Australian S. uberis isolates. 
 
To confirm this result, a C5a DNA dot blot using a randomly-primed DIG-labelled 
C5a peptidase gene probe was performed on the Australian S. uberis isolates (n = 40) 
and also three human and one bovine S. agalactiae isolates (WCH59, RO800, RO799 
and VW9211) as additional positive and negative controls.  All of the S. agalactiae 
human isolates were positive. The bovine S. agalactiae isolate (VW9211) and all of 
the S. uberis isolates were negative, confirming the earlier results obtained using the 
C5a peptidase-specific PCR (Figure  6-9). 
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Figure  6-9. DNA blot analysis for the prevalence of C5a peptidase gene in Australian isolates. 
 
White boxes indicate DNA dots of each S. agalactiae strain.  All of the S. agalactiae human isolates, 
WCH59, RO800 and RO799, were positive however the S. agalactiae bovine isolate, VW9211, and all 
of the Australian S. uberis isolates were negative.  A key detailing the position of each of the genomic 
DNAs from the Australian S. uberis isolates and S. agalactiae used is given below.  Genomic DNA 
from most isolates* were dotted at two different DNA concentrations (200 and 20ng) on columns 1-2, 
3-4, 5-6, 7-8, 9-10 and 11-12 respectively.  The S. uberis positive and negative controls [genomic 
DNA from the tester strain 2893-1 (Position; G11-12; 200ng and 20ng) and the driver strain 3217-2 
(Position; H11-12; 200ng and 20ng)] are indicated by black boxes. 
 
*Due to space constraints on the blot, the S. agalactiae human isolates WCH59, RO800 were dotted at 
a single concentration (200 ng) at positions H1 and H2 respectively.   
Column 1-2 
  
A1-2 (2481-1) 
B1-2 (2907-1) 
C1-2 (2956-4) 
D1-2 (2530-2) 
E1-2 (3064-1) 
F1-2 (6104) 
G1-2 (5867) 
H1 (WCH59) 
H2 (RO800) 
Column 3-4 
 
A3-4 (2169-2) 
B3-4 (2285-1) 
C3-4 (2520-1) 
D3-4 (2730-5) 
E3-4 (5851) 
F3-4 (6093) 
G3-4 (Blank) 
H3-4 (2407-7) 
Column 5-6 
 
A5-6 (2874-4) 
B5-6 (2893-1) 
C5-6 (2988-1) 
D5-6 (3133-3) 
E5-6 (3217-3) 
F5-6 (5660-4) 
G5-6 (684-1) 
H5-6 (796-2)  
Column 7-8 
 
A7-8 (2042-5) 
B7-8 (2565-2) 
C7-8 (2581-2) 
D7-8 (2690-2) 
E7-8 (3147-5) 
F7-8 (3147-4) 
G7-8 (3147-1) 
H7-8 (RO799) 
Column 9-10 
 
A9-10 (3217-1) 
B9-10 (5838-3) 
C9-10 (686-10) 
D9-10 (796-3) 
E9-10 (853-4) 
F9-10 (868-4) 
G9-10 (883-4) 
H9-10 (VW921) 
Column 11-12 
 
A11-12 (2655-5) 
B11-12 (3217-5) 
C11-12 (3217-2) 
D11-12 (3327-3) 
E11-12 (Blank) 
F11-12 (686-5) 
G11-12 (Positive control,  
tester, 2893-1) 
H11-12 (Negative control, 
driver, 3217-2) 
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6.3.7.2 SUAM, PauA and GapC gene PCRs 
All of the 40 Australian S. uberis isolates investigated, including the tester (2893-1) 
and driver (3217-2) DNAs, were positive using gene-specific PCR for SUAM, PauA 
and GapC genes (Table  6-7). 
 
6.3.7.3 HasA gene PCR or Southern blot analysis 
Thirty-two out of the 40 Australian S. uberis isolates tested were positive using 
either PCR or Southern blot analyses.  Although the HasA gene PCR results have 
been presented earlier in Chapter 5, the results have been included in Table  6-7 to 
facilitate comparison with the results obtained with regard to additional virulence 
factors. 
 
6.3.7.4 Lbp gene PCR 
Of the 40 Australian S. uberis isolates tested, 36 were Lbp gene PCR positive.  Of 
particular interest, the tester strain (2893-1) was negative whereas the driver strain 
(3217-2) was Lbp gene PCR positive. 
 
6.3.7.5 CAMP factor gene PCR 
Of the 40 Australian S. uberis isolates tested, 14 were positive using a CAMP factor 
gene PCR.  As observed previously using the Lbp gene PCR, the tester strain 
(2893-1) was negative whereas the driver strain (3217-2) was CAMP factor gene PCR 
positive. 
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6.3.8 Prevalence and association of putative virulence factors and 
tester-specific sequences with disease status 
The prevalence and association of each individual tester-specific sequence, 
tester-specific ORF or putative virulence-associated genes with clinical / subclinical 
mastitis (n = 31) and with cows with low cell counts (n = 9) is shown in Table  6-8. 
 
The putative virulence factors PauA, SUAM and GapC genes and T2-01 ORF1, 
which encoded a collagen surface protein homologue, were present in 94 to 100% of 
isolates associated with clinical / subclinical mastitis.  However these sequences 
were also present in the majority of isolates (89 to 100%) associated with cows with 
low cell counts.  Chi-square analyses demonstrated that the association between the 
presence of this particular tester-specific sequence or the individual putative virulence 
genes and disease status was not statistically significant (Table  6-8). 
 
The T4-06, HasA gene, T4-25, T3-02, T4-19 ORF1 and T3-06 sequences were 
present in 48 to 90% of isolates associated with clinical / subclinical mastitis whereas 
these sequences were present in only 0 to 56% of isolates associated with cows with 
low cell counts.  Notably, T3-06 was present in 68% of isolates associated with 
clinical mastitis but was absent from all of the isolates associated with cows with low 
cell counts (Table  6-8).  Chi-square analyses demonstrated a statistically significant 
link between T4-06 (P = 0.016), HasA gene (P = 0.016), T4-25 (P = 0.002), T3-02 
(P = 0.002), T3-06 (P = 0.008) and disease status whereas the relationship between 
T4-19 ORF1 (P = 0.085) and disease status was not statistically significant (Table 
 6-8).   
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The prevalence of CAMP factor gene, T4-15 ORF1, T1-16, T4-18, T4-17 ORF2, 
T1-15, T4-01 ORF1 and T4-16 sequences in the Australian S. uberis isolates (n = 40) 
associated with clinical / subclinical mastitis (6 to 39%) was higher than isolates 
associated with cows with low cell counts (0 to 33%).  However, taken as a whole, 
the prevalence of these sequences was low, ranging between 5 and 35% (Table  6-8).  
In addition, Chi-square analyses demonstrated that there was no statistically 
significant association between the occurrences of these individual tester-specific 
sequences or the occurrence of CAMP factor gene and disease status in the 
Australian S. uberis isolates investigated (Table  6-8). 
 
In contrast to all earlier tester-specific sequences, the tester-specific T4-17 ORF1 
sequence and the virulence factor Lbp gene sequence demonstrated a recriprocal 
relationship and were more prevalent in isolates associated with cows with low cell 
counts than isolates associated with clinical / subclinical mastitis.  However the 
differences were not statistically significant (Table  6-8). 
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Table  6-8. Association between putative virulence factors / tester-specific sequences and disease 
status 
 
 No. of insert / ORF or virulence associated gene 
present in Australian isolates from cows  
with 
Clone IDa / 
ORF or 
virulence 
associated 
gene 
No. of insert / ORF 
or virulence 
associated gene 
present in 
Australian isolates % 
Clinical/ 
subclinical 
mastitis 
% Low cell counts % 
Chi-square
P valueb 
PauA 40 100 31 100 9 100 n/a 
SUAM 40 100 31 100 9 100 n/a 
GapC 40 100 31 100 9 100 n/a 
T2-01 ORF1 37 93 29 94 8 89 0.64 
Lbp 36 90 27 87 9 100 0.256 
T4-06 33 83 28 90 5 56 0.016 * 
HasA 33 83 28 90 5 56 0.016 * 
T4-25 32 80 28 90 4 44 0.002 * 
T3-02 26 65 24 77 2 22 0.002 * 
T4-17 ORF1 20 50 15 39 5 56 0.705 
T4-19 ORF1 19 48 17 55 2 22 0.085 
T3-06 15 38 15 48 0 0 0.008 * 
CAMP factor 14 35 11 36 3 33 0.905 
T4-15 ORF1 13 33 12 39 1 11 0.120 
T1-16 10 25 9 29 1 11 0.274 
T4-18 10 25 9 29 1 11 0.274 
T4-17 ORF2 8 20 8 26 0 0 0.088 
T1-15 8 20 8 26 0 0 0.088 
T4-01 ORF1 5 13 4 13 1 11 0.886 
T4-16 2 5 2 6 0 0 0.434 
 
a Clone identification. 
b P value obtained following Chi-square analysis of percentage prevalence. 
Shaded area indicates tester-specific inserts / ORFs and virulence-associated genes which 
demonstrated a statistically significant link with disease status. 
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6.3.9 Association between tester-specific inserts / ORFs or virulence 
associated genes and GCC type 
The prevalence of each of the tester-specific sequences and known 
virulence-associated genes, sub-classified according to GCC (ST5/143 [n = 14] and 
ST86 [n = 4]) is presented in Table  6-9. 
 
PauA, SUAM, GapC, Lbp genes and T2-01 ORF1 sequences were highly prevalent 
in both GCC ST5/143 (86 to 100%) and GCC ST86 (75 to 100%).  Chi-square 
analyses demonstrated that the link between these tester-specific sequences or 
putative virulence genes and either GCC ST5/143 or GCC ST86 was not statistically 
significant (Table  6-9). 
 
T4-06, HasA gene, T4-25, T3-02, T4-19 ORF1, T4-15 ORF1 and T3-06 sequences 
were present in 64 to 93% of isolates belonging to GCCs, ST5/143 whereas these 
sequences were present in only 0 to 50% of isolates belonging to GCC ST86 (Table 
 6-9).  Chi-square analyses demonstrated a statistically significant linkage 
relationship between the occurrence of the “whole insert” sequences T4-25 
(P = 0.004); T3-02 (P = 0.001); T3-06 (P = 0.023) and the GCC type ST5/143 with 
exception of T4-06 (P = 0.126). 
 
In addition, there was a statistically significant linkage between the occurrence of 
the ORF-specific sequences T4-19 ORF1 (P = 0.001), T4-15 ORF1 (P = 0.011) and 
the virulence-associated factor HasA gene (P = 0.004) with GCC ST5/143 (Table 
 6-9). 
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Whilst the prevalence of T4-17 ORF1, T1-16, T4-18, T4-17 ORF2, T1-15, T4-01 
ORF1 and T4-16 sequences among the isolates associated with GCCs, ST5/143 (7 to 
29%) was slightly higher than the prevalence of these inserts with GCC ST86 (0 to 
25%), this difference was not statistically significant (Table  6-9). 
 
In contrast with all other results, CAMP factor gene exhibited an inverse 
relationship, being more prevalent in isolates belonging to GCC ST86 than those 
belonging to GCC ST5/143; but this relationship was not statistically significant (Table 
 6-9). 
 
In summary, of the 20 tester-specific sequences and the virulence associated 
genes tested, only HasA gene (hyaluronate synthase), T4-25 (ribos5-phosphate 
isomerase RpiB and tagatose-6-phosphate kinase), T3-02 (putative acyl-CoA 
synthetase), and T3-06 (collagen-like surface protein) sequences demonstrated a 
statistically significant linkage relationship between their occurrence and both disease 
status and GCC type (P < 0.05) (Table  6-8 and Table  6-9).   
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Table  6-9. Association between tester-specific inserts / ORFs or virulence-associated genes 
and GCC type 
 
 No. of insert / ORF or virulence associated gene present in 
Australian isolates belonging to 
 
Clone IDa / 
ORF or 
virulence 
associated 
gene 
No. of insert / ORF 
or virulence 
associated gene 
present in 
Australian isolates 
belonging to GCCs 
(n = 18) 
% GCC ST5/143 % 
GCC 
ST86 % 
Chi-square
P valueb 
PauA 18 100 14 100 4 100 n/a 
SUAM 18 100 14 100 4 100 n/a 
GapC 18 100 14 100 4 100 n/a 
Lbp 17 94 13 93 4 100 0.582 
T2-01 ORF1 15 83 12 86 3 75 0.612 
T4-06 15 83 13 93 2 50 0.126 
HasA 14 78 13 93 1 25 0.004 * 
T4-25 14 78 13 93 1 25 0.004 * 
T3-02 12 67 12 86 0 0 0.001 * 
T4-19 ORF1 12 67 12 86 0 0 0.001 * 
T4-15 ORF1 10 56 10 71 0 0 0.011 * 
T3-06 9 50 9 64 0 0 0.023 * 
CAMP factor 8 44 6 43 2 50 0.800 
T4-17 ORF1 5 28 4 29 1 25 0.888 
T1-16 3 17 2 14 1 25 0.612 
T4-18 3 17 2 14 1 25 0.612 
T4-17 ORF2 2 11 2 14 0 0 0.423 
T1-15 2 11 2 14 0 0 0.423 
T4-01 ORF1 2 11 2 14 0 0 0.423 
T4-16 1 6 1 7 0 0 0.582 
 
a Clone identification. 
b P value obtained following Chi-square analysis of percentage prevalence. 
Shaded areas indicates tester-specific inserts / ORFs and virulence-associated genes which 
demonstrated a statistically significant linkage relationship with GCC types.  
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6.3.10 Sequence analyses of collagen-like surface protein encoding in T3-06 
ORF1 and T2-01 ORF1 
The T3-06 ORF1, which encoded a collagen-like surface protein, exhibited a strong 
correlation with clinical and subclinical mastitis and association with the GGC type 
ST5/143.  In addition, T2-01 ORF1 encoded a similar collagen-like surface protein 
homologue.  Both T3-06 ORF1 and T2-01 ORF1 represented additional putative 
S. uberis virulence factors and were subjected to additional sequence analyses. 
 
The amino acid sequences of T3-06 ORF1 (388 aa) and T2-01 ORF1 (165 aa) 
were used to search the reference S. uberis strain 0140J genome sequence.  
Although an unannotated T2-01 ORF1 homologue was identified (307/334, 91% 
nucleotide identity), the only T3-06 homologue exhibited low nucleotide sequence 
identity (151/270, 55%) (Table  6-4 and Table  6-5).  When both T3-06 ORF1 and 
T2-01 ORF1 amino acid sequences were aligned using CLUSTALW, regions of 
protein sequence identity corresponding with conserved motifs characteristic of 
collagen-like surface proteins were identified (Figure  6-10). 
Chapter 6. S. uberis virulence factors 
 
 
199 
 
 
 
 
 
 
 
Figure  6-10. Amino acid sequence alignment of the T3-06 ORF1 and T2-01 ORF1 using CLUSTALW. 
 
T3-06 ORF1 and T2-01 ORF1 were aligned using CLUSTALW.  Regions of protein sequence identity 
corresponding with conserved Gly-X-Y motifs characteristic of collagen-like surface proteins are 
shaded. 
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6.3.10.1 Analyses of Gly-X-Y triplet amino acid motifs in T3-06 ORF1 and 
T2-01 ORF1 
The central region of the collagen-like surface protein encoded by T2-01 ORF1 
comprised one region containing 21 continuous Gly-X-Y motif repeats.  In contrast 
T3-06 ORF1 encoded nine different types of Gly-X-Y repeat motifs; three (Gly-X-Y)2; 
two (Gly-X-Y)3; one (Gly-X-Y)4; one (Gly-X-Y)5 and two (Gly-X-Y)6 arranged in a 
co-linear fashion (Table  6-10).  Only three out of the 22 types of Gly-X-Y motifs were 
present in both T2-01 ORF1 and T3-06 ORF1 (Table  6-11). 
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Table  6-10. Comparison of Gly-X-Y motifs in T3-06 ORF1 and T2-01 ORF1 
 
Type Gly-X-Y motif repeat (21 continuous) in T2-01 ORF1 
1 G  K  N  G  Q  D  G  K  D  G  A  P  G  R  D   
 G  V  D  G  K  D  G  A  P  G  R  D  G  R  D   
 G  K  D  G  M  P  G  R  D  G  R  D  G  H  D   
 G  K  D  G  M  P  G  R  D  G  M  N  G  K  D   
 G  Q  A  
  
Type Gly-X-Y motif repeat (total 33 Gly-X-Y motifs) in T3-06 ORF1 
1 G  K  D  G  Q  D  G  Q  D  G  K  D  G  V  D  G  K  T   
2 G  Q  D  G  E  D  G  V  D  G  Q  D  G  K  D  G  E  T   
3 G  Q  D  G  E  D  G  V  D  G  Q  D  G  S  T  
4 G  Q  D  G  V  D  G  E  D  G  Q  T  
5 G  V  D  G  E  D  G  Q  T  
6 G  Q  D  G  E  D  G  R  S  
7 G  N  S  G  Y  W  
8 G  E  S  G  Q  W   
9 G  D  T  G  L  W 
  
 
T2-01 ORF1 comprised one continuous 21 Gly-X-Y triplet amino acid motif.  In contrast T3-06 ORF1 
encoded 33 Gly-X-Y motifs consisting of 9 co-linear (Gly-X-Y)n motif repeats comprising three n = 2 
(Gly-X-Y)2; two n = 3 (Gly-X-Y)3; one n = 4 (Gly-X-Y)4; one n = 5 (Gly-X-Y)5 and two n = 6 (Gly-X-Y)6.  
The individual Gly-X-Y motifs are underlined. 
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Table  6-11. Comparison and distribution of specific Gly-X-Y triplet motifs 
in T3-06 ORF1 and T2-01 ORF1 
 
Gly‐X‐Y motif  T2‐01 ORF1  T3‐06 ORF1 
GQD  1  8 
GVD  1  5 
GKD  5  3 
GED    5 
GST    1 
GQT    2 
GET    1 
GNS    1 
GYW    1 
GKT    1 
GES    1 
GQW    1 
GRS    1 
GLW    1 
GDT    1 
GRD  6   
GAP  2   
GMP  2   
GKN  1   
GHD  1   
GMN  1   
GQA  1   
Total number of   
Gly-X-Y motifs 
(22 types) 
 
21   
(10 types) 
 
33 
  (15 types) 
 
The shaded area corresponded three of the 22 types of triplet motifs (Gly-X-Y) present in both T2-01 
ORF1 and T3-06 ORF1. 
 
T2-01 ORF1 and T3-06 ORF1 contain 10 and 15 different types of Gly-X-Y motifs respectively. 
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6.3.10.2 Nucleotide sequence analysis of S. uberis T4-19 
transposase-like sequence and S. agalactiae insertion sequence ISSag2  
The T4-19 sequence (transposase-like gene, 919 bp) encoding two ORFs and the 
insertion sequence ISSag2 encoding the putative transposase OrfB and OrfA genes 
from S. agalactiae strain O90R (2962 bp, AF329275) were aligned using CLUSTALW.  
The alignment demonstrated high nucleotide sequence identity between the two 
transposase-like gene sequences (Figure  6-11).  Although the sequences of T4-19 
ORF1 and 2 only cover a part of putative S. uberis transposase-like genes (Table  6-4), 
their orientation was the same as that observed in the S. agalactiae ISSag2, encoding 
OrfB and OrfA respectively.  In particular, the size of the intergenic region gap (36 bp) 
between the two ORFs in the S. uberis T4-19 transposase-like genes and 
S. agalactiae ISSag2 was identical (Figure  6-12). 
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Figure  6-11. Nucleotide sequence alignment of the S. agalactiae insertion sequence ISSag2 [encoding 
OrfA and OrfB] with the nucleotide sequence of the S. uberis clone T4-19 encoding the 
transposase-like genes ORF1 and ORF2. 
 
T4-19 ORF1 and ORF2 exhibited high nucleotide sequence identity with the putative transposase OrfB 
(607/618, 98%) and OrfA (238/260, 92%) in the S. agalactiae insertion sequence ISSag2. 
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Figure  6-12. Comparison of the gene organization of the transposase ISSag2 from 
S. agalactiae and the S. uberis clone T4-19 transposase-like gene sequence encoding 
T4-19 ORF1 and ORF2. 
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6.4 Discussion 
6.4.1 Subtractive hybridization 
Following subtractive hybridization, initial screening of tester-specific sequences by 
DNA dot blot analyses identified 12 tester-specific sequences in the 19 clones 
randomly selected from the clone libraries (Table  6-3).  The percent of tester-specific 
sequences among the randomly selected clones (63%) compared favorably with 
expectations based on an earlier study which demonstrated 24 out of 42 (57%) 
subtracted DNA fragments were tester-specific sequences (Ahmed et al., 2002).  
This result confirms that the subtractive hybridization assay used in this study 
effectively subtracted and enriched for tester-specific DNA sequences in the Rsa I 
digested tester genomic DNA. 
 
As anticipated, given a success rate of ~60% following subtractive hybridization 
enrichment of tester-specific sequences (Ahmed et al., 2002), the tester-specific 
libraries did contain sequences which were present in both the tester and driver 
DNAs.  In addition to the 12 tester-specific clones, 7 non-tester-specific clones were 
identified following the initial screening by DNA dot blot analyses. 
 
The nucleotide sequence of the non-tester-specific inserts in the libraries were 
mostly housekeeping genes and exhibited very high nucleotide sequence identity (91 
to 100%) with the reference S. uberis J0140 genome sequence (Table  6-5). 
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6.4.2 The association between the presence of the tester-specific inserts / 
ORFs and disease status or types of GCC of the isolates 
The linkage between the occurrence of individual tester-specific sequences or 
ORFs, virulence-associated genes and either disease status or GCC type identified 
three major groupings. 
 
The first group contained tester-specific sequences or virulence-associated genes 
(PauA, SUAM, GapC, Lbp genes and T2-01 ORF1) which were highly prevalent 
(>80%) among the S. uberis isolates regardless of disease status or GCC type.  
There was no statistically significant (P < 0.05) association between the prevalence of 
any of these sequences and either disease status or types of GCC.  Whilst PauA, 
SUAM, GapC and Lbp genes are considered to be putative S. uberis 
virulence-associated genes, they are highly likely to be present in all S. uberis isolates 
including isolates associated with cows with low cell counts or GCC ST86.   Indeed, 
an earlier study reported a 100% prevalence of the SUAM gene in the global S. uberis 
population (Luther et al., 2007) which supports this hypothesis, and further reduces 
the likelihood that these genes are associated with S. uberis strain-specific virulence. 
 
The second grouping comprised T3-02, T3-06, T4-06, T4-25, T4-15 ORF1 and 
T4-19 ORF1 sequences and the virulence-associated gene (hasA).  There was a 
statistically significant (P < 0.05) link between the distributions of each of these DNA 
sequences and disease status and / or GCC type.  Of these, T3-02 (putative 
acyl-CoA synthetase), T4-06 (phosphotransferase system mannose / fructose / 
N-acetylgalactosamine-specific component IIC), T4-25 (ribos5-phosphate isomerase 
RpiB and tagatose-6-phosphate kinase) and T4-15 ORF1 (acetyltransferase GNAT 
Chapter 6. S. uberis virulence factors 
 
 
208 
family) exhibited high protein sequence identity with housekeeping genes and were 
not thought to represent putative virulence factors of S. uberis. 
 
The results obtained following hasA analysis are in agreement with earlier studies 
which reported the linkage between hasA and disease status (Coffey et al., 2006; 
Pullinger et al., 2006; Tomita et al., 2008).  The T3-06 sequence (collagen-like 
surface protein) was thought to be a surface protein and like hasA, there was a 
statistically significant link between the occurrence of this tester-specific sequence 
and both disease status and GCC type. 
 
Virulence-associated genes are often found in regions flanking prophage, 
transposon and insertion sequences.  For instance, the hyaluronidase gene and the 
pyrogenic exotoxins SpeA; SpeC; SpeH; SpeI; SpeK; SpeL; SpeM and SSA have 
been identified in a number of phage genomes (Bisno, 2003; Canchaya et al., 2002).  
By analogy, T4-19 ORF1, which was demonstrated to encode a mobile genetic 
element, could also be associated with S. uberis pathogenesis.  
 
As T3-02, T4-06, T4-25 and T4-15 ORF1 sequences exhibited extensive protein 
sequence indentity to genes involved in carbohydrate and lipid metabolism.  The 
statistically significant link (P < 0.05) between the distributions of these DNA 
sequences and disease status and / or types of GCC, could indicate their essential 
role in the growth or survival of S. uberis in diverse environments rather than their 
possible roles as virulence factors. 
 
Of interest, T3-02 ORF1 contained several conserved domains characteristic of 
enzymes involved in the synthesis of acetoacyl-CoA (CaiC, 
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COG0318;(Marchler-Bauer et al., 2005), however, BLASTP analysis of T3-02 ORF1 
gave the highest match with a putative acyl-CoA synthetase in Carnobacterium sp. 
(Table  6-4) and the second highest match with a long-chain fatty acid-CoA ligase from 
S. aureus.  There were no significant matches with any Streptococcus spp. (data not 
shown).  As T3-02 ORF1 exhibited higher amino acid identity with genes from 
S. aureus and Bacillus spp., than with Streptococcus spp., these results strongly 
suggest that T3-02 ORF1 may have been acquired by horizontal gene transfer from 
distantly related species rather than closely related Streptococcus spp. such as 
S. agalactiae or S. pyogenes. 
 
The third category comprised T1-15 (reticulocyte binding protein), T1-16 
(transcriptional regulator Cro/ CI family), T4-16 (hypothetical protein), T4-18 
(hypothetical protein), T4-01 ORF1 (bacteriophage related protein) and T4-17 ORF2 
(alpha-like protein 1) sequences with low prevalence (<25%) in the 40 Australian 
isolates.  Although these sequences may represent strain-specific virulence, their 
low prevalence, and lack of any statistically significant linkage with disease status or 
GCC type, makes them unlikely candidates for S. uberis virulence-associated factors.  
 
There were some exceptions to this broad categorization, such as those 
encountered with both T4-17 ORF1 (IS1193 transposase) and CAMP factor gene.  
These were present in isolates regardless of disease status or GCC type.  However 
unlike other tester-specific sequences, the prevalence of T4-17 ORF1 sequences in 
isolates associated with cows with low cell counts was higher than the prevalence in 
isolates associated with clinical / subclinical mastitis. 
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In addition, the CAMP factor gene was present in the driver strain 3217-2 which 
was an isolate from a cow with a low cell count (Tomita et al., 2008).  These findings 
strongly suggest that neither T4-17 ORF1 nor the CAMP factor genes are likely to be 
significant S. uberis virulence-associated factors. 
 
6.4.3 ORFs encoding putative collagen-like surface protein identified in 
S. uberis 
Two types of ORFs encoding putative collagen-like surface protein were identified 
in the sequences of T3-06 and T2-01 ORF1.  The collagen-like surface protein 
encoded by T3-06 ORF1 was more closely related to a homologue encoding 
collagen-like surface protein from S. agalactiae whereas the T2-01 ORF1 was more 
closely related to one from S. pyogenes (Table  6-5).  In addition, BLASTN analysis of 
T2-01 ORF1 sequence demonstrated high nucleotide sequence identity (91%) with a 
homologue in the S. uberis strain 0140J genome sequence whereas T3-06 sequence 
exhibited only 55% nucleotide sequence identity with the reference genome sequence.  
In fact, BLASTN analyses of both T3-06 and T2-01 ORF1 sequences against the 
S. uberis genome sequence demonstrated homology with only a single sequence of 
the reference genome sequence (Nucleotide positions 1066469 to 1067923) 
suggesting only one type of the homologue present in the genome of S. uberis strain 
0140J.  The flanking regions of the homologue in both the clone T2-01 and the 
reference S. uberis strain 0140J encoded a CobB/CobQ-like glutamine 
amidotransferase.  This result strongly suggests that these homologues encoding 
collagen-like surface protein are located in the same region of the S. uberis genome 
and most likely represent alleles of collagen-like surface protein gene. 
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Collagen proteins contain domains of repeated Gly-X-Y motifs that form a 
characteristic triple-helical structure (Xu et al., 2002).  The number and arrangement 
of the motifs between T2-01 ORF1 and T3-06 also differed.  Specifically, T2-01 
ORF1 contained 21 continuous motifs whereas the clone T3-06 encoded nine types of 
continuous Gly-X-Y motifs (Table  6-10).  In addition, the individual types of Gly-X-Y 
motifs were substantially different, with only three of the 22 types of Gly-X-Y motifs 
present in both T2-01 ORF1 and T3-06 (Table  6-11), which further supports the 
occurrence of at least two different types of collagen-like surface protein genes in the 
S. uberis tester strain 2893-1. 
 
Of particular importance was, the high prevalence of putative collagen-like surface 
proteins identified in the tester-specific clone libraries.  An additional clone (T4-08) 
was a duplicate of T2-01.  Therefore in three (15%) of the 20 clones randomly 
chosen from the tester-specific libraries were related to collagen-like surface proteins.  
The high prevalence of these sequences could reflect the importance of this family of 
proteins in S. uberis pathogenesis.  This hypothesis was further supported by the 
observation that there was a statistically significant link (P = 0.008) between the 
occurrence of the T3-06 sequence in isolates from clinical / subclinical mastitis 
whereas there was no association with isolates obtained from cows with low somatic 
cell counts (Table  6-8).   
 
Collagen-like surface proteins have been identified and recognized as a virulence 
factors in a range of Gram positive bacteria including S. aureus (Visai et al., 2000), 
S. pyogenes (Rasmussen et al., 2000; Visai et al., 1995), S. agalactiae (Tettelin et al., 
2005), S. equi (Karlstrom et al., 2006; Lannergard et al., 2003), E. faecalis (Rich et al., 
1999; Rozdzinski et al., 2001) and E. faecium (Nallapareddy et al., 2003).  
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Specifically, the collagen-binding protein CNA from S. aureus has been shown to be 
necessary for bacterial adherence to cartilage and demonstrated to be a proven 
virulence factor in septic arthritis (Visai et al., 2000).  The involvement of a 
collagen-like surface protein in the adherence and internalization of S. pyogenes has 
also been suggested (Caswell et al., 2007).  In addition, it has been hypothesized 
that collagen binding by Streptococcus spp. may not only initiate infections of collagen 
containing tissues but also interfere with tissue regeneration (Hung et al., 2002).  For 
instance, it has been suggested that a S. pyogenes prophage collagen-like protein 
induces antibodies which may cross-react with collagen in tissue and result in 
polyarthritis (Hynes et al., 1995). 
 
Several recognized virulence factors of S. pyogenes such as the M1 protein, a 
collagen-like surface protein was up-regulated during growth of S. pyogenes in 
hyaluronic acid (HA) enriched media (Zhang et al., 2007).  Accordingly, it is possible 
that collagen-like surface proteins in S. uberis could be involved in enhanced 
adherence to the host cell in the presence of host tissue such as HA and collagen.  
This on-going hypothesis is supported by earlier studies which have demonstrated 
that incubation of S. uberis with extracellular matrix proteins, particularly collagen, 
increased adherence and internalization in mammary epithelial cells (Almeida et al., 
1999; Almeida and Oliver, 2001).  In addition, it has been demonstrated that 
S. uberis expresses a collagen up-regulated ligand which increases adherence 
between the bacterium and host cell by direct interaction with host cell receptor(s) 
(Almeida and Oliver, 2001).  However, the exact role of collagen-like proteins in the 
pathogenesis of S. uberis remains to be elucidated. 
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The acquisition of the collagen-like surface protein gene in S. pyogenes is 
considered most likely to have occurred via horizontal gene transfer, as identical 
alleles have been found in different serotypes of S. pyogenes, indicative of very 
recent horizontal gene transfer (Lukomski et al., 2000).  In addition, the 
fibronectin-collagen-T antigen region in S. pyogenes, which contains genes encoding 
the fibronectin-binding protein SfbI and/or protein F2, a collagen binding protein (Cpa), 
and the T antigen, exhibit a complex gene arrangement which is indicative of a zone 
of frequent genetic rearrangement (Bessen and Kalia, 2002; Towers et al., 2003).   
 
As in S. pyogenes, sequence analysis of T3-06 and T2-01 OFR1 exhibited the 
highest protein sequence identity with collagen-like surface protein homologues in 
other Streptococcus spp. (Table  6-4 and Table  6-5).  These results strongly suggest 
that the acquisition of these sequences most likely occurred via horizontal gene 
transfer.  
 
6.4.4 Mobile genetic element bacteriophage / transposon 
Evidence of substantial recombination in S. uberis, which could be due to 
transduction by bacteriophage (Hill and Brady, 1989), has been suggested in previous 
studies (Coffey et al., 2006; Pullinger et al., 2006; Tomita et al., 2008; Zadoks et al., 
2005a).   
 
The presence of bacteriophages in S. uberis has been demonstrated in previous 
studies.  A lysogeny-based study demonstrated that 38 of 98 strains of S. uberis 
carried a lysogenic phage (Hill and Brady, 1989), and a recent study isolated a 
prophage from a S. uberis strain (ATCC 700407) following exposure to mitomycin C.  
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Partial sequencing of the phage DNA demonstrated sequence similarity to other 
streptococcal phage lysins (Celia et al., 2007). 
 
In this present study, nucleotide sequence determination of tester-specific 
sequences also identified the occurrence of genetic mobile elements including 
bacteriophages and transposons in four clones from the tester specific clone libraries. 
 
Virulence-associated genes are often found in regions flanking prophage, 
transposon and insertion sequences (Bisno, 2003; Canchaya et al., 2002).  The 
sequence of T4-17 ORF1 exhibited greatest amino acid sequence identity with 
transposase IS1193 found in S. thermophilus strain.  The flanking region of T4-17 
ORF1 comprised T4-17 ORF2 encoding a S. agalactiae alpha-like protein 1 
homologue, which is a member of the family of surface proteins, that contain long 
tandem repeats, including the Rib, Alp2 and Alp3 proteins in S. agalactiae (Bolduc et 
al., 2002).  Alpha-like proteins confer protective immunity against S. agalactiae 
(Stalhammar-Carlemalm et al., 1993) and are involved in the internalization of this 
pathogen in human epithelial cells (Bolduc et al., 2002).  Accordingly, the alpha-like 
protein encoded by T4-17 ORF2 could be involved in the pathogenesis of S. uberis.  
However, given that the prevalence of the T4-17 ORF2 in the 40 Australian S. uberis 
isolates was low (20%), it is unlikely to be an important virulence factor. 
 
6.4.5 Transposase-like genes 
The transposase-like genes encoded by T4-19 ORF1 and ORF2 exhibited high 
amino acid sequence identity with the putative transposases OrfB (98%) and OrfA 
(92%) encoded by the insertion sequence ISSag2 in S. agalactiae (Table  6-4)(Figure 
 6-11) (Franken et al., 2001).   
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A search of the Conserved Domain Database at NCBI (Marchler-Bauer et al., 
2005) showed that both the S. uberis T4-19 ORF2 and the S. agalactiae ISSag2 
putative transposase OrfA contained several conserved domains, including the 
domain pfam01527, characteristic of the Transposase 8 family.  This family consists 
of various E. coli insertion elements and other bacterial transposases, some of which 
are members of the IS3 family (Marchler-Bauer et al., 2005).  Furthermore, the 
orientation of the two putative S. uberis transposase genes T4-19 ORF1 and T4-19 
ORF2 were identical to that observed in the S. agalactiae strain O90R encoded OrfB 
and OrfA respectively (Figure  6-12).  Taken together, these results strongly suggest 
that the S. uberis T4-19 represents part of an insertion sequence most likely acquired 
via horizontal gene transfer from other Streptococcus spp. (Franken et al., 2001). 
 
The flanking regions of the S. agalactiae strain O90R transposase ISSag2 
comprise the scpB and lmb genes which encode the C5a peptidase and laminin 
binding protein (lmb) respectively (Franken et al., 2001).  The C5a-peptidase, initially 
identified in S. pyogenes, cleaves the chemotactic complement component C5a 
(Chen and Cleary, 1990) and the lmb involved in the binding of S. pyogenes to human 
laminin (Spellerberg et al., 1999).  The C5a peptidase is present in a wide range of 
beta-haemolytic streptococci and is thought to have been acquired by horizontal gene 
transfer (Cleary et al., 1992; Chmouryguina et al., 1996).  The C5a peptidase gene is 
present in all human isolates of S. agalactiae whereas only 40% of the animal isolates 
possess this gene (Franken et al., 2001).  Given the similarity between the putative 
S. uberis T4-19 transposase and the S. agalactiae strain O90R ISSag2 transposase, 
it is postulated that S. uberis isolates containing T4-19-like sequences may also 
possess C5a-peptidase. 
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However, the dot blot analysis and the PCR analysis failed to identify the presence 
of C5a peptidase-related sequences in the Australian S. uberis isolates tested.  
Specifically, it has been demonstrated that S. agalactiae strains of bovine origin that 
harbor only a single copy of ISSag2 do not contain the flanking genes, scpB 
(encoding C5a peptidase) and lmb (Franken et al., 2001).  In particular, only 
S. agalactiae strains of bovine origin that contain multiple copies of the ISSag2 
insertion sequence concomitantly encode either the C5a peptidase or lmb flanking 
genes (Franken et al., 2001).  Accordingly the negative C5a peptidase-specific PCR 
and dot blot results were to be expected given that Southern blot analysis using a 
T4-19 “whole insert” probe suggested the occurrence of only a single copy of a T4-19 
transposase-like sequence in the Australian isolates (Figure  6-8).  Nevertheless, 
despite being a transposase homologue, the T4-19 ORF1 sequence was not only 
linked with clinical / subclinical mastitis (P = 0.085) but also highly associated with 
GCC type ST5/143 (P = 0.001) (Table  6-8 and Table  6-9) and as such may represent 
a useful virulence marker. 
 
6.4.6 Other potential S. uberis virulence determinants 
Other potential S. uberis virulence determinants have been proposed such as the 
M protein in S. pyogenes (Lancefield, 1962) or the M-like protein in other streptococci 
(Nicholson et al., 2000) which are involved in anti-phagocytosis (Perez-Casal et al., 
1995). The C-terminal region of the M protein region is highly conserved among 
streptococci (Nicholson et al., 2000).  However, to date, no M protein homologue has 
been identified in S. uberis.  In this study, the tester-specific sequence T2-01 ORF1 
was demonstrated to encode a collagen-like surface protein with high amino acid 
sequence identity with the C-terminal region of the M protein from S. pyogenes.  
However, given the ubiquitous occurrence of the M protein LPXTG motifs in many 
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other surface proteins, it is as yet unknown as to whether T2-01 ORF1 represents a 
true M protein homologue. 
 
6.4.7 Conclusions 
Subtractive hybridization facilitated the identification and characterization of two 
sequences, T3-06 and T4-19 ORF1 that were highly associated with clinical / 
subclinical mastitis.  Although additional research will be required, it is hypothesized 
that the collagen-like surface protein identified in the tester-specific clone T3-06 may 
represent a new S. uberis virulence factor.   
 
The T4-19 transposase-like gene, whilst unlikely to represent a virulence factor, 
may still prove to be a useful S. uberis virulence marker.  In addition to the T4-19 
transposase-like gene, three additional clones (T1-16; T4-01 and T4-17) related to 
known bacteriophage and transposon sequences were identified in this study.  The 
occurrence of such bacteriophage, transposon and transposase-like sequences are 
indicative of their possible role in horizontal gene transfer and account for the 
substantial recombination observed in the S. uberis population. 
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7 Chapter 7 General Discussion 
Reliable species identification methodologies are pivotal for the determination of 
clinically relevant isolates and for the design and execution of any epidemiological 
study.  For example, the inadvertent inclusion of closely related species by the use of 
some species identification methodologies adversely impacts on the reliability and 
credibility of any epidemiological study undertaken. 
 
Earlier S. uberis epidemiological studies utilized species-specific 16S and 23S 
rRNA gene PCRs (Hassan et al., 2001) for primary identification following aesculin and 
hippurate hydrolysis (Coffey et al., 2006; Field et al., 2003; Pullinger et al., 2006; 
Zadoks et al., 2005a).  However, 16S rRNA sequence analyses for S. uberis 
(Pullinger et al., 2006) in the present study demonstrated that the 16S and 23S rRNA 
gene PCRs (Hassan et al., 2001) could not differentiate S. uberis from S. iniae-like and 
S. pseudoporcinus-like isolates.  Accordingly, in addition to 16S and 23S rRNA gene 
PCRs (Hassan et al., 2001), 16S rRNA sequence analyses (Pullinger et al., 2006) was 
utilized for confirmation of species identification of the Australian S. uberis isolates 
used in this study.  Alternatively, PauA gene PCR (Zadoks et al., 2005a) could be 
used for rapid species identification since pauA is S. uberis species-specific and 
absent in other Streptococcus spp. or other bacteria commonly associated with 
bovine mastitis (Ward and Leigh, 2004). 
 
Prior to the adoption of 16S rRNA gene sequence analysis for species identification 
confirmation for S. uberis (Pullinger et al., 2006), it is highly likely that additional 
Streptococcus spp. that were closely related to S. uberis were included in previous 
S. uberis epidemiological studies (Baseggio et al., 1997; Douglas et al., 2000; 
Gillespie et al., 1998; Jayarao et al., 1991c; Jayarao et al., 1993; Khan et al., 2003; 
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Phuektes et al., 2001b).  The implications of this would undoubtedly adversely 
impact on the integrity of the results. 
 
Since its recognition as an important cause of mastitis worldwide in the 1980s, 
numerous S. uberis PFGE-based epidemiological studies have been conducted 
(Baseggio et al., 1997; Douglas et al., 2000; Gillespie et al., 1998; McDougall et al., 
2004; Phuektes et al., 2001b; Wang et al., 1999).  These studies have demonstrated 
that a genetically diverse population of S. uberis exists worldwide and this hypothesis 
has been further corroborated by the PFGE results in the present study (D = 99.5%; 
95% CI, 97.8% to 100%) (Tomita et al., 2008). 
 
However, based solely on PFGE results, there is limited evidence with regards to 
the relatedness of S. uberis isolates from different herds or the identification of 
possible hypervirulent S. uberis strains (Baseggio et al., 1997; Douglas et al., 2000; 
Gillespie et al., 1998; McDougall et al., 2004; Phuektes et al., 2001b; Wang et al., 
1999).  This lack of evidence can be attributed to the somewhat ambiguous gel 
banding patterns generated by PFGE and also to the inherent difficulties associated 
with the inter-laboratory comparison of PFGE-based epidemiological studies. 
 
In particular, PFGE may not be suitable for the accurate phylogenetic analysis of 
S. uberis due to substantial recombination (Coffey et al., 2006; Tomita et al., 2008; 
Zadoks et al., 2005a).  Although the high discriminatory power of PFGE analysis has 
been useful for the identification of S. uberis at a subspecies level, it has since been 
superseded by MLST analysis for detailed phylogenetic and epidemiological studies 
(Coffey et al., 2006; Pullinger et al., 2007; Pullinger et al., 2006). 
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Accordingly, a MLST assay (Coffey et al., 2006) was utilized for the 
characterization of the Australian S. uberis isolates since its unambiguous results and 
the availability of a web-based reference database greatly facilitates inter-laboratory 
comparisons for the study of global epidemiology (Feil and Enright, 2004) and for the 
possible identification of hyper-virulent strains of S. uberis (Coffey et al., 2006; 
Pullinger et al., 2007; Pullinger et al., 2006; Tomita et al., 2008). 
 
In earlier epidemiological studies it has been hypothesized that the cow’s 
environment, including soil and faeces, could act as a reservoir of S. uberis (Zadoks 
et al., 2003; Zadoks et al., 2005a).  Specifically, a 16S ribotyping study has 
demonstrated that the distribution of ribotypes does not differ significantly between 
environmental, fecal and milk samples (Zadoks et al., 2005b) suggesting a constant 
circulation of S. uberis within a herd environment. 
 
The results obtained following 16S ribotyping (Zadoks et al., 2005b) have been 
further supported by a recent MLST study which demonstrated that milk samples 
harbour a similar population of S. uberis clonal complexes as observed in the cow’s 
environment (Pullinger et al., 2006).  This hypothesis has been corroborated by the 
findings in the present study where one of the STs (ST184) identified in an 
environmental sample in the earlier study (Pullinger et al., 2006) was also identified in 
one Australian isolate from milk (Tomita et al., 2008).  This finding further supports 
the hypothesis that the cow’s environment could act as a S. uberis reservoir (Zadoks 
et al., 2003; Zadoks et al., 2005a). 
 
In the present study, detailed phylogenetic analyses following MLST of the 
Australian isolates clearly identified lineages highly-associated with clinical or 
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subclinical mastitis (GCC ST5 and GCC ST143) and a ST lineage highly-associated 
with cows with low somatic cell counts (GCC ST86).  Specifically, S. uberis STs 
belonging to GCC ST5 or 143 may represent hyper-virulent STs.  These findings 
further support earlier hypotheses with regard to the possible occurrence of 
hyper-virulent S. uberis lineages (Coffey et al., 2006; Pullinger et al., 2007; Pullinger 
et al., 2006; Tomita et al., 2008; Wang et al., 1999). 
 
The MLST results present in the present study will facilitate inter-laboratory 
comparison in the S. uberis MLST database on the Internet for future global 
epidemiological studies and will significantly aid the identification, characterization, 
elimination and possible vaccination against highly virulent S. uberis STs. 
 
MLST analyses demonstrated substantial recombination in the Australian isolates 
(Tomita et al., 2008) and these findings are in agreement with previous studies 
(Coffey et al., 2006; Zadoks et al., 2005a).  Evidence of substantial recombination in 
the global S. uberis population was further supported by results obtained following 
subtractive hybridization analysis, which identified mobile genetic elements in the 
S. uberis tester-specific clone libraries.  Specifically, the identification and 
characterization of bacteriophage (T4-01; T4-17 ORF1) and transposase-like 
sequences (T4-19 ORF1 and ORF2) in the S. uberis genomic DNA is indicative of 
their possible role in horizontal gene transfer and could account for the substantial 
recombination observed in the S. uberis population both in this study and in previous 
studies (Coffey et al., 2006; Tomita et al., 2008; Zadoks et al., 2005a). 
 
An alternative explanation arises from the observation that closely related 
Streptococcus spp. were identified in milk samples following biochemical testing, 
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species-specific PCRs (Hassan et al., 2001) and 16S rRNA gene sequence analysis 
(Pullinger et al., 2006).  The occurrence of such closely related Streptococcus spp. 
could result in the acquisition by S. uberis of possible virulence factors such as the 
transposase-like (T4-19) and the collagen-like surface protein (T3-06) sequences via 
horizontal gene transfer or homologus recombination (Zadoks et al., 2005a). 
 
Of the putative S. uberis virulence factors, PauA, SUAM and GapC have been 
selected and tested as vaccine candidates (Almeida et al., 2006; Fontaine et al., 
2002; Leigh, 1999; Leigh et al., 1999).  In particular, a candidate vaccine consisting 
of the S. uberis plasminogen activator, PauA, protected 37.5–62.5% of cows from 
clinical disease following experimental challenge but is not commercially available 
(Leigh, 1999; Leigh et al., 1999). 
 
In the context of the present study, the distribution of the PauA and SUAM genes in 
the Australian isolates appeared not to be associated with clinical / subclinical 
mastitis.  Nevertheless, these genes were present in all of the isolates in this study 
and could still represent possible vaccine candidates.  However, the results of the 
present study strongly suggest that neither PauA nor SUAM are directly involved in 
the pathogenicity of S. uberis. 
 
In the present study, subtractive hybridization facilitated the identification and 
characterization of two additional putative S. uberis virulence factors.  Specifically, 
both the transposase-like (T4-19) and the collagen-like surface protein (T3-06) 
sequences were highly associated with clinical / subclinical mastitis.  In the case of 
the T4-19 transposase-like sequence, this sequence is unlikely to represent a 
virulence factor.  However, the flanking regions of such mobile genetic elements 
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(Bisno, 2003; Canchaya et al., 2002) are often associated with virulence factor genes 
such as in the case of the C5a peptidase virulence factor in S. agalactiae (Tettelin et 
al., 2005).  Accordingly, by analogy, a S. uberis virulence factor could occur in the 
flanking regions of the T4-19 transposase-like sequence.   
 
The tester-specific sequences (T3-06, T2-01, T4-08) encoding the collagen-like 
surface protein are highly likely to represent a “new” S. uberis virulence factor.  Such 
collagen-like surface proteins have been identified and characterized as virulence 
factors in other Streptococcus spp. (Karlstrom et al., 2006; Lannergard et al., 2003; 
Nallapareddy et al., 2003; Rasmussen et al., 2000; Rich et al., 1999; Rozdzinski et al., 
2001; Tettelin et al., 2005; Visai et al., 1995; Visai et al., 2000).  In the present study 
these sequences were also highly-associated with cases of clinical and subclinical 
mastitis in the Australian S. uberis isolates.  In addition, the high prevalence (15%) of 
these sequences in the tester-specific clone libraries further supports the hypothesis 
that this collagen-like surface protein could represent a new S. uberis virulence factor 
and future vaccine candidate. 
 
In conclusion, the results of MLST analysis using a unique, well defined and 
clinically relevant Australian S. uberis isolates and inter-laboratory comparison of the 
S. uberis MLST profiles clearly identified lineages of S. uberis highly associated with 
clinical and subclinical mastitis.  These results strongly support the hypothesis that 
specific S. uberis STs are highly associated with mastitis. 
 
In addition, results obtained following subtractive hybridization clearly identified 
sequences highly associated with clinical and subclinical mastitis.  The T4-19 
transposase-like sequence is unlikely to represent a virulence factor.  However, by 
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analogy with homologous transposase sequences in S. agalactiae, T4-19 could 
nevertheless be linked to an as yet uncharacterized S. uberis virulence factor 
encoded by regions flanking the transposase sequence in the genome of S. uberis. 
 
Of particular significance, the collagen-like surface protein encoded by T3-06 
exhibited a high association with cases of clinical mastitis in the Australian isolates.  
Collagen-like surface proteins have been characterized as virulence factors in others 
Streptococcus spp. and accordingly the T3-06 encoded collagen-like surface protein 
could represent a new S. uberis virulence factor and future vaccine candidate for the 
control of mastitis. 
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